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ABSTRACT
y-aminobutyric acid (GABA) and acetylcholine (ACh) aie important regulators of 
hippocampal function. The hippocampus is governed by a diverse population of 
GABAergic local circuit neurones (interneurones) and moreover, receives a dual 
cholinergic and GABAergic input from the medial septal nucleus (MSN). This 
thesis describes electrophysiological, pharmacological and neuroanatomical 
approaches in rodent brain slice preparations to investigate the interaction between 
these cholinergic and GABAergic systems of the mammalian hippocampus.
Intracellular and patch clamp recordings were made from hippocampal pyi'amidal 
neurones in hippocampal and septo-hippocampal slice preparations. In the 
presence of ionotrophic glutamate and G ABA receptor antagonists, electrical 
stimulation of afferent fibres within either the stratum oriens or MSN evoked an 
isolated slow excitatory postsynaptic potential (EPSP), with mean peak 
amplitudes of 6.109±0.54mV and 8.975±1.123mV and peak latencies of 
10.14+2.743s and 10.264+0.95s respectively, in CAl pyramidal neurones. These 
evoked slow depolarising synaptic responses were suppressed by the selective 
muscarinic acetylcholine receptor (mAChR) antagonist atropine (5|aM) suggesting 
that they were mediated via activation of mAChRs.
In order to investigate whether GABAergic interneurones of the hippocampus are 
modulated by this cholinergic input, similar experiments were carried out in which
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whole-cell current clamp recordings were made from hippocampal intemeurones 
located within the stratum oriens and stratum radiatum of area CAl. In total, 42 
out of 59 hippocampal interneurones responded to electrical stimulation within the 
stratum oriens with a general slow depolarisation of mean peak amplitude and 
peak latency of 7.091±0.521mV and 16.29+0.983s respectively. However, the 
underlying waveform of these slow depolarisations differed subtly and could be 
broadly classed as: L A  slow depolarisation (n-20), similar to that seen in the 
pyi'amidal neurones (mean peak amplitude 8.207+0.852mV and peak latency 
15.99+1.459s). 2. A “blphasic response” (n=10) where an initial fast 
hyerpolarisation (-9.011+1.646mV, 1.565+0.2076s) preceded a slower
depolarisation (6.288+1.042mV, 19.14+1.954s). 3. A “fast plateau response” 
(n=IO) where an initial fast depolarisation (9.841+1.175mV, 1.025+0.189s) 
merged with a slower depolarisation (9.076+0.878mV, 15.28+1.738s) and 4. an 
“oscillatory response” (n=2) where the membrane potential oscillated at a 
frequency of l-2Hz. Pharmacological analysis showed that all types of evoked 
EPSPs in interneurones were sensitive to application of atropine (5|uM, n=12) and 
thus were mediated via activation of inAChRs. A minority of interneurones (17 of 
59) did not respond to electrical stimulation within the stratum oriens at all. This 
group was further investigated by bath application of the cholinergic agonist 
carbachol (lOjaM) in an attempt to phaimacologically activate mAChRs. Although 
some of these cells responded with a slow depolarisation (7 of 17) or an 
oscillatory response (2 of 17) a proportion of these cells remained entirely 
unresponsive (8 of 17) suggesting that a subpopulation of interneurones are
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insensitive to cholinergic modulation, at least with respect to membrane 
depolarisation. Post-hoc neuroanatomical analysis of recorded cells revealed the 
majority of the interneurones in this study had a cell body location in either the 
stratum oriens or stratum radiatum. Stratum radiatum interneurones generally had 
a stellate-like appearance with dendrites radiating within the dendritic layer of the 
stratum radiatum and the stratum lacunosum moleculare (n=24). In contrast all 
stratum oriens cells were bipolar and displayed dendrites, which extended in a 
horizontal axis parallel with the stratum oriens (n=24). The recovery of axonal 
processes was generally insufficient for full identification of the cells in terms of 
efferent output selectivity. However, taken overall there was no apparent 
correlation between the location or dendritic morphology of individual 
interneurones and the nature of the cholinergic response evoked.
Further extracellular and patch clamp recordings were conducted to investigate the 
neui'omodulatory role of nicotinic acetylcholine receptors (iiACliR) within the 
hippocampus. Field excitatory postsynaptic potentials (fEPSPs) were recorded in 
both the CAl and CA3 regions in response to stimulation of Schaffer-collateral 
and mossy fibre afferents respectively. The selective nAChR agonist, 1,1- 
dimethyl-4-phenyl-piperazinium iodine (DMPP, 30pM) resulted in a significant 
increase (30.84+5.98%, n=8, P=0.0078) in the fEPSP slope and amplitude at the 
mossy fibre-to-CA3 synapse but not at the Schaffer collateral-to-CAI synapse (- 
16.99+7.04%, n=5, P=0.I25). These data suggest that activation of iiAChRs have 
a potentiating effect on glutamate transmission at the mossy fibre-to-CA3 synapse 
but not the Schaffer collateral-to-CAl synapse.
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In order to assess whether DMPP was acting pre- or postsynaptically, whole-cell 
voltage clamp recordings were performed in the presence of the voltage dependent 
Na"^  channel blocker tetrodotoxin (TTX, IjaM) in order to record miniature 
spontaneous EPSCs (mEPSCs). 30pM DMPP increased the frequency of mEPSCs 
from 0.24±0.08Hz to 0.78+0.13Hz (n~4, P=0.0326) but had no significant effect 
on amplitude (I5.35±3.07pA to 12.06+1.5pA n=4, P=0.0473) of mEPSPs 
recorded in CA3 pyramidal neurones indicating a presynaptic locus of the nAChR 
responsible.
DMPP was also shown to increase the frequency of spontaneous IPSPs onto CAl 
interneurones from 7.48+1.93Hz to 13.05+2.8Hz (n=6, P=0.0403) with no 
significant effect overall on amplitude (20.42±2.47pA to 23.41+3.04pA, n=6, 
P=0.0836) thus indicating a potentiation of GAB A release within the CAl region. 
This increase in frequency was TTX sensitive and therefore is likely to represent 
an action potential dependent effect, indicating a postsynaptic locus for the 
nAChR-mediated effect. In a proportion of CAl interneurones (8 of 14) an inward 
current (mean amplitude 89.88±26.2pA) was recorded on application of DMPP, 
which was insensitive to TTX, indicating a direct activation of nAChRs on CAl 
interneurones.
In conclusion it seems that the cholinergic modulation of the hippocampus is 
complex, with mAChR activation exciting pyramidal neurones and certain
V
interneurones whilst inhibiting other interneurones and suppressing glutamatergic 
transmission. Conversely, activation of nAChRs entranced glutamate release at 
some synapses whilst exciting (inward current) certain interneurones.
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1. INTRODUCTION
I .I .G e n e r a l  I n t r o d u c t io n
Neurones are the building blocks of the central and peripheral nervous systems 
(CNS & PNS). In order for the nervous system to funetion effectively neurones 
must be able to communicate. Neurones communicate with each other at 
specialised junctions known as synapses where signalling takes place through 
chemical or direct electrical transmission in a process known as synaptic 
transmission. Signals transmitted from one neurone (presynaptic neurone) can lead 
to excitation or inhibition in the target neurone (postsynaptic neurone) through the 
modulation of a plethora of ion channels. Whether a neurone exerts an inliibitory 
or excitatory effect on the postsynaptic neurone depends on the nature of the 
neurotransmitter released from its terminal (presynaptic terminal) as well as the 
postsynaptic receptors present on the target cell.
The process of synaptic transmission between individual neurones is subject to 
modulation by other neurotransmitter systems by both pre- and postsynaptic 
mechanisms. This thesis aims to deal with the cholinergic modulation of synaptic 
transmission within the mammalian hippocampus, in particular the cholinergic 
modulation of GABAergic transmission. This introductory chapter will therefore 
serve to provide a brief overview of all relevant neurotransmitter systems. It will 
also introduce the hippocampus, summarising the major architecture, cell types
and cholinergic input, in addition to providing a detailed review of the present 
literature on the cholinergic modulation of hippocampal systems.
1.2. T h e  c h o l i n e r g i c  s y s t e m
1.2.1. Acetylcholine
Acetylcholine was first described back in 1906 (Hunt & Taveau, 1906) and was 
the first substance shown to be a neurotransmitter (Dale, 1934; Dale et a l, 1936; 
Dale, 1938). Chemically it is composed of choline and an acetyl group, 
synthesised in the axon terminal by the enzyme choline acetyltransferase (ChAT) 
where it is subsequently taken up into vesicles for storage and release. It is 
released from presynaptic terminals to act on postsynaptic acetylcholine receptors 
generating an excitatory postsynaptic response that can be detected as excitatory 
voltage (EPSP) or current deflections (EPSC). The response is terminated when 
acetylcholine is broken down by the enzymes acetylcholinesterase (AChE) and 
butyrylcholinesterase (BuChE) back to choline and acetate.
1.2.2. Cholinergic receptors
Receptors for acetylcholine were originally classified by Dale (1914; 1938) as 
either nicotinic or muscarinic due to the separate actions of the plant alkaloids 
nicotine and muscarine. Each class of receptor is structurally and functionally 
distinct. Nicotinic acetylcholine receptors (nAChRs) belong to the superfamily of 
ligand-gated ion chaimel (ionotrophic) receptors, whereas muscarinic
acetylcholine receptors (mAChRs) are members of the guanine nucleotide-binding 
protein (G-protein) coupled (metabotrophic) receptor family.
1.2.2.1. Nicotinic acetylcholine receptors
iiAChRs are the archetypal ligand-gated ion channel discovered over 90 years ago 
(Langley, 1907). They have since been subject to intense study and as a result 
have been purified, cloned and sequenced to elucidate their structure and function. 
iiACliRs are present at both peripheral (neuromuscular junction and autonomic 
ganglia) and central synapses. In the periphery nAChRs modulate fast excitatory 
synaptic transmission at both the neuromuscular junction and autonomic ganglia 
whereas as in the CNS nAChR have been implicated in a more long-lasting 
neuromodulatory role in addition to their role in fast excitatory synaptic 
transmission (Womiacott, 1997). nAChRs can now be further classified into three 
subfamilies (Clementi et a/., 2000a):
1 ) Muscle nAChR (neuromuscular j unction).
2) Neuronal nAChR- a-Bungarotoxin sensitive (CNS).
3) Neuronal nAChR- a-Bungarotoxin insensitive (autonomic ganglia and 
CNS).
All members of the ligand-gated ion channel superfamily are believed to have a 
pentameric architecture and nAChRs are no exception (Cooper et a l, 1991; 
Unwin, 1995). Each receptor is made up of 5 separate subunits arranged within the 
plasma membrane to form a central aqueous cation channel (Unwin, 1995).
Agonist binding induces a conformational change, which leads to the direct 
opening of the ion channel and resultant ion (K'*' and Na"^ ) flux. Selective agonists 
for nAChRs include nicotine and DMPP with classical antagonists including the 
competitive antagonist tubocurarine known since Langley’s original studies 
(1907) and the non-competitive antagonist mecamylamine.
Although most early work on the structure was conducted on the muscle, nACliR 
attention has now turned towards the neuronal types. Seventeen nAChRs subunit 
genes have now been cloned (Boulter et al,  1986; Boulter et al,  1987; Nef et al, 
1988; Couturier et al,  1990a; Couturier et al, 1990b; McGehee & Role, 1995; 
Sharpies & Wonnacott, 2001). These genes encode for the seventeen nAChR 
subunits, al-10, pl-4, y, ô and s, with two a l ,  one pi, Ô and y or s making up the 
foetal and adult muscle types respectively (Mishina et al, 1986). All remaining a 
and p subunits are expressed in numerous combinations to make up the large 
diversity of neuronal nAChRs subtypes. Subunit composition of the receptor is an 
important factor in conferring individual characteristics such as desensitisation 
rate, open and closure time, ion channel permeability and agonist and antagonist 
sensitivity (Deneris et al, 1991; Alkondon & Albuquerque, 1993; Papke, 1993; 
McGehee & Role, 1995). The a-Bungarotoxin (a-BgTx) insensitive subfamily of 
nAChRs are composed of a2-6 subunits in a 2:3 stoichiometry with p2-4 subunits, 
whereas a7-9 subunits can form homomeric receptors which make up the a-BgTx 
sensitive subfamily (Couturier et al,  1990a; Gerzanich et al,  1994).
Choline, a precursor and one of the breakdown products of acetylcholine has 
recently been shown to be a selective agonist for the a7-containing subtype (Papke 
et a l,  1996; Alkondon et al, 1997b). This receptor shows distinctive features such 
as high calcium permeability, high single channel conductance and rapid 
desensitisation kinetics (Seguela et al, 1993). Selective antagonists for this 
receptor include aBgTx (Couturier et al, 1990a) and methylcaconatine 
(Wonnacott et a/., 1993).
Binding studies with nAChR agonists have shown that nAChRs are located in 
numerous areas of the mammalian brain including cortical areas, the 
periaquaductal grey matter, the basal ganglia, the thalamus, the hippocampus, the 
cerebellimi and the retina (Gotti et al, 1997). Due to the large number of nACliR 
subunits, a large number of heteromeric subtypes may exist but the predominant 
forms expressed in the CNS are thought to include a4p2, a4a5|32, and a7, with 
a3p4 and a3p4a5 predominant in PNS (Clementi et al, 2000b) . Use of the 
reverse transcription polymerase chain reaction (RT-PCR) teclmique has indicated 
the presence of a l ,  a3, a4, a5, a l ,  p2, p3 and p4 subunits within the 
hippocampal formation (Sudweeks &Yakel 2000, Jones et al, 1999). Specific 
functional subtypes known to be expressed in the hippocampus include the a4p2 
and a l  containing receptors (Alkondon & Albuquerque, 1993; Alkondon et al, 
1998; Alkondon et al, 1999). These functional subtypes were identified using 
electrophysiologieal recording techniques in conjunction with a range of subtype 
selective antagonists. Various nAChR-mediated responses were recorded from
hippocampal neurones in both cultures and the acute slice preparation. The 
various nAChR-mediated responses were individually isolated by subtype 
selective antagonists such as aBgTx indicating the presence of a7-containing 
receptors and the selective antagonist dihydro-13-erythroidine indicating functional 
a4p2 receptors. Recent studies on the a7-containing subtype of nAChRs have 
shown that they are present at both pre- and postsynaptic sites at almost all 
synapses in the stratum radiatum and that they show the highest levels on the 
GABAergic interneurones (Fabian-Fine et al., 2001; Kawai et al,  2002)
1.2.2.2. Muscarinic acetvlcholine receptors
mAChRs are G-protein coupled receptors in that they transduce their intracellular 
signal via coupling to guanine nucleotide-binding proteins (Hulme et al,  1990). 
This superfamily of receptors has a characteristic structure consisting of one 
polypeptide chain formed into seven hydrophobic transmembrane-spanning 
domains joined by intracellular and extracellular loops. Agonist binding triggers a 
conformational change, which leads to the activation of specific G-proteins. The 
activated G-protein then stimulates or inhibits one of many effector systems. The 
ultimate outcome of agonist binding depends on the type of G-protein activated 
and the effeetor system targeted. Due to this additional step of G-protein 
activation mAChRs mediate slower neurotransmission than the nicotinic ligand- 
gated ion channels. Selective agonists for mAChRs include muscarine and 
pilocarpine, with the classical antagonist atropine.
Originally only two types of mAChR subtypes were defined based on the affinity 
for the antagonist pirenzepine (Hammer et al, 1980). These were defined as Ml 
and M2. However molecular cloning techniques eventually lead to the 
identification of five distinct mACliR genes (ml, m2, m3, m4 and m5). These 
genes encode for 5 subtypes of mAChR termed M1-M5 (Kubo et al,  1986; 
Bonner et al, 1987; Boimer et al,  1988). Clear pharmacological classification of 
mAChR subtypes has remained difficult to achieve due to limited selectivity of 
agonists, although certain antagonists can show some degree of selectivity, for 
example pirenzepine shows some selectivity for the Ml subtype, ADFX 116 
shows some selectivity for the M2 subtype and V A-dimethyl 1 -4-piperidinyl 
diphenylacetate (4-DAMP) can show selectivity for both Ml and M3 (Hammer et 
al,  1980; Giachetti et al, 1986; Hammer et al, 1986; Doods et al, 1987b). More 
recently toxins isolated from the green mamba snake venom have been shown to 
exhibit selectivity for certain mAChR subtypes including M l, M2 and M4 (Max et 
al, 1991, 1993a; Max et al, 1993b; Liang et al,  1996; Carsi et al,  1999). These 
toxins have proved useful for functional studies as subtype selective antagonists 
(Cuevas & Adams, 1997; Marino et al, 1998).
In general M l, M3 and M5 mAChR subtypes predominantly couple to G q /G n  
class of G-protein leading to activation of the enzyme Phospholipase C (PLC) and 
thus stimulation of phosphoinositol hydrolysis to release the intracellular 
messengers inositol triphosphate (IP3) and diacylglycerol (DAG) (Bomier et al, 
1988; Peralta et al, 1988; Hulme et al, 1990; Felder, 1995). M2 and M4 mAChR 
subtypes predominantly couple to the G/Go class of G-protein, which leads to the
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inhibition of the enzyme adenylate cyclase (AC) and a decrease of the intracellular 
messenger cyclic adenosine 5’ monophosphate (cAMP) (Peralta et al, 1988; 
Hulme et al, 1990; Felder, 1995). The ultimate outcome of mAChR activation 
depends on the cell type examined. However in excitable cells, such as muscle and 
neurones, mAChR activation can lead to the modulation of K"^  ion charmels, 
voltage dependent calcium channels and non-selective cation currents via direct or 
indirect mechanisms (Caulfield, 1993).
All five subtypes of mAChR have been localised in the hippocampus, cortex, 
striatum, olfactory tubercle, thalamus and basal forebrain (Buckley et al, 1988; 
Brann et al, 1993). However mAChR proteins have differential cellular 
distributions within individual regions of the brain. Levey and colleagues (1995) 
used subtype specific antibodies to localise ml-m4 receptor proteins within the 
hippocampal formation by immunocytochemistry. These studies revealed that ml 
and m3 receptor proteins were primarily expressed in pyiamidal neurones and 
dentate granule cells and that m2 and m4 receptor proteins were primarily 
expressed in non-pyramidal neurones, m2 receptor proteins also showed a striking 
localisation in fibres and puncta surrounding pyramidal neurones (Levey et al,
1995). A further immunohistochemical study showed that hippocampal 
interneurones show differential expression of m2 receptors, with the perisomatic 
inhibitory cells expressing m2 receptors only on their terminals and dendritic 
inhibitory cells expressing m2 receptors on their soma and dendrites (Hajos et al,
1998). The study by Levey and Colleagues (1995) further investigated which 
mAChR receptor proteins were expressed by septo-hippocampal projection fibres.
192-igG immiinotoxin lesions of the cholinergic septo-hippocampal projection 
produced a decrease in m2-immunoreactive fibres within the hippocampus and 
thus indicated that a subset of m2 receptors are presynaptically localised in 
cholinergic axons of the septo-hippocampal pathway (Levey et al,  1995). Further 
immunocytochemical studies by Rouse and Colleagues in 1999 showed that the 
vesicular acetylcholine transporter (vAChT), a protein found exclusively in 
cholinergic synaptic vesicles co-localised with the m2 receptor protein. Electron 
microscopic examination of this tissue showed m2 receptors to be located 
presynaptically in cholinergic axon terminals thioughout the hippocampal 
formation.(Rouse et al, 1999).
1.3. T he  G ABA erg ic  system
1.3.1. G ABA
The neutral amino acid y-aminobutyric acid (GABA) is the major inliibitory 
neurotransmitter within the adult CNS. GAB A is synthesised from glutamate in 
neurones expressing the enzymes Glutamate Decarboxylase 65/67 (GAD). It is 
released from presynaptic terminals to act on postsynaptic GAB A receptors 
generating an inhibitory postsynaptic response that can be detected as voltage 
(IPSP) or current (IP SC) deflections. Termination of action is due to GAB A 
uptake into neurones and surrounding glial cells by G ABA transporters (GATl-3) 
and the subsequent breakdown of GAB A by transaminase to form succinic acid 
semialdehyde (Cherubini & Conti, 2001).
1.3.2. GABAergic receptors
Early work with the neurotransmitter GABA indicated that it produced inhibitory 
hyperpolarising postsynaptic responses in neurones (Krnjevic & Schwartz, 1967), 
which could be blocked by the alkaloid bicuclline (Curtis et al, 1970). During the 
1970s Bowery and colleagues showed that GABA could also act to inliibit 
noradrenaline release in the heart (Bowery & Hudson, 1979; Bowery et al,  1981). 
However this response was not blocked by bicuculline and ultimately lead to the 
classification of two pharmacologically distinct GABA receptors named GABAa 
and GABAb (Hill & Bowery, 1981). This novel GABAb receptor was also shown 
to be present in the brain (Bowery et al, 1980; Bowery et a l,  1987) and was 
activated by the specific agonist baclofen (Bowery et al, 1980; Hill & Bowery, 
1981). However work with conformationally restricted analogues of GABA had 
identified a bicuculline insensitive receptor (Jolmston et al, 1975). These 
analogues were later shown not to effect binding of the GABAb agonist baclofen 
and as such a third subclass of GABA receptor was suggested and named GABAc 
(Drew a/., 1984).
1.3.2.1. GABAa receptors
GABAa receptors mediate most of the fast inliibitory synaptic transmission in the 
CNS. They are responsible for the membrane hyperpolarisation corresponding to 
the fast IPSP seen on afferent stimulation and belong to the ligand-gated ion 
channel superfamily (Schofield et al, 1987). As with all others members of this 
superfamily they have a pentameric architecture (Nayeem et al,  1994). Five
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subunits are arranged within the plasma membrane to form a charmel that is 
mainly selective for chloride and bicarbonate ions (Bormann et al, 1987). The 
channel is gated by GABA, muscimol and other synthetic agonists but can also be 
modulated, in terms of channel opening time and frequency, by benzodiazepines, 
barbiturates, neurosteriods and ethanol (Macdonald & Olsen, 1994; Johnston, 
1996a) Classical antagonists are bicuculline and the channel blocking non­
competitive antagonist picrotoxin (Akaike et al, 1985).
The first two receptor subunits identified (a and (3) were cloned by Schofield in 
1987 and since then the number of known subunits has increased to six a (al-6), 
tluee (3 (pi-3), four y (y 1-4), and one 5, s, 0, n (Pritchett et al, 1989; Shivers et al, 
1989; Ymer et al, 1989; Olsen & Tobin, 1990; Pritchett & Seeburg, 1990; Ymer 
et al, 1990; Wisden et al, 1991; Harvey et al., 1993; Bonnert et al,  1999; Martin 
& Dunn, 2002). Alternative splicing of individual subunit proteins increases 
diversity further (Whiting et al, 1990; Bateson et al, 1991). Despite the large 
variety of subunits only a limited number of combinations are thought to be 
expressed in vivo (McKernan & Whiting, 1996). Pritchett et al (1989) showed that 
at least one a, p and y subunit is required to form a fully functional channel. The 
suggested stoichiometry of the receptor is a 2:2:1 arrangement (Chang et al, 1996; 
Tretter et al, 1997; Farrar et al, 1999). Immunoprécipitation studies using 
GABAa subunit-selective antibodies in combination with western blot analysis 
and binding studies have shown that the most common formation is two a l 
subunits in combination with two p2 subunits and a single y2 subunit. This 
receptor subtype seems to show classical GABAa receptor pharmacology and
11
biophysical properties and accounts for an estimated 43% of GABAa receptor 
population in the adult brain (McKernan & Whiting, 1996). However alterations 
in subunit composition can alter both physiological and pharmacological 
characteristics of the receptor complex such as, channel open time, desensitisation 
kinetics, benzodiazepine recognition and neurosteriod efficacy (Pritchett et al, 
1989; Verdoorn et al, 1990; Saxena & Macdonald, 1994; Adkins et al,  2001; 
Rudolph et al,  2001; Smith et al, 2001),
GABAa receptors are present in most areas of the mammalian CNS, however 
expression of GABAa receptor subtypes shows regional, neuronal and synapse 
specificity (Fritschy & Brunig, 2003). A large diversity of GABAa receptor 
subunits are expressed within the hippocampus (Wisden et al, 1992). The use of 
subunit-selective antibodies has allowed individual subtypes and subunit 
combination of these receptors to be uncovered. These include alp2y2 found in 
hippocampal interneurones and pyramidal neurones, a2p2/3y2 in hippocampal 
pyramidal neurones, a4p5 in hippocampal dentate gyrus cells and a5p3y2 in 
pyramidal neurones (McKernan & Whiting, 1996; Fritschy & Brunig, 2003).
1.3.2.2. GABAr receptors
GABAb receptors were cloned by Kaupmann and colleagues in (1997). These 
receptors are present at both pre- and postsynaptic sites mediating an inhibition of 
transmitter release and the prolonged membrane hyperpolarisation corresponding 
to the slow IPSP seen on stimulation of afferent fibres respectively (Dutar & 
Nicoll, 1988c, b). GABAb receptors belong to the G-protein coupled receptor
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superfamily (Kuriyama & Ohmori, 1990; Kaupmann et al, 1997). This family 
shows the characteristic structure of a seven transmembrane domain protein. 
However functional GABAb receptors are only formed after heterodimerisation of 
two of these seven transmembrane domain proteins known as GABA(bi) and 
GABA(b2) (Jones et a l,  1998; Kaupmaim et al, 1998; White et al, 1998; 
Billinton et al, 2000). They are activated by agonists GABA and (-) baclofen 
(Bowery et al, 1980; Bowery et al, 1981; Hill & Bowery, 1981) and antagonised 
by phaclofen, saclofen as well as a range of more recently developed selective and 
potent antagonists including CGP 55845A (3-V-[l-(S)-(3,4-
dichlorophenyl)ethyl]amino-2~hydroxypropyl-P-benzyl-phosphinic acid) (Davies 
e ta l ,  1993).
The fact that a number of spliced variants have been identified for both GABA(bi) 
and GABA(b2) subunits adds to the diversity of these receptors. There are currently 
5 known spliced variants for GABA(bi) named GABAb la-e and 3 known spliced 
variants for GABA(b2) named GABAsza-c. The precise spliced variant expressed 
can lead to differences in both regional and subcellular localisation of the receptor, 
agonist activation and transduction mechanisms (Billinton et al, 2001). For 
example western blot analysis using spliced variant selective antisera on 
membranes prepared from several major brain areas indicate that GABAbia was 
the predominant spliced variant expressed within the olfactory bulb and striatum 
whereas GABAbib was predominant within the cerebral cortex, thalamus, 
cerebellum and medulla (Benke et al, 1999). Further western blot analysis of 
various cellular subfractions demonstrated both GABAb ia and GABAb ib were
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enriched within the synaptic plasma membrane fraction with only GABAb i a 
showing an enrichment in the postsynaptic densities indicating that GABAbia and 
GABAb lb may be located post- and presynaptically respectively (Benke et al,
1999).
GABAb receptors couple to the G-proteins of the G/Go family, which can 
ultimately lead to an inhibition of adenylate cyclase, the opening of channels, 
responsible for the GABAfi-mediated slow IPSPs (Andrade et al, 1986; Cliristie 
& North, 1988; Dutar & Nicoll, 1988b) and an inliibition of Ca^ "^  channels, which 
may be responsible for GAB As-mediated inhibition of transmitter release. 
However, presynaptic inhibition of transmitter release within the hippocampus is 
not pertussis toxin sensitive and thus may be coupled to a different G-protein at 
the presynaptic site (Dutar & Nicoll, 1988c).
Immunocytochemical data has shown that both GABAb receptor proteins are 
present in the cerebellum, hippocampus, cortex, thalamus and basal ganglia 
(Margeta-Mitrovic et al, 1999; Billinton et al, 2000). Both GABAb receptor 
subunits show a similar distribution throughout the central nervous system 
although the GABA (b2) subunits are found exclusively in neurones (Clarke et a l ,
2000). In the hippocampus GABA(bi) mRNA is shown to be expressed 
homogeneously throughout all areas of the hippocampus whereas GABA(b2) 
mRNA shows lower levels in the CAl with a graded increase throughout towards 
the CA3 and dentate gyrus. (Clarke et al, 2000). The GABA(bi) spliced variants 
GABA(Bia) and GABA(Bib) also show high and moderate levels of expression
14
within the hippocampus respectively (Benke et al, 1999). It is interesting to note 
that GABA(Bib) receptors were rarely located at postsynaptic densities and 
therefore may be attributed to presynaptic or extrasynaptic sites (Benke et al,
1999).
1.3.2.3. GAB Ar receptors
GABAc receptors are pharmacologically distinct from the GABAa and GABAb 
receptor subclasses in that they are insensitive to the GABAa antagonist 
bicuculline and the GABAb agonist baclofen (Drew et al, 1984). They infact are 
thought to resemble a simpler version of the GABAa receptor in that they are 
ligand-gated chloride channels antagonised by picrotoxin but are not subject to 
modulation by benzodiazepines, barbiturates or neurosteriods (Polenzani et al, 
1991; Feigenspan et al, 1993; Qian & Dowling, 1993, 1994; Johnston, 1996b). 
GABA is a more potent agonist at these receptors compared to GABAa receptors 
and the partially folded GABA analogue cw-4-aminocrotonic acid (CACA) acts as 
a selective agonist for this receptor subtype (Johnston et al,  1975), with 1,2,5,6- 
tetrahydropyridine-4-yl methylpho sphinic acid (TPMPA) acting as a selective 
antagonist (Murata et al,  1996; Ragozzino et al, 1996).
GABAc receptors are thought to be constructed from p subunits (p i-3) cloned in 
the 1990’s (Cutting et al, 1991; Cutting et al, 1992; Wang et al, 1994; Ogurusu 
et al,  1995; Zhang et al,  1995; Ogurusu & Shingai, 1996). These subunits show a 
high degree of sequence similarity to GABAa receptor subunits yet they can form
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functional homomeric or heteromeric receptors with pharmacological properties 
similar to those exhibited by GABAc receptors. Differential expression of these 
subunits can again lead to diversity in the kinetics and pharmacology of receptors 
(Zhang et al, 1995; Chebib et al, 1998; Qian et al, 1999; Zhang et al, 2001). 
Recent studies have also shown that p subunits can co-assemble with GABAa 
receptor y2 and a l  subunits to form heteromeric receptors with distinct 
pharmacology (Qian & Ripps, 1999; Pan et al, 2000; Ekema et al, 2002; 
Milligan et a l , 2004).
The pi, p2 and p3 subunits are expressed within the retina and thi'oughout the 
mammalian CNS including the hippocampus (Enz et al, 1995; Boue-Grabot et 
al, 1998; Wegelius et al, 1998; Enz & Cutting, 1999).
1.4. T he Glutam aterg ic  System
1.4.1. G lutam ate
L-Glutamate is the major excitatory neurotransmitter within the adult CNS and 
was the first excitatory amino acid to be so recognised (Hayashi, 1952, 1954). 
Although it was initially difficult to accept that a common metabolite could have a 
specific neurotransmitter function it was subsequently shown that glutamate acted 
on specific postsynaptic receptors to elicit excitatory postsynaptic responses 
(EPSPs or EPSCs) (Curtis & Watkins, 1960, 1963) and strong evidence was 
provided to indicate that it could be stored in synaptic vesicles and released fr om
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the presynaptic terminal by Ca^  ^dependent exocytosis (Nicholls, 1989; Maycox et 
al,  1990; Nicholls & Attwell, 1990). Together with the presence of glutamate 
uptake carriers in the plasma membrane of glial cells and neurones to terminate 
the postsynaptic action of glutamate (Nicholls & Attwell, 1990), glutamate 
successfully fulfilled the criteria for classification as a neurotransmitter.
1.4.2. Glutamatergic receptors
Glutamate receptors are found throughout the mammalian CNS. The first 
glutamate receptors to be characterised were cation-selective ligand-gated ion 
chamiels. These ionotrophic glutamate receptors are classified into tlnee subtypes 
based on pharmacological and electrophysiologieal data (Johnston et al, 1974; 
McCulloch et al, 1974; Watkins & Evans, 1981).
1) NMDA
2) AMPA
3) Kainate
These three receptors were named after their selective agonists, W-Methyl-D- 
aspartate (NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA) and kainate (Watkins & Evans, 1981; Watkins et al,  1991) and differ in 
activation and deactivation timecourses, desensitisation rates and ion permeability. 
Genes encoding subunits for all subtypes of ionotrophic glutamate receptors were 
cloned throughout the early 1990’s (Hollmann et al, 1989; Settler et al, 1990; 
Boulter et al,  1990; Egebjerg et al, 1991; Moriyoshi et al, 1991; Werner et al,
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1991; Bettler et al,  1992; Herb et al, 1992; Monyer & Seeburg, 1992; Monyer et 
al., 1992). Metabotrophic glutamate receptors belonging to the G-protein coupled 
superfamily have also been recognised (Sladeczek et al, 1985; Sugiyama et al,
1987) and subsequently cloned (Houamed et al, 1991; Masu et a l,  1991; Tanabe 
et al,  1992).
1.4.2.1 ■ AMPA receptors
AMPA receptors (formerly known as quisqualate receptors) mediate the majority 
of fast excitatory neurotransmission in the CNS. In the hippocampus and 
neocortex they are usually responsible for the generation of the fast component of 
dual component EPSPs (Collingridge et al, 1983). AMPA receptors are ligand 
gated cation-selective channels displaying fast kinetics of activation and 
inactivation (Trussell & Fischbach, 1989; Colquhoun et al, 1992) permeable to 
both and Na"^  and generally show low calcium permeability (Lino et al, 1990; 
Jonas & Sakmann, 1992). Most antagonists, including CNQX and NBQX, for 
these receptors are more commonly thought of as non-NMDA receptor antagonists 
as they are selective for both AMPA and kainate receptors. However more 
recently GYKI53655 has been shown to be selective for AMPA receptors alone 
(Paternain et al, 1995).
Four genes (GluRl-4) encode for 4 AMPA receptor subunits (Hollmann et al, 
1989; Bettler et al, 1990; Boulter et al, 1990; Keinanen et al, 1990), which 
assemble into both homomeric and heteromeric receptors. However alternative 
splicing leads to each subunit existing in two forms (spliced variants) known as
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“flip” and “flop” (Sommer et al, 1990). The expression of these two isoforms is 
developmentally regulated. Prenatal brains express only the “flip” form of each 
subunit, which persist tliroughout life, whereas the “flop” form is expressed 
postnatally and thus is co-expressed with the “flip” form (Monyer et al, 1991). 
This differential expression is responsible for conferring differences in 
desensitisation kinetics (Colquhoun et al, 1992). The GluR2 subunit is a 
particularly important AMPA subunit. An arginine residue (R) present in the 
second transmembrane domain of this subunit, introduced through RNA editing, is 
responsible for the characteristic low calcium permeability of AMPA receptors 
(Sommer et al, 1991). However AMPA receptors lacking this subunit do exist 
and show significantly enhanced calcium permeability. These receptors have a 
discrete localisation within the CNS. In the hippocampus such GluR2 deficient 
receptors are preferentially expressed by interneurones where they are suggested to 
play an important role in the low threshold of spike generation (Geiger et al,
1995).
Autoradiographic studies have shown AMPA receptors localised in numerous 
regions of the CNS including the hippocampus cortex, septum, striatum and 
cerebellum (Monaghan et al, 1985; Young & Fagg, 1991). Individual AMPA 
receptor subunits show widespread but differential distribution within the CNS. 
Immunocytochemical studies have shown stronger reactivity of the GluRl 
subunits in hippocampal interneurones than pyramidal neurones and the absence 
of GluR2 and GluR3 from all hippocampal interneurones with the exception of 
Calbindin containing subtypes (Geiger et al, 1995; Leranth et al, 1996). All
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GiuRl -4 subunits are absent from axons and presynaptic terminals (Leranth et al.,
1996).
1.4.2.2. Kainate receptors
Kainate glutamate receptors were originally identified based upon a high affinity 
for the agonist kainate. As kainate is also an agonist at AMPA receptors these 
receptors were sometimes known as high affinity kainate receptors. However with 
advances in cloning techniques they are now known to constitute an entirely 
separate group from AMPA receptors. Kainate receptors are ligand-gated ion 
chamiels present both pre- and postsynaptically within specific regions of the 
mammalian CNS. Although the demonstration of functional kainate receptors in 
the brain has proved difficult, use of the AMPA selective antagonist GYKI 53655 
allowed postsynaptic kainate responses to be isolated in CA3 pyramidal neurones 
(Vignes & Collingridge, 1997) and the selective agonist ATP A allowed kainate 
receptors comprised of or containing the GluR5 subunit to be associated with 
presynaptic modulation of inhibitory GABA transmission within the hippocampus 
(Clarke et al, 1997). Since the development of these selective agonists and 
antagonists a role for both pre- and postsynaptic kainate receptors in synaptic 
transmission has been proposed in many regions of the nervous system (Kullman, 
2001; Huettner, 2003).
The first kainate receptor submiit gene cloned was for the GluR5 subunit (Bettler 
et al,  1990). An additional four genes (GluR6, GluR7, KAl and KA2) were 
subsequently cloned (Egebjerg et al, 1991; Werner et al,  1991; Bettler et al,
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1992; Herb et al, 1992; Lomeli et al, 1992) with the total number now standing 
at five genes known to encode kainate subunits, although alternative splicing and 
RNA editing can again increase the total number of subunit isoforms (Bettler et 
al,  1990; Sommer et al,  1991; Sommer et al, 1992). GluR5-7 subunits can form 
homomeric receptors or pair with KAl or KA2 subunits to form heteromeric 
receptors (Bettler et al, 1990; Egebjerg et al, 1991; Werner et a l,  1991; Herb et 
al, 1992; Sommer et al, 1992; Schiffer et al, 1997) with subunit composition 
again conferring differing pharmacology (Alt et al, 2004).
GluR5-7 subunit expression is generally more restricted than that of AMPA 
receptor subunits GluRl-4. However all subunits are expressed in the 
hippocampus although expression level varies according to regions. GluR5 and 
GluR7 subunits show lower levels of expression compared to GluR6, which 
shows high levels of expression particularly in CA3 pyiamidal neurones (Bettler 
et al, 1990; Egebjerg et al, 1991; Lomeli et al, 1992) KAl expression is limited 
to CA3 pyramidal neurones and dentate gyi’us granule cells whereas the KA2 
subunit is expressed in all neurones in the CAl, CA3 and dentate gyrus (Werner et 
al, 1991; Herb et al, 1992).
1.4.2.3. NMDA receptors
The NMDA receptor is a very well characterised subtype of glutamate receptor 
widely distributed within the mammalian CNS (especially in the hippocampus). 
These receptors are responsible for the slower component of the dual component 
EPSP evoked in the hippocampus (Collingridge et al, 1988) and can be
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pharmacologically distinguished from other glutamate receptors by the 
competitive blockade by D-AP5 (Davies et al, 1981). They bind both glutamate 
and NMDA, although activation of the channel requires glycine to bind as a co­
agonist (Johnson & Ascher, 1987). Distinct biophysical properties of these ligand- 
gated ion channels include; a large single chamiel conductance, (Ascher et al,
1988), slow kinetics (Lester et al, 1990), high calcium permeability (Lino et al,
1990), voltage sensitivity due to a voltage dependent channel block by magnesium 
ions (Mayer et al, 1984; Nowak et al, 1984) and modulatory sites for Zn^ ,^ and 
polyamines (Westbrook & Mayer, 1987; Ransom & Stec, 1988; Williams et al,
1991)
The high calcium permeability of this receptor subtype is important in initiating 
intracellular processes including long-term metabolic (Collingridge & Singer,
1991) or structural changes. However excessive activity of this receptor could be 
detrimental leading to large calcium influx, excitotoxcity and ultimately cell death 
(Rotliman & Olney, 1987). The Mg^”^ block of this receptor is an important factor 
in controlling excessive activity of this receptor.
The first NMDA receptor subunit was cloned in 1991 (Moriyoshi et al, 1991) and 
was named the NRl subunit. These subunits could form homomeric channels with 
the hallmark features of NMDA receptors (Moriyoshi et al, 1991). A total of 8 
spliced variants have been reported for this NRl subunit (Anantharam et al, 1992; 
Durand et a l,  1992; Nakanishi et al, 1992; Sugihara et al, 1992; Yamazaki et al, 
1992; Hollmaim et al, 1993), which confer differences in pharmacology and
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biophysical characteristics. An additional four NMDA receptor subunits were 
cloned in 1992 (Monyer & Seeburg, 1992; Monyer et al, 1992) named NR2A-D. 
These receptor subunits caimot form functional NMDA receptors unless 
coexpressed with an NRl subunit and are generally thought to have a modulatory 
role (Monyer et al,  1992). Recently NR3 subunits have been cloned, NR3A 
subunits (originally known as NMDA-L) both rat (Sucher et al, 1995) and human 
(Eriksson et al, 2002), which are thought to be expressed during brain 
development and an NR3B subunit (Matsuda et al, 2002). These subunits are 
again proposed to have a modulatory role with NR3A reducing conductance (Das 
et al, 1998) and NR3B reducing calcium permeability (Matsuda et al, 2002).
NRl RNA is expressed in almost all neurones throughout the CNS and PNS with 
particularly high levels in the cerebellum, hippocampus and cerebral cortex 
(Moriyoshi et al, 1991) although expression of spliced variants are differentially 
regulated. The level of NRl subunit expression exceeds that of the other subunits 
combined (Goebel & Poosch, 1999). NR2 subunits show differential expression 
throughout the brain with the hippocampus showing higher levels of NR2A and 
NR2B compared to others (Goebel & Poosch, 1999), NR3A subunit expression is 
developmentally regulated peaking at postnatal day (P) 8 and decreasing from P12 
to adulthood in the rat CNS and shows low levels of expression in the 
hippocampus (Goebel & Poosch, 1999; Wong et al,  2002).
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1.4.2.4. Metabotrophic glutamate receptors
Glutamate receptors that couple to effector systems through the action of G- 
protein were first discovered in the mid 1980’s (Sladeczek et al, 1985; Sugiyama 
et al, 1987) and subsequently cloned in the early 1990’s (Houamed et al, 1991; 
Masu et al, 1991; Abe et al, 1992; Nakanishi, 1992; Tanabe et al, 1992; 
Nakajima et al,  1993; Okamoto et al,  1994; Saugstad et al, 1994). These 
metabotrophic glutamate receptors (mgluRs) are thought to be important in a 
number of important CNS functions including the regulation of synaptic 
transmission (Gereau & Conn, 1995), plasticity (Bortolotto & Collingridge, 1993; 
Fitzjohn et al, 1998) and emergent network oscillations (Taylor et al, 1995; 
Whittington et al., 1995; Cobb et al, 2000)
mGluRs possess the 7 transmembrane domain motif found in most G-protein 
coupled receptors but are larger than and show very little sequence homology to 
all other identified G-protein coupled receptors. These are therefore thought to 
comprise a new family of receptors (Conn & Pin, 1997; Pin et al, 2003). They are 
now known to form a family of 8 subtypes known as mgluRi-mgluRg with 
alternative splicing increasing diversity further (Pin et al, 1992; Tanabe et al, 
1992; Minakami et al, 1994). These subtypes are classified into thi'ce groups 
based on their amino acid sequence identity, signal transduction and 
pharmacology (Nakanishi, 1992).
• Group I- mgluRi and mgluRs (spliced variants-mgluRia-d, mgluRsa-b).
• Group II- mgluRi and mgluRs.
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Group ni-mgluRd, mgluRe, mgluRy and mgluRg (spliced variant 
mgluRda-b).
Group I mgluRs are activated by the selective agonist 3,5-dihydroxyphenylglycine 
(DHPG) (Ito et al, 1992) with (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) 
selective for only mglus receptors. These mgluRs couple to Gq to stimulate 
phospholipase C and phosphoinositol hydrolysis (Masu et al, 1991; Abe et al,
1992). Group II mgluRs are activated by the selective agonist 2R,4R-APDC 
(Schoepp et a l,  1995) and couple to Gj to inhibit adenylate cyclase and inhibit 
cAMP formation (Tanabe et al, 1992). Group III mgluRs are activated by the 
selective agonist L-AP4 (Nakajima et al, 1993; Saugstad et al,  1994) and couple 
to Gi and inliibit adenylate cyclase (Nakajima et al, 1993; Okamoto et al, 1994; 
Saugstad et al, 1994).
mGluRs can excite hippoeampal pyramidal neurones via activation of a range of 
ion channels (Charpak et al, 1990; Guerineau et al, 1994) and nonselectlve 
cation conductances (Guerineau et al, 1995) and can inhibit voltage dependent 
Ca^  ^channels (Swartz & Bean, 1992).
All mGluR sunbunit RNAs are differentially but widely distributed within the 
brain. In the hippocampus mGluRi show low expression within the CAl region 
whereas mGluRi and mGluRs show high expression within the CA3 pyramidal 
layer (Masu et al,  1991; Abe et al,  1992). More recent immunocytochemical 
studies showed that mGluRlb and c are absent in area CAl and show strongest
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expression in CA3 pyramidal neurones (Lujan et al, 1996) and somatostatin 
eontaining interneurones are particularly enriched in the mGluRla subtype (Baude 
et al,  1993). mGluR4 subunits were shown to have a postsynaptic localisation on 
cell bodies and dendrites of pyramidal neurones and are also present at presynaptic 
sites (Bradley et al, 1996) while mGluR7 were shown to have a presynaptic 
localisation at glutamatergic synapses (Bradley et al, 1996; Shigemoto et al,
1996). A recent comprehensive study for all subtypes mGluRl-8 in the 
hippocampus (Shigemoto et al, 1997) reported group II and group III receptors to 
show a predominantly presynaptic localisation with group I receptors showing a 
predominantly postsynaptic localisation.
1.5. T he hippocam pus
1.5.1. General
The hippocampus is a region of the temporal lobe known to play a central role in 
learning and memory formation since the 1950’s. In 1954 a patient known as 
“HM” underwent a bilateral temporal-lobe resection, destroying the anterior two- 
thirds of the hippocampus and the hippocampal gyrus, to cure severe epilepsy. 
After the operation “HM” was reported to have “a very grave recent memory loss” 
(Scoville, 1954; Scoville & Milner, 1957) in that he could not remember any 
events subsequent to the resection and showed partial amnesia for the tliree years 
leading up to the operation. Since then many experimental and elinical studies 
have confirmed these observations showing that the hippocampus is involved in 
learning and memory processes in humans, monkeys and rats (O'Keefe & Nadel,
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1978; Zola-Morgan et al, 1986; Mumby et al, 1992; Zola-Morgan et al, 1992; 
Jaffard & Meunier, 1993; Jarrard, 1993; O'Keefe, 1993; Alvarez et al, 1995; 
Mumby et al, 1995; Rempel-Clower et al, 1996). The cognitive map theory of 
O’Keefe highlighted the importance of the rodent hippocampus in forms of spatial 
learning (O'Keefe & Nadel, 1978; O'Keefe, 1993). Although more recently other 
studies in humans, primates and rats indicate an important role in various aspects 
of short-term memories and declarative memories (Eichenbaum, 1996; Rempel- 
Clower et al, 1996; Jackson et al, 1998; Hasselmo, 1999). The mechanisms 
underlying memory formation are complex but involve the generation of various 
network oscillatory states including theta and gamma rhythms coupled with 
changes in synaptic strength known as synaptic plasticity (Stewart & Fox, 1990; 
Bliss & Collingridge, 1993).
The hippocampus is an area of the brain that is important in the pathology relating 
to major neurological disorders such as Alzheimer’s disease (AD) (Flyman et al, 
1990; Arriagada et al, 1992) and temporal lobe epilepsy (Schwartzki'oin, 1994; 
Dutar et al, 1995). That the hippocampus is affected in AD is unsurprising given 
the foremost manifestation of AD as being memory impairment (Terry & 
Katzman, 1983). Numerous structural and chemical changes are present within the 
AD hippocampus including the presence of neurofibrillary tangles, neuritic 
plaques (Ball, 1978; Hyman et al, 1990; Arriagada et al, 1992) and neuronal loss 
(West et al, 2000) leading ultimately to changes in major neui'otransmitter 
systems. Of particular prominence is the cholinergic system. The “cholinergic 
hypothesis” highlights the significant loss of cholinergic activity in different areas
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of the AD brain including the hippocampus (Bartus et al, 1985; Kâsa et al,
1997). This loss of cholinergic activity includes loss of cholinergic axons, reduced 
AChE and ChAT expression (Araujo et al,  1988b; Kâsa et al, 1997), consistent 
losses of nAChRs shown both in vitro and in vivo with specifically reduced levels 
of alpha 4, 3 and 7 subunit containing subtypes (Nordberg, 2001) and a loss of M2 
subtype mAChRs (Araujo et al, 1988b; Quirion et al, 1989a; Quirion et al, 
1989b). Although numerous other neurotransmitter systems and hypotheses have 
been proposed to have a role in the development and progression of AD (Bowen 
et al, 1983; Mann & Yates, 1986) the cholinergic system is most widely studied 
and relates to the work described in this thesis.
Before the hippocampal region was associated with the learning and memory 
process in the 1950’s it was already known to play a significant role in the 
generation and/or spread of Temporal Lobe Epilepsy (TLE). The neurosurgical 
technique known as temporal-lobe resection was developed to treat this seizure 
syndrome. As the hippocampal formation dominates the region of excision, 
experience with this teehnique lead Scoville and Milner (1957) to their original 
conclusion that the hippocampus was involved in learning and memory but it also 
further implicated the hippocampus in generations of these seizures. Animal 
models of TLE alongside studies of human patients have consistently reported 
hippocampal involvement (McIntyre & Racine, 1986; Spencer et al, 1993). The 
underlying cause of the epileptic seizures is thought to result from an excessive 
hyperexcitability of the principal cells within the hippocampal formation (Jefferys,
1993). Recently it has been suggested that cell damage particularly in the
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populations of interneurones may lead to a loss of inhibition that may contribute to 
the hyperexcitability of the principal cell population (Dinocourt et al, 2003; 
Kobayashi & Buckmaster, 2003).
1.5.2. Anatomy
The hippocampus is a limbic structure connected to cortical regions of the brain 
thorough the perforant pathway and numerous subcoitical regions e.g. locus 
coeruleus, raphe nucleus and medial septum, through the fornix. These 
connections provide the hippocampus with enviromnental, motivational, 
emotional and autonomic information (Gulyas et al, 1999a). This highly 
organised structure was first studied in detail by Ramon y Cajal in 1891 who 
divided it into four main regions named the Ammons horn or hippocampus 
proper, the dentate gyrus, the entorhinal cortex and the sublcular complex 
(Raymon Y Cajal, 1891), which together form the hippocampal formation (Fig. 
1.1). The Ammons horn can be further divided into cornu ammon, meaning rams 
horn, 1-4 (CAl-4) (Lorente de No, 1934), of which CAl and CA3 are the major 
areas. The CA2 and CA4 regions are smaller in size and less defined, especially in 
rodent species.
The hippocampus proper and dentate gyrus are layered cortices consisting of tliree 
distinct layers of cells; a polymorphic layer, known as the stratum oriens (SO) or 
hilus, the principal cell layer, known as the stratum pyramidale (SP) or stratum 
granulosum (SG) and the molecular layers, known as the stratum radiatum (SR)
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and stratum lacunosum-moleculare (S-LM) or stratum moleculare (SM) 
(Andersen et al, 1971).
The entorhinal eortex provides the major sensory input to the hippocampus via 
fibres of the alvear and perforant pathways. Through its connections to regions 
such as the olfactory cortex it can send the hippocampus information on the 
surrounding environment, whereas the subicular complex provides the major 
source of efferent fibres from the hippocampus.
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Figure 1.1 The H ippocam pal Form ation .
Diagram adapted from Brown and Zador (1990), original drawing by Raymon y Cajal. 
Each region of the hippocampal formation is indicated, dentate gyrus, entorhinal cortex, 
subiculum with the hippocampus proper separated into CA1-CA4 regions. Principal cell 
types are illustrated and the direction of the arrows represents the flow of information 
throughout the hippocampal formation. The circled numbers 1-4 indicate the different 
strata of the hippocampus; 1-stratum oriens, 2-stratum pyramidale, 3- stratum radiatum, 
4- stratum lacunosum-moleculare.
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1.5.3. Cytology
1.5.3.1. Principal cells
The major cell population within the hippocampus are the principal cells of which 
there are three types; pyramidal neurones, located within the hippocampus proper 
region; dentate granule cells and mossy cells both located within the dentate gyrus 
region (Fig. 1.1). These cells are all excitatory in nature and release glutamate as 
their major neurotransmitter.
The individual characteristics of hippocampal principal cells have been well 
doeumented since the studies of Raymon y Cajal and (1893) and Lorente de No 
(1934). Pyramidal neurones have large conical shaped cell bodies arranged in a 
thick layer to form the stratum pyramidale. Cell size and thus layer thickness 
decreases from CA3 to CAl. Each pyramidal neurone has one or two thick apical 
dendrites radially orientated in the molecular layers and numerous basal dendrites 
in the stratum oriens reaching the alveus (Fig. 1.2). The dendrites of pyramidal 
neurones are covered in spines and become longer and more slender as progress 
from CA3 to CAl region. The branching pattern of dendrites also varies 
depending on location of the cell (Ishizuka et al, 1995). CA3 pyramidal neurone 
axons usually emerge from the lower pole of cell body. The main axon generally 
projects outwith the hippocampus via the fimbria whilst a major collateral forms a 
side projection to the CAl region. This is known as the Schaffer collateral 
projection and ramifies extensively within the stratum oriens and stratum 
radiatum of area CAl (Schaffer, 1892). The CAl pyramidal neurone axons
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emerge adjacent to the apical dendrite and project to the subiculum and entorhinal 
cortex.
Granule cells are monopolar with smaller cell bodies arranged in a layer to form 
the stratum granulosum. These cells typically give rise to only two main radially 
orientated dendrites, these are confined to the molecular layer emitting several 
branches that are again covered in spines. Basal dendrites in this cell type are rare 
(Seress & Pokomy, 1981). Granule cell axons, known as mossy fibres give rise to 
numerous collaterals remaining in the hilus, and project close to the pyramidal cell 
layer innervating the most proximal apical dendritic region of CA3 pyramidal 
neurones (Claiborne et al, 1986) forming the stratum lucidum (SL). Mossy cells 
are found in the hilar region of the dentate gyrus, they have spiny dendrites 
confined to the hilus and their axons innervate the molecular layer of the dentate 
gyrus (Amaral, 1978).
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F igure 1.2 Pyram idal neurone s tructure
A. Light micrograph of a typical pyramidal neurone within the CA1 region of the 
hippocampus. B. Cam era Lucida reconstruction of the sam e cell. Note the conical shape 
of the cell body, the thick apical dendrite extending through the stratum radiatum into the 
molecular layers and the num erous basal dendrites fanning out within the stratum oriens
The trisynaptic circuit can be used to show principal cell connectivity by outlining 
the three major synapses in the hippocampus (Andersen et a l, 1971):
I. Fibres originating in the superficial layers of the entorhinal cortex form the 
perforant path and synapse onto granule cells of the dentate gyrus 
(McNaughton, 1980).
II. Granule cells then send their axons, the mossy fibres to the CA3 region 
where they synapse on CA3 pyramidal neurones in the stratum lucidium 
(Blackstad & Kjaerheim, 1961).
III. The CA3 pyi'amidal neurones send their Schaffer collateral axons to the 
CAl region where they synapse on CAl pyramidal neurones.(Andersen et 
a l, 1971; Swanson et a l, 1978).
To complete the circuit CAl pyramidal neurones send their axons back to the deep 
layers of the entorhinal cortex partially via the subicular complex. The major 
excitatory circuits are summarised in figure 1.3.
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Figure 1.3 S chem atic d iagram  o f the trisynaptic  circuit
Diagram illustrates the three major synapses (I to III) within the hippocampal formation. I. 
Fibres of the perforant path (PP) synapse onto dentate gyrus (DG) granule cells. II. The 
granule cells send their major axons (mossy fibres) to synapse onto the CA3 pyramidal 
neurones. III. The CAS pyramidal neurones send their schaffer collaterals to synapse onto 
the CA1 pyramidal neurones.
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1.5.3.2. GABAergic interneurones
Interneurones are classically thought of as local circuit neurones in that they do 
not project outside the region of the brain that their cell bodies are located. They 
can be excitatory or inhibitory and vary in their neurotransmitter content. However 
for the purpose of this thesis the word interneurone will be used to describe a 
GABAergic inhibitory cell of the hippocampus.
GABAergic interneurones make up 10-15% of the total cell population in the 
hippocampus (Woodson et a l, 1989; Aika et a l, 1994; Freund & Buzsaki, 1996). 
These cells are normally inliibitoiy in nature releasing GAB A as their major 
neurotransmitter (Ribak et a l, 1978; Somogyi et al, 1984; Kosaka et a l, 1985; 
Somogyi et a l, 1985). They share some common features such as excitatory and 
inhibitory inputs on their dendritic shafts, electrodense cytoplasm containing 
numerous mitochondria, soma containing large amounts of rough endoplasmic 
reticulum and invaginated nuclei containing intranuclear rods (Gulyas et a l, 
1999b). However other than these basic features interneurones show a high degree 
of functional and structural diversity. They differ morphologically with respect to 
dendritic architecture and axonal targeting (Lorente de No, 1934; Somogyi et a l, 
1983; Gulyas et a l, 1993a; Han et a l, 1993; Buhl et a l, 1994a; Freund & 
Buzsaki, 1996; Parra et a l, 1998), as well as neurochemically with respect to 
their expression of neuropeptides (Somogyi et a l, 1984; Kosaka et a l, 1985; 
Sloviter & Nilaver, 1987; Deller & Leranth, 1990) and calcium binding proteins 
(Kosaka et a l, 1987; Nitsch et a l, 1990; Gulyas et a l, 1991; Miettinen et al, 
1992). Interneurones can also be discriminated pharmacologically in terms of
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neurotransmitter receptor expression (McBain & Dingledine, 1993; Hajos et a l, 
1998; Parra et a l, 1998) and physiologically with regard to membrane properties, 
firing properties (Buhl et a l, 1994b; Buhl et a l, 1996; Parra et a l, 1998) and 
response to various neurotransmitters (Parra et al., 1998). This overwhelming 
diversity leads to problems in a consistent classification system and suggests a 
large number of distinct subtypes of inhibitory cells must exist within the 
hippocampus (Maccaferri & Lacaille, 2003). Such wide variability has also lead to 
the suggestion that each hippocampal interneurone may be different from the next 
and that maybe no such classification system can be applied (Parra et a l, 1998). In 
order to provide an overview of hippocampal interneurones a brief summary of the 
major subtypes based on axonal targeting is given.
1. Perisomatic Interneurones
The first and best-characterised class of interneurone are the perisomatic 
interneurones so called because their postsynaptic target is the perisomatic region 
(somata, proximal dendrites and axon initial segment) of principal cells. This class 
of interneurone includes Chandelier (axo-axonic) cells and basket cells.
Axo-axonic cells have large cell bodies located within or adjacent to the principal 
cell layers, their (smooth beaded) radially orientated dendritic tree spans all layers 
(Buhl et a l, 1994b) and they contain the calcium binding protein parvalbumin 
(PV) (Kosaka et a l, 1987). They possess long myelinated axon trunks emitting 
unmyelinated collaterals which form synaptic contacts on axon initial segments of
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principal cells (Somogyi et a l, 1983; Somogyi et al, 1985; Gulyas et a l, 1993a; 
Buhl et a l, 1994a; Buhl et a l, 1994b).
Basket cells are not as homogenous and differ in their soma location, shape, 
axonal and dendritic arbors, receptor expression patterns and neurochemical 
content, containing either PV (Kosaka et a l, 1987; Sik et a l, 1995) or vasoactive 
intestinal polypeptide (VIP) (Acsady et a l, 1996a; Acsady et a l, 1996b) and 
cholecystokinin (CCK) (Harris et a l, 1985; Nunzi et a l, 1985). However all 
basket cells share the common feature that they form synaptic contacts on somata 
and proximal dendrites of principal cells (Buhl et a l, 1994a; Freund & Buzsaki, 
1996).
In general perisomatic cells have large cell bodies located in the principal cell 
layers, numerous mitochondria and a radial dendritic tree spanning most, if not all 
layers of the hippocampus. They have long myelinated axon trunks emitting 
unmyelinated collaterals forming synaptic contacts on the perisomatic region of 
principal cells. The function of these interneurones is thought to be in controlling 
the output of principal cells (Miles et a l, 1996). They control the coherent activity 
of hippocampal networks (Freund, 2003) and have been shown directly to be 
effective in synchronising activity of principal cells (Cobb et a l, 1995).
2. Dendritic Inhibitory Interneurones
The second major class of interneurone form synaptic contacts on dendrites of 
principal cells and are therefore collectively known as dendritic inhibitory cells.
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These cells show great variation in their soma location and their axonal and 
dendritic arbors, allowing further classification of dendritic inlribitory 
interneurones into at least 10 different subtypes. Table 1.1 will summarise some 
of the major types of dendritic inhibitory interneurones found in the hippocampus. 
In general these cells have horizontal or oblique dendritic trees with unmyelinated 
axons and contain the calcium binding protein calbindin D28K (Gulyas & Freund, 
1996). One of the most distinctive subtypes of dendritically targeting cells is the 
O-LM cell. These represent a discrete population of interneurones with 
horizontally orientated dendrites, soma within stratum oriens and whose axons 
typically extend to the stratum lacunosum-moleculare where they ramify 
extensively (Gulyas et a l, 1993a; Gulyas et a l, 1993b; McBain et a l, 1994; Sik et 
a l, 1995). They also express a number of distinct neurochemical markers 
including the neuropeptide somatostatin (Kohler & Chan-Palay, 1982) and the 
mGluR receptor (McBain et a l, 1994).
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S ubtype D escription
Bistratified: > Soma located within or near SP or at SO/A border.
> Dendritic tree is spine-free, varicose and
multipolar. Dendrites are radially orientated, 
occupying SO. SR and SP but not reaching SLM.
> Axon projects to SR and SO regions terminating on 
dendrites.
Trilaminar: > Large soma, similar in location to bistratified cells.
1) Horizontal >  Dendrites run horizontally at SO-A border.
> Axon in SR. SO and SP.
>  Trilaminar cells also project outwith the
hippocampus possibly to the medial septum.
2) Radial > Soma location similar to bistratified cells.
> Dendritic tree similar to bistratified cell but often do 
reach SLM.
> Axon in SO, SR and SP.
SLM- >  Oval som a located in SO.
Proiectinq: >  Horizontal dendrites in SO.
1) O-LM > Axon project to SLM region terminating on distal
apical dendrites.
2) R-LM > Pyramidal shaped som a located in SR.
> Dendritic tree spans SO and SR avoiding SLM.
> A single primary axon extends from an apical 
dendrite projecting to SLM.
3) P-LM >  Som a located in SP.
> Dendritic tree spans SO and SR rarely SLM
>  Primary axon from apical dendrite projects to SLM.
Radiatum >  " 'Sornaln  SP and SR 
cells > Dendrites confined to SR.
> Axon forms sparse arbor extending throughout the 
SR. _
LM cells > Soma located in the SLM
> Dendrites predominantly horizontally orientated in 
SLM and SR may extend into SP or into SM of the 
dentate gyrus.
> Axon collaterals arborize in SLM or SLM/SR 
border.
Tab le  1.1 Types o f dendritic  Inh ib itory cells.
Table sum m arises major features of distinct dendritic inhibitory interneurones including, 
som a location, dendritic arbour, axonal projection and neurochemical markers (if 
available). Abbreviations: SO-stratum oriens, SP-stratum pyramidale, SR-stratum 
radiatum, SLM-sfrafum lacunosum-moleculare, SM-stratum moleculare, A-alveus, PV- 
parvalbumin, CB-calbindin, SOM-somatostatin and NPY-neuropeptide Y. References: 1- 
(Buhl et al., 1994a), 2-(Sik et al., 1995), 3-(Freund & Buzsaki. 1996), 4-(Gulyas et al., 
1993a), 5-(McBain etal., 1994), 6-(0liva etal., 2000), 7-(Kunkel et a i, 1988), 8-(Lacaille & 
Schwartzkroin, 1988), 9-(Williams etal., 1994).
CB
CB
CB
SOM
and
NPY
SOM
SOM
CB
CB
3&4
7,8.9
& 3
41
The function of dendritic inhibitory cells differs from perisomatic cells in that they 
are involved in controlling the efficacy and plasticity of excitatory inputs rather 
than the output of principal cells (Miles et a l, 1996; Freund, 2003).
3. Interneurone-selective interneurones.
The third and most recently defined class of interneurone form synaptic contacts 
only with other interneurones (Gulyas et a l, 1996). These interneurones are 
known as interneurone-selective cells (IS-cells). They differ in soma location, 
dendritic tree and can be divided into 3 subtypes (IS 1-3) according to their 
connectivity and neurochemistry (Freund & Buzsaki, 1996). IS 1-cells are most 
numerous in area CAl but are found in other regions. They contain the calcium 
binding protein calretinin (OR) and contact dendritic inliibitory cells, other ISl- 
cells and VIP-containing basket cells (Acsady et a l, 1996b; Gulyas et al, 1996). 
IS2-cells, unlike other IS-cells are only present in the hippocampus proper. Their 
cell bodies are located at the SR/SLM border and contain the neuropeptide VIP. 
These cells contact dendritic inliibitory cells and IS 1-cells. IS3-cells also contain 
the neuropeptide VIP and contact dendritic inhibitory cells but are present in both 
dentate gyrus and hippocampus proper region (Acsady et a l, 1996a; Acsady et al, 
1996b). These IS cells in conjunction with an extrinsic input from GABAergic 
cells in the medial septal nucleus and input from interneurones which also 
innervate principal cells (Cobb et a l, 1997) are thought to exert GABAergic 
control over other interneurones of the hippocampus.
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Principal cells along with interneurones, which are mainly GABAergic, although 
some cholinergic local neurones have been found, (Frotscher et a l, 1986; 
Frotscher et a l, 2000) make up the hippocampal neuronal network. It is proposed 
that patterned signalling of the principal cells, coupled with changes in synaptic 
plasticity, at the glutamatergic synapses, may underlie the processes of learning 
and memory (Stewart & Fox, 1990; Bliss & Collingridge, 1993). However the 
Interneurones of the hippocampus are extremely important in that they act to 
govern principal cell properties such as action potential generation, firing patterns 
and membrane potential oscillations, whilst also regulating other interneurones 
(Freund & Buzsaki, 1996; McBain & Fisahn, 2001). They may also have a direct 
role in regulating synaptic plasticity at glutamatergic synapse (Davies et a l, 1991). 
Overall they are considered to set the conditions for synaptic plasticity (Paulsen & 
Moser, 1998) and play an important role in the synchronisation of principal cell 
activity (Cobb et a l, 1995; Freund, 2003).
1 .6 . T h e  S e p t o -H ip p o c a m p a l  P r o j e c t io n
The medial septal nucleus and diagonal band of Broca (MSN/DB) provides one of 
the major subcortical inputs to the hippocampus. Five morphologically distinct 
cell types have been distinguished in these nuclei (Jakab & Leranth, 1995). 
However, the two major populations are the cholinergic and GABAergic principle 
projection neurones. These neurones have large cell bodies (Brashear et a l, 1986) 
and project via the fimbria-fornix to terminate in all layers of the hippocampus. 
The septo-hippocampal projection was first described in early neuroanatomical
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studies of the whole brain published in 1910 (Elliot Smith, 1910; Herrick, 1910). 
These studies were the first to note the existence of a “matrix of fibres” running 
from the septal area to the hippocampus. The existence of this projection was 
further established with immunohistochemical evidence showing the distribution 
of AChE within the rat brain (Lewis and Shute, 1967a; 1967b). These studies 
illustrated a cholinergic projection to the hippocampal formation arising from the 
MSN/DB complex, which was subsequently termed “the septal radiation”. More 
recently monoclonal antibodies to the ACh synthesising enzyme, clrAT, were used 
to study cholinergic structures within the hippocampus and showed chAT+ 
terminal fields organised in discrete bands and laminae. Lesions of the MSN/DB 
complex virtually abolished this chAT+ staining confirming that the majority of 
hippocampal cholinergic terminals originate from neurones of the MSN/DB 
complex (Matthews et a l, 1987). ACh release from septal neurone projection 
fibres within the hippocampus was shown in vivo by Smith in 1974. These 
experiments entailed placing modified cortical cups over the dorsal surface of the 
hippocampus in anaesthetised rabbits. The collected samples within the cups were 
subsequently assayed for ACh using the dorsal muscle of the leech. These 
experiments showed that electrical stimulation within the medial septum caused 
an increased release of ACh within the hippocampus and provided the first direct 
evidence for the existence of a cholinergic septo-hippocampal pathway (Smith, 
1974). The GABAergic component of the septo-hippocampal projection was 
highlighted by Kohler and colleagues in 1984. This study used a combination of 
retrograde fluorescent tracing from the hippocampus and GAD-
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immunohistochemistry to illustrate that a significant portion of the 
septohippocampal projection was GABAergic in nature. (Kohler et a l, 1984)
The cholinergic afferents aie thin non-myelinated beaded fibres (Freund & Antal, 
1988; Heimrich & Frotscher, 1993) making up 2/3 of all projections. These 
afferents contact both principal cells (pyramidal neurones, dentate granule cells 
and mossy cells) (Frotscher & Leranth, 1985; Deller et al, 1999) and GABAergic 
interneurones (Leranth & Frotscher, 1987; Dougherty & Milner, 1999) synapsing 
on dendritic shafts, spines and cell bodies (Frotscher & Leranth, 1985). The 
GABAergic afferents are myelinated (Gartner et al, 2001) and thus are thick in 
diameter with large varicose swellings (Freund & Antal, 1988). They make up 
only 1/3 of all projections. These GABAergic afferents contact only interneurones 
of the hippocampus (Freund & Antal, 1988). The MSN/DB therefore provides a 
major cholinergic and GABAergic input to the hippocampus.
Neurones in the MSN/DB show rhythmical activity, which is thought to be 
involved in the generation and patterning of hippocampal EEG activities such as 
theta rhythm and gamma oscillations (Vanderwolf, 1975; Stewart & Fox, 1990) 
recorded in behaving animals. These oscillatory states are essential for 
hippocampal function and are thought to underlie processes of learning and 
memory as the destruction or temporary inactivation of septal inputs can disrupt 
hippocampal theta rhythm ultimately impairing hippocampal dependent learning 
tasks (Winson, 1978; Mitchell et a l, 1982). Both the cholinergic and GABAergic 
components of the septo-hippocampal projection have been implicated in the
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production of these oscillatory states (Stewart & Fox, 1990; Toth et a l, 1997; 
Fisalin et a l, 1998; Cobb et a l, 1999; Cobb et a l, 2000).
1 .7 . C h o l in e r g ic  in p u t
1.7.1. General
The cholinergic nature of the septo-hippocampal projection was first demonstrated 
by Lewis & Shute (1967a; 1967b) using histochemical detection of AChE and 
lesion studies. However the key evidence that ACh was a major neurotransmitter 
in this pathway came when stimulation of the MSN was shown to cause a direct 
increase in ACh release within the hippocampus (Smith, 1972; Rommelspacher & 
Kuhar, 1974; Smith, 1974; Dudar, 1975).
However septal afferents are not the only source of acetylcholine within the 
hippocampus, as intrinsic local cholinergic neurones have been described 
(Frotscher et a l, 1986; Matthews et a l, 1987; Frotscher et al., 2000). It is 
suggested that these cells may be important in regulating hippocampal oscillatory 
states (Cobb et a l, 1999) although this remains to be conclusively established.
1.7.2. Actions of acetylcholine on hippocampal neurones
1.7.2.1. Cholinergic responses in Principal cells
46
1.7.2. LI. Postsynaptic actions-mAChRs
Original observations that ACh excited mammalian cortical neurones (Kimjevic & 
Phillis, 1963; Spehlmann, 1963) showed that cells responded with an increase in 
their frequency of firing. This was some of the first direct evidence that ACh may 
act as a neurotransmitter within the mammalian CNS. The action of acetylcholine 
on hippocampal pyramidal neurones has since been widely investigated (reviewed 
below) and the response produced was reasonably uniform.
Extracellular studies showed that direct application of cholinergic agonists caused 
a slow excitation of hippocampal pyramidal neurones in vivo (Biscoe & 
Straughan, 1966; Bird & Aghajanian, 1976). Subsequent intracellular studies 
using the in vitro hippocampal slice preparation confirmed that application of 
cholinergic agonists, including the muscarinic selective agonists muscarine and 
pilocarpine, (Dingledine et a l, 1977; Benardo & Prince, 1981; Dodd et a l, 1981; 
Benardo & Prince, 1982; Haas, 1982; Segal, 1982; Cole & Nicoll, 1983, 1984a, b) 
produced a sustained membrane depolarisation of pyramidal neui'ones. Subsequent 
studies using direct electrical stimulation of cholinergic projection fibres in the 
stratum oriens (Cole & Nicoll, 1983, 1984a; Müller & Misgeld, 1986; Madison et 
al, 1987; Segal, 1988) produced a similar period of sustained depolarisation. This 
event has been termed the slow excitatory postsynaptic potential (EPSPm), the m 
signifying the fact that the response could be attributed to the activation of 
mAChRs. This EPSPm was consistently accompanied by an increase in input 
resistance in both CAl and CA3 pyramidal neurones (Cole & Nicoll, 1983, 1984a; 
Müller & Misgeld, 1986; Madison et a l, 1987; Segal, 1988).
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Other reported features of hippocampal pyramidal neurones response to mAChR 
activation include; a depression of the slow afterhyperpolarisation potential (AHP) 
which follows action potentials (Benardo & Prince, 1982; Cole & Nicoll, 1983, 
1984a). During a maintained depolarisation of a neurone at firing frequency the 
slow AHPs, which follow each successive action potential, summate due to the 
slow inactivation of the current involved ( I a h p )- This summation results in a 
progressive increase in the duration between action potentials, a phenomenon 
known as spike frequency adaptation (SFA). As such any depression of the I a h p  
ultimately results in a reduction of spike frequency adaptation, which has also 
been observed (Cole & Nicoll, 1983; Madison et al, 1987; Segal, 1988). Indeed 
cholinergic agonists generally produce these effects at concentrations below that 
required to cause a substantial membrane potential depolarisation (Cole & Nicoll, 
1983; Segal, 1988). In the absence of cholinergic agonists positive current 
injection results in repetitive action potential firing returning to resting levels on 
cessation of the current injection. However in the presence of cholinergic agonist 
slow afrerdepolari sing potentials (sADPs) and plateau potentials are observed after 
cessation of the evoked action potentials (Fraser & Macvicar, 1996).
These cholinergic responses could be enhanced by the acetylcholinesterase 
inhibitor physostigmine (Cole & Nicoll, 1984a; Segal, 1988) and all were 
completely abolished by the selective mAChR antagonist atropine (Cole & Nicoll, 
1984a; Benson et a l, 1988; Dutai- & Nicoll, 1988a; Segal, 1988; Fraser & 
Macvicar, 1996) confirming their muscarinic nature. The depolarisation (Benson
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et a l, 1988) and blockade of AHP was also antagonised by the Ml selective 
antagonist Pirenzepine (Dutar & Nicoll, 1988a; Segal, 1988). Although other 
studies (Millier & Misgeld, 1986; Pitler & Alger, 1990) have indicated that both 
M2 and M3 receptor subtypes may also be involved and that the receptor 
responsible may depend on the region studied, for example M2 receptors may 
contribute more in the CA3 region than the CAl (Segal, 1988). Also earlier 
studies may have indicated a prominent role for the Ml subtype due to the lack of 
recognition of the M3 subtype (Pitler & Alger, 1990). These studies together with 
the selective mAChR agonist data described above suggests that these 
postsynaptic effects are mediated by numerous mAChRs present on hippocampal 
pyramidal neurones. This correlates well with autoradiographic and binding data 
showing that M l, M2 and M3 receptors are all expressed within the hippocampus 
(Spencer et a l, 1986; Doods et a l, 1987a; Levey et al, 1995).
mAChR subtypes mediate these complex postsynaptic cholinergic responses 
(Müller & Misgeld, 1986; Benson et a l, 1988; Dutar & Nicoll, 1988a; Segal, 
1988; Pitler & Alger, 1990) via modulation of various potassium conductances, 
calcium conductances and nonselective cation conductances (Colino & Halliwell, 
1993; Haj-Dahmane & Andrade, 1999). The various potassium conductances 
include; the Mcurrent (Im ) (Halliwell & Adams, 1982; Madison et a l, 1987), the 
slow Cd^ activated iC  current (Ia h p ) (Madison et al, 1987), the leak current 
( I l e a k )  (Madison et a l, 1987; Benson et a l, 1988; Fraser & Macvicar, 1996) and 
the fast inactivating A current ( I a )  (Nakajima et al., 1986). The production of the 
slow EPSPm is thought to be the result of both the depression of the I l e a k ,  hence
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the associated increase in input resistance, and the activation of the non-selective 
cation conductance both presumably mediated via the activation of the Ml and/or 
M3 mAChR subtypes (Dutar & Nicoll, 1988a; Pitler & Alger, 1990). The 
mACliR-mediated depression of the Iahp is responsible for the observed 
depression of the slow AHPs and ultimately for the observed reduction of SFA. 
This effect was initially suggested to be pirenzepine insensitive and thus mediated 
via activation of the M2 mAChR subtype (Muller & Misgeld, 1986). However 
subsequent studies by Dutar and Nicoll (1988a) showed that this effect was 
pirenzepine sensitive and was insensitive to the M2 preferring antagonist 
gallamine, suggesting an activation of Ml mAChRs. The slow ADPs and plateau 
potential reported by Fraser and Mac Vicar were suggested to result from 
activation of a Ca^'^-activated non-selective cation current and activation of high 
voltage activated Ca^  ^channels.
A recent study by (Power & Sah, 2002) showed that activation of muscarinic 
receptors on CAl hippocampal pyramidal neurones by synaptic stimulation of 
cholinergic afferents or application of muscarinic agonists evoked a calcium wave 
propagating from the apical dendrite to the soma where it invades the nucleus. 
These authors suggested that this rise in free calcium might initiate novel gene 
transcription and underlie the long-term effects of acetylcholine on learning and 
memory.
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1.7.2.1.2.Postsynaptic action-nAChRs
The production of a nicotinic receptor mediated postsynaptic response in 
pyramidal neurones is the subject of an ongoing dispute.
Alkondon (1997a) reported that pyramidal neurones, recorded in the acute 
hippocampal slice preparation, responded to application of nicotinic agonists with 
an inward current that had slow kinetics of activation and inactivation. Hefft 
(1999) subsequently reported that afferent stimulation in the stratum radiatum 
could trigger cuiTents generated by the activation of nicotinic receptors but 
attributed this to activation of intrinsic cholinergic neurones within the slice rather 
than stimulation of cholinergic fibres from the medial septum. However studies by 
four other groups (Jones & Yakei, 1997; Frazier et a l, 1998b; McQuiston & 
Madison, 1999c; Sudweeks & Yakel, 2000) generally disagree with these findings 
reporting no, or at least occasional and barely detectable, nACliR mediated 
responses to ACh application in the majority of pyramidal neurones.
The lack of a substantial postsynaptic nicotinic response in pyramidal neurones 
could be attributed to the receptor subunits they express. Receptor expression 
studies have found only very limited detection of any a  nAChR subunits in 
pyramidal neurones (Sudweeks & Yakel, 2000). The most abundant a  nAChR 
subunit expressed in pyi'amidal neurones is the a5 subunit, which requires the 
expression of other a  and p subunits to form a functional channel (Ramirez- 
Latorre et a l, 1996). Although Sudweeks and Yakel did report a small yet 
detectable expression of a l  subunits within the pyramidal neurone population,
51
receptors containing this subunit are thought to be located presynaptically (Fabian- 
Fine et a l, 2001). Thus the major postsynaptic responses of pyramidal neurones to 
acetylcholine are mediated by mAChR receptors.
7.7.2.L3.Presvnavtic actions alterins transmitter release
Acetylcholine acts on both presynaptic muscarinic and nicotinic ACh receptors to 
alter release of glutamate in many brain regions (McGehee et a l, 1995; Gray et 
a l, 1996; Qian & Saggau, 1997). The first evidence of a presynaptic effect of ACh 
in the hippocampus came from studies on evoked glutamatergic EPSPs in the CAl 
region (Hounsgaard, 1978; Valentino & Dingledine, 1981; Rovira et a l, 1982; 
Roviraerrz/., 1983).
Hounsgaard’s (1978) initial experiments showed that iontophoretically applied 
acetylcholine decreased EPSP amplitude. Valentino and Dingledine (1981) 
reproduced these results and reported this effect to be muscarinic in nature as it 
was antagonised by the mAChR selective antagonist atropine. Rovira (1982; 
1983) subsequently reported that EPSP amplitude was decreased by selective 
mAChR agonists, that septal stimulation produced a similar depression of the 
EPSP and that these effects could be reversed by selective mAChR antagonists. 
Further studies implicated the M2 receptor subtype (Dutar & Nicoll, 1988a; 
Marchi & Raiteri, 1989; Segal, 1989) and showed the reduction in EPSP 
amplitude to be due to a mAChR mediated inhibition of presynaptic voltage 
dependent calcium chamiels (VDCC) (Segal, 1989; Qian & Saggau, 1997; 
Fernandez de Sevilla et a l, 2002). More recently Fernandez de Sevilla and Buno
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(2003) showed that stimulation of cholinergic fibres within the stratum oriens of 
the hippocampus produced a similar presynaptic inhibition of evoked EPSCs 
mediated by mAChRs. Thus synaptically released acetylcholine acts on 
presynaptic mAChRs (possibly of the M2 subtype) to inhibit VDCC and 
ultimately decrease glutamate release from the presynaptic terminal at the Schaffer 
collateral-to-CAl synapse (Qian & Saggau, 1997; Fernandez de Sevilla et al, 
2002; Fernandez de Sevilla & Buho, 2003) and the associational-commisural-to- 
CA3 synapse (Vogt & Regehr, 2001).
The initial study by Rovira (Rovira et al, 1982) also provided evidence that 
nAChR agonists had the opposite effect on glutamate transmission and increased 
the evoked EPSP amplitude. Studies on miniature EPSCs (mEPSCs) showed that 
activation of nAChRs increased the frequency of mEPSC recorded in CA3 
pyramidal neurones, indicating an enhanced glutamate release at mossy-CA3 
synapse (Gray et a l, 1996). This enhancement was proposed to be the result of 
increased calcium concentration in the presynaptic terminal due to direct 
activation of the calcium permeable a l  subunit containing nAChRs, rather than 
activation of voltage dependent calcium channels (Gray et a l, 1996; Radcliffe et 
a l, 1999). However a recent paper by Vogt & Regehr (2001) disagree with this 
hypothesis as when they repeated these experiments using Fur a 2 as a ratiometric 
indicator, no detectable changes in presynaptic calcium levels were seen upon 
activating nAChRs.
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In summary, presynaptic mAChRs and nAChRs have opposing effects on 
glutamate transmission. mAChR activation results in a decrease of glutamate 
release resulting in decreased glutamate transmission whereas nAChR activation 
results in an increase of glutamate release resulting in increased glutamate 
transmission.
1.7.2.2. Cholinergic responses in Interneurones
An interaction between the septo-hippo campai cholinergic input and the 
GABAergic interneurones of the hippocampus is suggested by a number of 
sources yet the physiology of this interaction has not been subject to a thorough 
investigation. The evidence suggesting that these two transmitter systems must 
interact comes from both anatomical, immunocytochemical and 
electrophysiological studies.
Anatomical studies showed that cholinergic afferents terminate on the surface of 
GABAergic interneurones where they form synaptic contacts (Frotscher & 
Leranth, 1985). Immuncytochemical studies have shown that mAChRs, ml to m4, 
particularly m2, (Levey et a l, 1995; Hajos et a l, 1998) and nAChRs, including 
the calcium permeable a7-type (Freedman et a l, 1993; Fabian-Fine et a l, 2001; 
Kawai et a l, 2002), are present on the surface of interneurones. The study by 
Levey and colleagues (1995) showed m2 immunoreactivity in a network of 
neurones situated along the stratum oricWalveus border in addition to m2 
immunoreactivity forming a dense plexus of fibres and puncta in a basket-like 
formation within the pyramidal cells layer (Levey et al., 1995). A more detailed
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study by Hajos and colleagues showed that receptor distribution may vary 
depending on interneurone type (Hajos et a l, 1998). This study identified specific 
subtypes of interneurones expressing m2 receptors illustrating m2 immunoreactive 
somata located within the CAl region at the stratum oriensleXwQus border. These 
neurones were shown to have horizontal dendrites and axonal projections to the 
dendritic regions of pyramidal neurones. This study also reported the presence of 
m2-immunoreactive axon terminals within the stratum pyramidale surrounding 
the soma and axon initial segment of CAl and CA3 pyramidal neurones in a 
basket like manner. Co-localisation of m2 receptor protein with G ABA confirmed 
that the majority of m2 positive soma and terminals were GABAergic in nature 
(Hajos et al, 1998). Thus it has been postulated that m2 receptors are expressed 
exclusively on the terminals of perisomatic inhibitory neurones (basket cells and 
axo-axonic cells) whereas they are expressed on the soma and axon initial 
segment of the dendritic inhibitory neurones (Hajos et a l, 1998). From these 
studies it appears likely that the interneurone circuits of the hippocampus are 
under a significant regulation by the cholinergic system.
1.7.2.2.1. Postsynaptic actions-mAChR
Numerous electrophysiologieal studies have shown that unlike principal cells, 
activation of mAChR (via agonist application) produces a variety of responses in 
interneui'ones. Initial studies on a very small number of interneurones (n=3) 
(Benai'do & Prince, 1982) demonstrated that interneurones depolarised on 
application of ACh. Reece and Schwartzkroin (1991) recorded from two distinct 
types of interneurones (basket cells and LM cells) and showed that again
55
application of cholinergic agonists produced a depolarisation from resting 
membrane potential although the time course of this depolarisation varied. 
Atropine fully blocked these responses and the Na^ channel blocker tetrodotoxin 
(TTX) had no effect thus providing the first direct evidence that cholinergic 
agonists directly excite hippocampal interneurones via the activation of 
muscarinic receptors.
Further evidence was provided in 1992 when Pitler and Alger (Pitler & Alger, 
1992) recorded an increased frequency of IPSPs in pyramidal neuiones in 
response to application of carbachol or synaptically released acetylcholine (due to 
electrical stimulation in the stratum oriens) indirectly showing an increase of 
GAB A released onto pyramidal neurones and thus an excitation of interneurones 
mediated via activation of mAChRs. In 1993 Behrend & Ten Bruggencate also 
showed that acetylcholine receptor agonists excite GABAergic interneurones but 
showed a depression of GAB A released from their terminals. This earlier work 
lead Hajos and colleagues (1998) to hypothesise from receptor expression studies 
that, ACh could decrease GAB A release from interneurones expressing m2 
receptors exclusively on their terminals and could increase G ABA release from 
interneurones expressing m2 receptors on their soma and axon initial segment 
thereby switching inhibitory control of pyramidal neurones from predominantly 
somatic to predominantly dendritic sites.
The significance of such a switch in functional terms, has been discussed by 
Paulsen and Moser (1999). Briefly, these authors proposed a model for the role of
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interneurones in mnemonic processing. They suggested that the hippocampal 
network alternates between information encoding (“read in”) mode and 
information retrieval (“read out”) mode and that the principal cells participate in 
each mode. However activity of specific sets of interneurones targeting specific 
domains of the principal cells may regulate these processing modes. For example 
during “read in” mode the principal cell axon may be inliibited by axo-axonic 
interneurones with dendrites disinhibited to receive excitatory inputs, whilst 
during “read out” mode the axon must be disinliibited to allow information to be 
transferred from the hippocampus to regions such as the neocortex.
By employing the whole cell patch clamp technique to record directly from 
visualised hippocampal interneurones, McQuiston and Madison (1999a) 
confirmed the varying nature of muscarinic response in interneurones. 
Pharmacological activation of mAChRs produced; 1) a depolarisation, 2) a 
hyperpolarisation, 3) a biphasic response or 4) no detectable change in membrane 
potential. Fuithermore, these authors reported each form of response to be found 
in various anatomically distinct classes of interneurone but failed to find a 
relationship between interneurone type and the nature of the response. This same 
group also reported that, the AHP following a train of action potentials induced by 
applieation of a depolarising current could be replaced by a large and long-lasting 
ADP in the presence of muscarinic agonists. Again this response could not be 
attributed to a distinct interneurone subtype (McQuiston & Madison, 1999b).
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These authors also attempted to uncover the ionic mechanisms underlying the 
various inAChR-mediated responses in CAl interneurones and suggested that the 
depolarisation was a complex response involving the inhibition of a voltage 
independent leak K"^  current similar to that seen in the pyramidal neurones and the 
simultaneous activation of a cation current. The inAChR-mediated 
hyperpolarising currents showed similar properties to those of an inwardly 
rectifying channel and that the ADPs were produced by a novel ionic 
mechanism involving sodium influx (McQuiston & Madison, 1999b, a).
1.7.2.2.2. Postsynaptic actions-nAChR
Pharmacological activation of nAChRs is also reported to evoke a variety of 
responses in hippocampal interneurones. The majority of studies have 
concentrated on interneurones located within the stratum radiatum of the 
hippocampus and have typically shown a fast depolarisation mediated by a l-  
subunit containing receptors (Alkondon et a l, 1997a; Jones & Yakel, 1997; 
Frazier et a l, 1998b; McQuiston & Madison, 1999c). However McQuiston and 
Madison (1999c) reported a subset of interneurones within the stratum oriens that 
responded with the same a l  mediated fast depolarisation in combination with a 
depolarising response displaying slower kinetics. Alkondon and colleagues (1997) 
reported a similar fast and slow response in a small number of stratum radiatum 
interneurones but also reported stratum radiatum interneurones displaying only 
the slow response and subsequently attributed this slow response to the activation 
of a4p2 nAChR (Alkondon et a l, 1999). Sudweeks and Yakel (2000) showed fast 
responses in stratum radiatum interneurones and slow responses in stratum oriens
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interneurones and attributed the kinetic differences to subunit composition of 
receptors expressed on each cell type, implicating the a2 subunit in stratum oriens 
interneurone responses, and the a l  and p2 subunits in stratum radiatum 
interneurone responses. Ji and Dani (2000) reported the predominant response of 
stratum radiatum interneurones was the fast current sensitive to the a l  subunit 
containing nAChR selective antagonist methyllcaconitine (MLA) although a small 
number responded with a slower current or a combination of both the fast and 
slow current. In a subsequent study by Buhler and Dunwiddie (2001) 
concentrating on stratum oriens interneurones, the authors showed most cells 
responded to ACh application with a fast a l  mediated response. In addition to 
interneurones which respond with a fast and/or slow response, a further population 
of interneurones, usually located near the pyramidal layer, showing no nicotinic 
response have also been observed (McQuiston & Madison, 1999c).
In summary, interneurones respond to nAChR activation with either a fast 
depolarisation/inward current mediated by a l  containing receptors, a slow 
depolarisation/inward current mediated by a4p2 and possibly a2 containing 
receptors or a combination of both response types. A further population of 
interneurones appear unresponsive to nAChR activation. However, relating these 
different responses to individual subtypes of interneurones on the basis of their 
soma/dendrite location and axonal projections is still not clear.
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NAChR-mediated EPSCs produced by afferent stimulation of cholinergic fibres 
have been reported in two separate studies on stratum radiatum and stratum 
lacunosum-moleculare interneurones (Alkondon et a l, 1998; Frazier et a l, 
1998a). However the response was rather infrequent when compared to agonist 
application studies. Alkondon and Colleagues (1998) showed EPSCs remaining 
after addition of an antagonist cocktail, blocking NMDA and AMP A ionotrophic 
glutamate receptors, GABAa receptors, 5-HT3 receptors and ATP receptors, 
which could be blocked by a7~subunit selective antagonists in only 20% of 
interneurones recorded. Similarly Frazier and colleges (1998a) reported only 17 
out of 125 interneurones (13.6%) with EPSCs remaining after addition of the 
same antagonist cocktail. Both authors proposed the lack of a consistent response 
was more likely due to difficulties in stimulating cholinergic afferent fibres within 
the hippocampal slice preparation rather than unresponsive interneurones. Other 
authors have been unable to reproduce these effects (McQuiston & Madison, 
1999c). However, in another recent study, Buhler and Dunwiddie (2001) 
identified two stratum oriens interneurones responding to afferent stimulation 
with a fast a7 mediated response.
L7.2.2.3 Pre~ and vostsvnavtic actions alterins transmitter release 
G ABA release from interneurones is reported to be modulated by the action of 
acetylcholine receptor agonists through presynaptie heteroreceptors.
Activation of mAChRs has been shown to decrease the frequency of spontaneous 
miniature IPSCs (mIPSCs) onto CAl pyramidal neurones (Behrends &
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TenBmggencate, 1993). Indicating a suppressant effect on the synaptic release 
mechanism at GABAergic terminals. M2 receptors have been located on the 
terminals of perisomatic interneurones (Hajos et a l, 1998) leading to the 
suggestion the activation of these receptors may mediate inhibition of G ABA 
release. However activation of mAChR was also shown to increase both the 
frequency and amplitude of spontaneous IPSPs onto CAl pyramidal neurones 
(Pitler & Alger, 1992; Behrends & TenBmggencate, 1993). This increase in 
G ABA release was suggested to result from direct excitation of a subset of 
hippocampal interneurones expressing mAChRs on their soma and dendrites 
(Hajos et a l, 1998).
Activation of nAChRs also results in an increase of GAB A release onto pyi'amidal 
neurones and other interneurones (Alkondon et al, 1997a; Albuquerque et al, 
1998; Alkondon et a l, 1999; Hulo & Muller, 2001; Buhler & Dunwiddie, 2002). 
However, this effect is sensitive to TTX (Alkondon et al, 1997a; Albuquerque et 
al, 1998; Alkondon et a l, 1999; Hulo & Muller, 2001). Therefore, increase of 
G ABA release is not due to the activation of presynaptic receptors but rather 
somatodendritic or preterminal nicotinic receptors leading to propagation of action 
potentials to the terminal region. Indeed, Buhler and Dunwiddie (2002) performed 
paired recordings from both hippocampal interneurones and pyramidal neurones 
and showed that application of ACh to the visually identified presynaptic 
interneurone could increase GABAergie IPSCs recorded in both a paired 
pyramidal neurone and a paired interneurone. If the cell body of the presynaptic 
interneurone was subsequently ruptured by advancing the pipette and returning it
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to its original position application of ACh to this neurone could no longer increase 
IPSCs in the paired pyramidal neurone. These experiments therefore illustrated 
that an intact cell body is needed for the production of IPSCs in pyramidal 
neurones.
The overall effects of cholinergic modulation of hippocampal interneurones will 
depend on the receptors they express and their postsynaptic target. Pyramidal 
neurones could be inhibited via activation of receptors increasing G ABA release 
from interneurones synapsing onto pyramidal neurones or could be disinhibited 
via activation of receptors 1) decreasing GAB A release from interneurones 
synapsing onto pyramidal neurones or 2) increasing GABA release from 
interneurones synapsing onto other interneurones.
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1.8. Summary
Both GABA and ACh modulate the activity of individual principal cells as well as 
co-ordinating the activity of populations of principal cells and glutamatergic 
synaptic plasticity. Thus understanding how these neurotransmitters interact with 
each other is pivotal in understanding hippocampal function.
The evidence reviewed throughout this introduction gives reason to believe that an 
important interaction may take place between the cholinergic and GABAergic 
systems of the hippocampus. Due to the fact that receptor distribution varies 
across the subclasses of interneurones and additionally that numerous responses to 
ACh have been recorded from these cells it seems likely that may acetylcholine 
differentially modulate functionally distinct types of interneurone. This differential 
modulation of GABAergic transmission should be investigated further as it relates 
directly to the regulation of principal cell network dynamics and ultimately how 
information is processed thi'ough the hippocampus.
A good example differential regulation of distinct subtypes of interneurones is 
shown by the localisation of M2 mAChRs on dendritic targeting inliibitory cells 
compared to the localisation of M2 mAChRs on perisomatic inhibitory cells. ACh 
is proposed to act on M2 receptors expressed on the soma of dendritic targeting 
interneurones to enhance GABA release from these cells whereas it acts on M2 
receptors expressed exclusively on the axon terminals of perisomatic targeting 
interneurones to suppress GABA release from these cells (Hajos et a l, 1998).
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Therefore differential modulation of interneurones switches inlribition from 
predominantly perisomatic to predominantly dendritic in nature.
McQuiston and Madison (1999c) hypothesised that interneurones sensitive to 
nicotine are dendritic inhibitory interneurones whereas the majority of 
interneurones uiuesponsive to nicotine are of the perisomatic inhibitory cell class, 
again switching inhibition from perisomatic to dendritic.
Most previous studies have focused on cultured systems and upon 
pharmacological stimulation of ACh receptors. It was therefore hoped that further 
investigation focusing on physiological interactions between the cholinergie and 
GABAergic systems would reveal important insights into the regulation of 
interneurones, which may ultimately be exploited and lead to the production of 
selective drug treatments to target functionally distinct hippocampal microcircuits.
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1.9. A im s
The aim of this thesis is to further investigate the interaction of cholinergic and 
GABAergic systems of the hippocampus. Specific questions to be addressed 
include;
1) Readdress the physiological action of the septo-hippocampal cholinergic 
projection on the principal cell population.
2) Assess the action of septo-hippocampal cholinergic afferents on 
hippocampal interneurones.
3) To assess how cholinergic modulation affects synaptic transmission in the 
hippocampus
4) To investigate how 1-3 affect network dynamics in the hippocampus.
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2.GENERAL METHODS
2.1. S l ic e  P r e p a r a t io n
All Animals (rats and mice) were bred in house, housed in group cages under 
controlled environmental conditions (temperature 19-23°C and 12hr light/dark 
cycles). Animals had ad libitum access to food and water.
2.1.1. Hippocampal slices for traditional intracellular an extracellular 
recordings
Male and female Wistar rats (3-5weeks) were killed by cervical dislocation and 
decapitated in aecordance with U.K. home office guidelines under the authority of 
the U.K. Animals (Scientific Procedures) Act, 1986.
An incision was made along the middle of the head using a scalpel and the skin 
separated to reveal the skull. Using sharp dissecting scissors the skull was cut 
down the midline from back to front and the bone folded to each side to expose 
the brain. The brain, separated from the spinal cord, was carefully removed with a 
small spatula and placed in a beaker of chilled (0-3°C), oxygenated (95% oxygen- 
5% carbon dioxide) artificial cerebrospinal fluid (aCSF; composition mM: NaCl, 
124, KCl, 3, NaHCOs, 26, NaH2? 0 4 , 1.25, MgS0 4 , 1, CaCU, 2, glucose, 10). 5% 
CO2 was included to maintain a correct PH of 7.4. The brain minus the cerebellum
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was subsequently hemisected and a surface trimmed parallel to the desired 
orientation was glued to the stage of a vibrating blade microtome (Leica VTIOOO, 
Milton Keynes, U.K.). Either horizontal (glued to top surface of brain) or 
parasagittal (glued to midline) orientation was chosen for slicing (Figure 2.1).
Ai
B I
Horizontal Orientation I I
Sagittal Orientation
I I
Figure 2.1 O rientation  fo r slicing
Diagram illustrating orientation for slicing. Lines indicate the incisions m ade and the 
exposed surface of the brain, which was glued to the stage of the vibrating blade 
microtome. Slices were subsequently cut from the directly opposing surfaces. Ai. For 
preparation of slices in a horizontal orientation the top surface of the brain was trimmed in 
parallel to the stage surface and slices were cut from the bottom surface of the brain. Aii 
Photograph of a horizontal slice containing the hippocampal formation. Bi. For preparation 
of slices in a sagittal orientation the brain was sliced down the midline, the exposed 
surface was glued to the stage surface and slices were cut from the lateral surfaces. Bii 
Photograph of a sagittal slice containing the hippocampus.
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400|um thick slices were cut on the vibrating blade microtome (Leica VTIOOOS). 
Throughout the slicing procedure the brain and slices were held in a chamber 
containing chilled aCSF. The slices were then transferred to a cold petri dish 
containing chilled aCSF where the hippocampal region of each slice was dissected 
free from surrounding brain tissue. Hippocampal slices were maintained in an 
interface incubation chamber with an oxygen-enriched atmosphere at room 
temperature. Following an incubation period of Ihour the slices were individually 
transferred to an interface recording chamber (see section 2.2.1.1) using a large 
bore suction pipette.
2.1.2. Hippocampal slices for patch clamp recordings
Male and female Wistar rats (PI6-28) were terminally anaesthetised with an 
Intraperitoneal injection of Pentobarbitone Sodium (lOOOmg/kg). Following 
unconsciousness and lack of the paw pitch pain reflex, the abdomen and rib cage 
were opened and a transcardial perfusion was performed. A hypodermic needle 
(19G 1 !4) was inserted and fixed into the left ventricle and an incision made in 
the right atrium, the heart was then perfused with 20-60ml of chilled high sucrose 
aCSF (composition mM: NaCl, 87, KCl, 2.5, NaHCOg, 25, NaH2P0 4 , 1,25, 
MgS0 4 , 7, CaCl2, 0.5, glucose, 11, sucrose, 75) in accordance with U.K. home 
office guidelines. Removal of the brain and preparation of 250pm slices followed 
an identical procedure to that stated above but in the presence of a high sucrose 
aCSF solution. Slices were transferred to a submerged holding chamber, heated to 
37°C for 1 hour and the high sucrose aCSF was gradually (10% every 15mins) 
ehanged to normal aCSF over a period of two hours. Slices were stored in the
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submerged style holding chamber at room temperature (19-24°C) until needed. 
They were then individually transferred to a submerged recording chamber (see 
section 2.2.1.1) using a large bore suction pipette as needed.
2.1.3. Septo-hippocampal slice preparation
Combined septo-hippocampal slices were prepared from male and female Wistar 
rats for use in electrophysiological recordings and confocal immunocytochemistry 
as previously described by Toth and colleagues (Toth et a l, 1997). Tissue used for 
electrophysiological experiments was prepared from 3-5 week old Wistar rats and 
Normal mice killed by cervical dislocation and subsequent decapitation in 
accordance with U.K home office guidelines under the authority of the U.K. 
Animals (Scientific Procedures) Act 1986. Tissue used for confocal 
immunocytochemistry experiments was prepared from 11 day old, 21 day old and 
3 week old Wistar rats. These animals were terminally anaesthetised with an 
intraperitoneal injection of Pentobarbitone Sodium (lOOOmg/kg). Following 
unconsciousness and lack of the paw pitch pain reflex, the abdomen and rib cage 
were opened and a transcardial perfusion was performed as previously described 
above but with a fixative (4% paraformaldehyde in O.IM phosphate buffer) 
replacing the aCSF.
The whole brain was removed as described above and subsequently hemisected 
down the mid-line separating the brain into two pieces (see figure 2.2, incision 1). 
Each half of the brain was taken separately and two subsequent incisions made. 
The first was a parasagittal cut made 2mm lateral from the mid-line extending
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from the rostral pole of the brain to a site close to the start of the fimbria (see 
figures 2.2, incision 2). The second was made from this point at 120° with respect 
to the sagittal plane (see figure 2.2, incision 3). The surface of the brain exposed 
by these two excisions was flattened and glued onto the surface of the microtome 
stage thus straightening the septo-hippocampal projection and allowing 5-600pm 
thick slices containing the intact pathway to be cut on the vibrating blade 
microtome. These septo-hippocampal slices were either maintained in an 
incubation chamber and subsequently used for intracellular recording or frozen in 
100% glycerol and later stained for confocal microscopy.
1 2
120
Figure 2.2 O rien tation  fo r septo -h ip pocam pal slices
Diagram illustrates the preparation of septo-hippocampal slices. Dotted lines (2 and 3) 
indicate the incisions made to expose the surface of the brain, which was flattened and 
glued to the stage of the vibrating blade microtome. Slices containing the entire 
straightened septo-hippocampal pathway were subsequently cut from the directly 
opposing surface (indicated by line 1).
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2.2. E lectrqphysiolqgy
Three types of electrophysiological technique were employed throughout this 
thesis. Sharp electrode intracellular recordings were employed to record from 
hippocampal pyramidal neurones in chapter 3, the whole-cell patch clamp 
technique was employed to record from both CAl and CA3 pyramidal neurones 
and interneurones in chapters 4 and 5 and standard extracellular recordings were 
employed in chapter 5. The recording setup, types of recording chambers, 
recording and stimulation electrodes and details of each recorded technique will 
be outlined in this section.
2.2.1. Recording set-up
The recording chambers, micromanipulators (mechanical model-Narishige, Japan 
& piezo electric driven model-Burleigh, USA), and upright microscope (BX50WI, 
Olympus, Japan) with fixed stage were mounted on a translation table. This itself 
was bolted to an anti-vibration table (Ealing, MA, USA). A steel Faraday cage, 
earthed to a ground common to the amplifier (Axoclamp-2B, Axon instruments, 
Union City, CA, USA), was placed around the recording system to isolate it from 
all extraneous electrical noise (Fig. 2.2). All other electrical equipment, signal 
processor (filter and DC amplifier -model 440, Brownlee Precision, CA, USA), 
digitiser (Digidata 1200 series, Axon instruments, Union City, CA, USA), 
humbug noise subtraction device (Quest Scientific, BC, Canada), PC, Digital tape 
(DAT) recorder (DTK-1404, bio-logic scientific instruments, Caix, France),
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master 8 pulse generator (A.M.P.I, Israel) were secured in an equipment rack 
alongside the Axoclamp 2B current and voltage clamp amplifier (Fig. 2.3).
Amplification and filtering settings varied depending on the type of recording 
configuration employed. Details of these parameters for each configuration ai'e 
provided in section 2.2.2.
Headstage Isolated
stimulatorX0.1
PC
stepactivateAxoclamp
2B
Amplifier
Master 8D igitizer
Humbug 10 V,
Brownlee
Amplifier
DAT
Recorder
Figure 2.3 F low  chart o f recording setup
Figure shows a flow chart of the apparatus used for electrophysiological recording. 
Direction of information transfer is represented by direction of arrows. The recording and 
stimulation eiectrode are indicated by the open triangies attached to the headstage and 
isolated stimulator respectively.
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Micromanipulators
Faraday cage
\ .
Antivibration table
Mm#
Equipment rack
Recording cham ber
Figure 2.4 R ecording  setup
Photographic images illustrating manipulators and microscope secured on antivibration 
table inside faraday cage, with all other equipment secured in racks alongside. Close up 
illustrates recording cham ber mounted under microscope.
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2.2.1.1. Types of Recording chambers
For intracellular and extracellular recording configurations slices were transferred 
to an interface type chamber (Fig. 2.5A). This consisted of a central chamber 
surrounded by an outer water bath, filled with distilled water. The outer water bath 
was heated to approximately 37°c and bubbled with 95% O2, 5% CO2 to provide a 
humid oxygen enriched atmosphere. Oxygenated aCSF was pumped, by means of 
a peristaltic pump (Mini Pulse 3, Gilson, France), through the central chamber 
providing a constant flow rate of l-3ml/min. The Hippocampal slices were placed 
on a nylon mesh suspended in the central chamber in order to be at the interface of 
warmed perfusing aCSF and the oxygen enriched atmosphere but not submerged.
All patch clamp and some extracellular recordings were performed in a submerged 
type of chamber (Fig. 2.5B) consisting of a small circular glass bottomed well 
(volume 1.5-2ml). The slices were submerged in the oxygenated perfusing aCSF 
(l-3ml/min) and maintained at a constant room temperature of 24°C. Slices were 
held in position on the bottom of the recording chamber by a platinum weighted 
grid of parallel nylon threads.
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A
Perfusing 
aCSF O2/CO2I I
Outer water 
bath filled with 
distilled water
Coiled tubing 
containing 
heated water 
(40°C)
(B
Inlet for 
heated water
Perfusing
aCSF
Nylon mesh
W aste aCSF
Central
cham ber
Top v iew
Raised
platform
B
Platinum 
weighted grid of 
nylon threads
► W aste 
Outlet
Glass Bottom Well 
F igure 2.5 Types o f recording cham bers.
A. Diagram illustrating the interface type of recording chamber. Traditional sharp electrode 
intracellular and extracellular recordings were performed in this type of chamber. B. 
Diagram illustrating the subm erged type of recording chamber. Both extracellular and 
patch clamp recordings were performed in this type of recording cham ber
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Hippocampal slices remained viable for up to 12 hours in the interface type of 
chamber and 6 hours for submerged type of chamber, although some deterioration 
was seen throughout the day, particularly in patch clamp recordings. At least a 
one-hour equilibration period was allowed before any electrophysiological 
recordings were obtained.
2.2.1.2. Recording & stimulation electrodes
Recording electrodes for intracellular and extracellular experiments were pulled in 
one stage using a Flaming Brown micropipette puller model P-87 (Sutter 
Instruments Co. USA) from standard walled (outer diameter: 1.2mm; inner 
diameter: 0.69mm) borosilicate glass capillaries (Harvard Apparatus, UK). Patch 
clamp electrodes were pulled in two stages using a vertical PP-830 type 
microelectrode puller (Narishige, Japan) from thin walled (outer diameter: 1.2mm; 
inner diameter: 0.94mm) borosilicate glass capillaries (Harvard Apparatus, UK). 
In the first stage the capillary was thinned over a length of approximately 7mm, 
the heating coil was then re-centred and the second stage started to pull and break 
the thinned section producing two separate microelectrodes. Electrode resistance 
and filling solutions varied according to the type of experiment performed. These 
are fully outlined in table 2.1.
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Filling S olu tions E lectrode resistance (M Q )
Intracellular 1.5M potassium methylsulphate 60-170
Extracellular Standard aCSF 1-5
Patch Clamp KmeS0 4 -based intracellular solution 5-10
Patch Clamp CsCI* based intracellular solution 5-10
Tab le  2.1 F illing so lu tions and final d .c. resistance o f recording e lectrodes.
Table sum m arises the type of filling solution and final d.c. resistance of recording 
electrodes for all recording configurations employed.
Filled recording electrodes were mounted into electrode holders where their filling 
solution came into contact with silver chloride coated silver wire. The electrode 
holder was then inserted into a unity gain head stage (current gain 0.1: Axon 
instruments, CA, USA) and connected to the axoclamp 2B amplifier via the 
microelectrode 1 (MEl) port. A silver chloride bath reference electrode 
submerged in the recording chamber was also connected to the headstage.
Bipolar stimulation electrodes were constructed from two lengths of 0.05mm 
diameter Nickel 80% /chromium 20% wire (Advent Research Materials Ltd., 
England) twisted together and cut at the end. Stimuli, comprised of square wave 
pulses 20-200ps, 0-30mA fixed current intensity, were produced by constant 
current isolated stimulator boxes (Digitimer Ltd., England), which in turn were 
triggered by master-8 pulse generator (A.M.P.I., Israel).
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All stimulating and recording electrodes were mounted on micromanipulators 
(Narishige, Japan and Burleigh, USA) to allow course and fine movement in all 
(x, y  and z) directional planes.
2.2.2. Recording Configurations
2.2.2.1. Intracellular current clamp recordings
Intracellular recordings were performed in an interface-recording chamber. 
Recording electrodes were backfilled with 2% biocytin and 1.5M potassium 
methylsulphate (filtered using 0.2pm syringe filter) to achieve a final DC 
resistance between 60 -  170MQ, which was measured before cell impalement in 
“bridge balance” mode by balancing the unwanted potential drop across the 
microelectrode.
Impalement of pyramidal neurones was achieved by advancing the recording 
electrode through the stratum pyramidale using a Narashige water hydraulic drive 
in two axes. Negative current pulses (0.1 nA) were applied through the recording 
electrode so that any increase in voltage deflection gave an indication that the 
electrode tip was approaching a cell membrane. Subsequent application of an 
oscillatory current “buzz” was then used to facilitate penetration of the electrode 
tip. After impalement, the membrane potential (Vm) of the cell could be measured 
as the potential difference between the recording electrode and the bath reference 
electrode. Prior to searching for cells the microelectrode was positioned
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extracellularly in the slice and the recorded voltage was set to zero. Immediately 
following the end of each experiment this reading was checked again and any 
correction in the recorded membrane potential was made.
Small (O.I to 0.5nA) positive and negative current steps were applied and the 
resulting depolarising and hyperpolarising voltage responses recorded were 
analysed allowing measurement of numerous cell properties such as; cell input 
resistance, calculated from the membrane voltage response to the hyperpolarising 
current steps, action potential amplitude, and action potential duration measured at 
% maximum amplitude. These traces were also used to give a tentative 
identification of cell type. Putative pyramidal neurones were identified on the 
basis of physiological characteristics such as spike frequency adaptation and the 
presence of a slow afterhyperpolaiisation following action potentials. Cell 
impalement and characterisation were routinely performed in normal aCSF, drugs 
were administered after a stable recording was obtained.
The bipolar stimulation electrodes were placed on the slice surface within the 
stratum oriens or directly within the medial septal nucleus (MSN) to stimulate 
cholinergic afferents known to be located within these areas (Frotscher & Leranth, 
1985) while recording the effect on the membrane potential of the impaled 
pyramidal neurone. Stimuli (ranging between 0.01-I2mA intensity and 0.02-0.2ms 
in duration) were delivered at a fixed intensity every 15s for ionotrophic glutamate 
and G ABA receptor mediated responses and every 5 minutes for mAChR 
mediated responses.
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Voltage and current signals recorded through the MEl port were amplified using 
an Axoclamp 2B (headstage gain 0.1, amplifier gain 10) and further amplified 
(XI0) using a Brownlee 440 signal processor giving a final signal amplification of 
XIOO. DC signals were low pass filtered at 5,0KHz, and 50Hz noise removed 
using a humbug (Quest scientific, BC, Canada) signal subtraction device. Output 
signals were digitised (500Hz to 2KHz) through a digidata 1200 interface (Axon 
Instruments Ltd.) connected to a PC.
2.2.2.2. Extracellular field recordings
These experiments were performed in both interface and submerged type 
recording chambers. Standard aCSF was used as the electrode filling solution to 
achieve a final DC resistance between 1-5MQ. Extracellular field potential 
recordings were made in both the CAl and CA3 region of the hippocampus. The 
1-5MQ recording electrodes were placed on the surface of the slice in the stratum 
pyramidale^ stimuli were delivered every 15s via the bipolar stimulation electrode 
positioned within the stratum radiatum and stratum lucidum to activate Schaffer 
collaterals and mossy fibres respectively, resulting field excitatory postsynaptic 
potentials (fEPSP) were recorded with respect to the reference electrode. In 
experiments investigating the effect of drug on the slope of the field EPSP, the test 
fEPSP size was adjusted to 50% of the maximum.
Voltage signals were amplified using an Axoclamp 2B (headstage gain O.I, 
amplifier gain 10) and further amplified (XIOO) using a Brownlee 440 signal
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processor giving a final signal amplification of X I000 Signals were low pass 
filtered at 5.0KHz, and 50Hz noise removed using a humbug (Quest scientific) 
signal subtraction device. Output signal were digitised (500Hz) through a digidata 
1200 interface (Axon Instruments Ltd.) connected to a PC.
2.2.2.3. Patch clamp whole-cell recording
Patch clamp experiments were performed in a submerged recording chamber. 
Electrodes were back filled with an intra-pipette solution, composition (mM): 
KmeS0 4 , 122.5, KCl, 17.5, NaCl, 9, MgCL, 1, EGTA, 0.2, GTP, 0.3, ATP, 3 and 
0.5% Neui’obiotin or CsCl, 135, MgCb, 2, HEPES, 10 nd 0.5% Neurohiotin. 
(Filtered using 0.2pm syringe filter) to achieve a final DC resistance between 6- 
lOMQ. Whole-cell current and voltage clamp recordings were obtained from CAl 
pyramidal neurones and interneurones under visual control using inhared 
differential interference contrast (DIC) optics and the blow and seal patch-clamp 
technique (Fig. 2.7).
Healthy target cells were chosen on a shiny, smooth appearance of the cell suiTace. 
The development of high resistance seal requires a clean plasma membrane 
surface and electrode tip, thus slight positive pressure was applied to the pipette 
interior while advancing through the slice towards the chosen target cell so that 
the pipette solution streamed outwards maintaining a clean electrode tip and 
cleaning the surface of the target cell. The electrode tip was slowly manoeuvred to 
the cell surface while recording voltage and current steps applied through the 
electrode. Once the electrode tip touched the cell membrane (as seen by slight
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dimpling of the cell membrane) the positive pressure was immediately released to 
form a low resistance seal, characterised by a reduced current trace. At this point 
application of slight negative pressure could increase the seal resistance until a 
high resistance gigaohm seal was achieved characterised, by no current flow. In 
some cases a gigaolim seal developed spontaneously without the need for suction. 
Subsequent hyperpolarisation of the electrode to -70mV and application of short 
suction pulses ruptured the membrane patch without breaking the gigaohm seal to 
achieve the whole cell patch-clamp formation. Either voltage or cui*rent clamp 
configuration was chosen for the duration of the experiment.
In current clamp mode applications of small positive and negative current 
injections were again used for cell identification. Putative interneurones could be 
tentatively identified and distinguished from pyramidal neurones on the basis of 
their physiological characteristics, such as high spontaneous firing rates, large 
spike afterhyperpolarisations, weak spike frequency adaptation and high input 
resistances. Stimulation electrodes were placed on the surface of the slice within 
the stratum oriens to stimulate cholinergic afferents while recording from the 
patched CAl pyramidal neurone or interneurone. Postsynaptic potentials were 
recorded as deflections in the membrane potential after stimulation.
In voltage clamp mode spontaneous and miniature excitatory and inhibitory 
postsynaptic currents (EPSC and IPSC) were recorded from both CAl and CA3 
pyramidal neurones and interneurones.
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Voltage and current signals were amplified using an Axoclamp 2B (head stage 
gain 0.1, amplifier gain 10) and further amplified (XI0 or XIOO) using a Brownlee 
440 signal processor. DC signals were low pass filtered at 2.0KHz, and 50Hz
noise removed using a humbug (Quest scientific) signal subtraction device.
Output signals were digitised (500Hz to 2KHz) through a digidata 1200 interface 
(Axon Instruments Ltd.) connected to a PC.
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Low  resistance seal
G igaohm  seal
Apply negative pressure
À
CELL A TTA C H ED  R EC O R D IN G
Short suction puises
W H O LE  C ELL R EC O R D IN G
Figure 2.6 B low  and seal Patch -c lam p techn ique
Diagram illustrating the formation of a high resistance gigaseal and subsequent steps to 
achieve the whole cell patch-clamp formation used for recording. Electrode tips were 
advanced through the hippocampal slice to the cell surface where positive pressure was 
released. This resulted in the formation of a low resistance seal between the electrode 
and cell membrane. Subsequent application of negative pressure increased seal 
resistance until a high resistance gigaohm seal was achieved resulting in the cell attached 
formation. After formation of the gigaohm seal application of short suction pulses ruptured 
the m em brane patch to achieve the whole-cell recording formation.
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2 .3 . D a t a  D is p l a y  a n d  S t o r a g e
Data display and storage methods were the same for all types of recordings 
performed. All digitised data was captured, viewed and stored onto a PC hard disk 
using Clampex 8 software (Axon Instruments, CA, USA). The DAT recorder 
provided a DAT record backup copy and a source of high-resolution (44KHz) 
signal for further analysis.
2 .4 . D a t a  A n a l y s is
All data was analysed offline using the software packages Clampfit 8 (Axon 
Instruments, CA, USA) or Mini Analysis version 5.06.0028 (Synaposoft Inc. GA, 
USA). Data are presented as means ± standard error of the mean (S.E.M.). The n 
value refers to the number of times a particular experiment was performed, each in 
a different slice taken &om a different rat.
Statistical analyses: Wilcoxon matched pairs test. Students t test, analysis of 
variants (ANOVAs) and subsequent post hoc tests (Bonferroini and Tukeys) were 
performed using Graph Pad Prism version 3.02 for windows (GraphPad Software, 
San Diego California, USA). The Kolmogorov-Smirnov two sample test for 
comparison of cumulative probability plots was performed directly on Mini 
Analysis (Synaptosoft Inc. GA, USA). All data was tested for normal distribution 
before any parametric tests were applied. Probability values of less than 0.05 were 
considered significant.
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2 .5 . B io c y t in /  N e u r o b io t in  L a b e l l in g
The intracellular markers Biocytin (Sigma-Aldrich, Poole, UK) or Neurobiotin 
(Vector Laboratories, Peterborough, UK) were present in both patch and 
intracellular electrodes, application of depolarising current pulses allowed 
sufficient diffusion of these markers into the neurone under observation. On 
completion of recordings slices were fixed overnight in a fixative solution 
composed of 2.5% paraformaldehyde, 1.25% gluteraldehyde, 15% (v/v) picric 
acid in 0.1 M phosphate buffer (PB; pH 7.4). After fixation slices were washed in 
O.IM PB and infiltrated with 10% and 20% sucrose. Each slice was then snap- 
frozen, thawed in PB and washed for a further 20 minutes. The slices were 
embedded in 10% gelatin and fixed for a period of 2 hours before they were re­
sectioned to 60pM thickness. The new 60pm sections were washed in PB 
containing 10% methanol and 3% H2O2 for 5 minutes to abolish background 
peroxidase activity.
After two 20 minute washes in O.IM PB and three 10 minutes washes in 
phosphate buffer saline (PBS; 0.9% NaCl) the sections were incubated overnight 
at 4°C with a 1% avidin-biotinylated horseradish peroxidase complex (ABC kit, 
Vector Laboratories, Peterborough, UK).
Three 30 minute washes in PBS and two 20 minute washes in PB sufficiently 
removed excess ABC before developing the sections using the 3,3’- 
diaminobenzidine (DAB) substrate kit for peroxidase (Vector laboratories,
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Peterborough, UK) with nickel intensification. Excess DAB was removed by three 
20-minute washes in PB. The sections were then washed in distilled water for 20 
minutes, floated onto glass slides and left to dry before being dehydrated in a 
series of ethanol solutions (50%, 70%, 90%, 100%, 2 minutes in each), 10 
minutes in histoclear and finally cover slipped.
All cells were subsequently scrutinised under light microscopy to confirm their 
true location and to identify where possible the nature and extent of the dendritic 
and axonal arbourisation. Strongly labelled cells were selected for graphical 
reconstruction using a drawing tube attachment (camera lucida).
2 .6 . CoNFOCAL M ic r o s c o p y
Septo-hippocampal brain slices for confocal analysis were prepared as described 
in section 2.1.3. Slices were washed thoroughly prior to overnight incubation with 
goat anti-ChAT (1:100 AB144P, Chemicon international) and mouse anti- 
parvalbumin (1:500, P-3088, Sigma-Aldrich, UK) in 0.3% triton X in PBS. After 
several washes in O.IM phosphate buffer, sections underwent a further 3 hour 
incubation in fluorescent secondary antibodies in 0.3% triton X in PBS (donkey 
anti-goat Alex Fluor 488 at 1:500, Invitrogen Molecular Probes and anti-mouse 
Rhodamine at 1:100, Jackson ImmunoResearch Laboratories). Sections were 
finally washed 3 times before being mounted under a coverslip in Vectasheild 
mounting medium for fluorescence (Vector Laboratories, Peterbourgh, U.K).
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Septo-hippocampal slices were visualised with a BioRad Radiance 2100 confocal 
laser scanning system equipped with a green (He-Ne) laser and a red diode laser. 
The excitation and emission wavelengths were 493nm and 519nm respectively for 
AlexoFlour 488 and 595nm and 61mn for Rhodamine,
Slices reacted for antibodies against ChAT and PV were visualised under 
brightfield in the first instance to locate the position of the medial septal nucleus 
and hippocampus and subsequently scrutinised under epifluorescence on a 
confocal microscope (BioRad Radiance 2100 confocal scanning system, BioRad, 
Hemmel Hempsted, UK). Z-series were scanned at 0.5pm z-separation. Confocal 
image stacks were viewed and analysed on Confocal Assistant version 4.02. 
Stacks were flattened and arranged to provide a complete image of the septo- 
hippocampal pathway.
2 .7 . D r u g s
All drugs were dissolved in deionised water and stored as frozen 1ml aliquots of 
stock solutions 100 to 1000 times’ the final concentration. Drug application and 
final dilution was either via perfusion medium for a period no less than 15 
minutes or pressure ejected directly onto the slices using a pico-injection system 
(Harvard Apparatus, UK) pressure pulse 3-8 PSI, 10msec in duration.
Atropine, Carbachol, Choline, Picrotoxin, Physostigmine (eserine)
dimethylphenyl-piperanzininm (DMPP) all purchased from Sigma-Aldrich 
Company Ltd (Poole, England, UK); Bicuculline and 6-nitro-
7 sulphamoylbenzo [/] quinoxaline-2,3 -dione (NBQX) purchased from tocris 
Cookson (Bristol, U.K.); Nicotine purchased from BDH chemicals Ltd (Poole, 
England, UK).
D-(E)-2-Amino-4-methyl-5-phosphono-3-pentanoic acid (CGP 40116), [l-(S)-3,4- 
dichlorophenyl)ethyl]amino-2-(6)-hydroxypropyl-p-benzyl-phosphoic acid (CGP 
5 5 845A) were gifts from Dr Kumlesh Dev, Novartis Pharmaceuticals, Basel, 
Switzerland.
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3. ISOLATION OF SLOW CHOLINERGIC RESPONSES IN
CAl PYRAMIDAL NEURONES BY STIMULATION OF
CHOLINERGIC AFFERENTS
3 .1 . I n t r o d u c t io n
In recent years it has become evident that activation of muscarinic acetylcholine 
receptors (mAChRs) has a variety of effects on the passive and active properties 
of glutamatergic principal cells within the hippocampus. As mentioned in chapter 
one, the major responses of pyramidal neurones to mAChR activation include:
1) A slow depolarisation from resting membrane potential (EPSPm).
2) A depression of the slow afterhyperpolarisation (AHP) following a train of 
action potentials.
3) A blockade of spike frequency adaptation (SFA)
4) A blockade of the ‘M current’. (Halliwell & Adams, 1982)
5) Production of afterdepolarisations (ADPs) and plateau potentials (PPs)
6) A calcium wave propagating from the apical dendrite to the soma.
7) Reduced glutamate release from presynaptic terminals of pyramidal 
neurones.
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MAChRs present on both CAl and CA3 hippocampal pyi'amidal neurones can be 
activated by application of the cholinergic agonists, acetylcholine (Benardo & 
Prince, 1981, 1982; Segal, 1982; Cole & Nicoll, 1983), carbachol (Haas, 1982; 
Cole & Nicoll, 1984a, b; Müller & Misgeld, 1986; Madison et a l, 1987; Benson 
et a l, 1988; Dutar & Nicoll, 1988a) muscarine (Cole & Nicoll, 1984b) and 
pilocarpine (Cole & Nicoll, 1984b) or by synaptically released acetylcholine on 
electrical stimulation of cholinergic afferents within the stratum oriens of the 
hippocampal slice preparation (Cole & Nicoll, 1983, 1984a; Müller & Misgeld, 
1986; Madison a/., 1987; Segal, 1988).
The aim of this initial results chapter was to further investigate the evoked 
cholinergic response in CAl pyramidal neurones. A second aim was to verify the 
functional integrity of the septo-hippocampal cholinergic projection within the 
hippocampal slice preparation for future studies investigating cholinergic 
regulation of GABAergic interneurones as detailed in chapter four of this thesis.
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3 .2 . R e s u l t s
3.2.1. Characterisation of CAl pyramidal neurones
16 CAl pyramidal neurones in the rat hippocampus were recorded initially using 
traditional sharp intracellular recording electrodes as described in chapter two. In 
order to fully characterise the impaled cell, positive and negative current injections 
were applied and the resultant depolarising and hyperpolarising voltage responses 
investigated (Fig. 3.1 A). The resulting voltage traces were used to give a tentative 
indication of cell type prior to anatomical confirmation. As illustrated in figure 3.1 
pyramidal neurones show characteristics such as spike frequency adaptation and 
small slow afterhyperpolarisations (AHPs). Throughout all experiments, cells 
were loaded with the intracellulai' marker biocytin and slices subsequently 
processed for light microscope evaluation to confirm the cells identity (Fig. 3.IB 
and C). Pyramidal neurones could be distinguished by their characteristic cone- 
shaped cell bodies, located within the stratum pyramidale, with basal dendrites 
extending into the stratum oriens and apical dendrites extending into the stratum 
radiatum and lacunosum-moleculare where they branched in a dichotomous 
manner. Their dendritic tree was characteristically covered with spines (Fig 
3.ID).
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Figure 3.1 C haracterisation  o f C A l pyram idal neurones.
A. Representative voltage traces (upper trace) recorded from a CA1 pyramidal 
neurone in response to applied intracellular current injection (lower trace). 
Positive and negative current steps resulted in depolarising and hyperpolarizing 
voltage responses respectively. Note that this cell showed pronounced spike 
frequency adaptation (SFA), indicated by increasing arrow length between 
action potentials on the upper trace, and small slow afterhyperpolarisations 
(AHP) characteristic of a pyramidal neurone. B. Low power (x20) light 
micrograph of the corresponding CA1 pyramidal neurone stained by 
intracellular injection of biocytin. 0 . Camera Lucida reconstruction of the sam e 
cell revealed a bipolar neurone with basal dendrites fanning out in stratum 
oriens and primary apical dendrites extending through stratum radiatum and 
lacunosum-moleculare where it branched in a dichotomous manner. D. higher 
power (x 40) LM micrograph of another CA1 pyramidal neurone revealed 
characteristic dense spines on the dendritic surface.
Other properties such as resting membrane potential and input resistance were 
monitored throughout the experiment to give a complete characterisation and 
monitor the physiological status of each CAl pyramidal neurone during the 
recorded period. Only neurones with a resting membrane potential of -50mV and 
lower were included in this study. The 16 pyramidal neurones recorded had a 
mean resting membrane potential of 60.73±2.93mV, mean input resistance of 
50.59±4.16MQ and mean action potential height and duration (measured at half 
maximal amplitude) of 69.41±2.03mV and 0.913±0.03ms respectively. This data 
is summarised in Table 3.1.
Resting 
membrane 
potential (mV)
-60.73+2.9
Cell input 
resistance 
(MQ)
50.59+4.2
Action potential 
amplitude (mV)
69.41 ±2.03
Action piotential 
duration (ms) 
(measured at % 
amplitude)
0.9110.03
Tab le  3.1 G eneral properties o f pyram idal neurones recorded in h ippocam pal 
slices.
In order to monitor the physiological status of CM  pyramidal neurones, four param eters 
were m easured throughout the sharp-electrode intracellular recordings. This table shows 
mean values ±S.E.M. of each param eter calculated from all CM  pyramidal neurones 
(n=16).
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3.2.2. Fast amino acid synaptic transmission
Application of a low intensity (<200pA, 0.02ms) single stimulus within the 
stratum oriens (Fig 3.2A) produced a compound depolarising then hyperpolarising 
synaptic response in the impaled pyramidal neurone (Fig 3.2Bi). This compound 
EPSP-IPSF displayed fast kinetics consistent with the activation of glutamatergic 
and GABAergic postsynaptic receptors respectively. Both the depolarising and 
hyperpolarising evoked components were strongly suppressed by subsequent 
application of a cocktail of antagonists for amino acid receptors (n=16) (Fig. 
3.2BÜ and 3.2C). The antagonist cocktail consisted of NBQX, CGP40116, 
Picrotoxin and CGP55845A selective antagonists for AMP A, NMD A, GABAa 
and GABAb mediated responses respectively as outline in figure 3.2D.
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Figure 3.2. inhib ition  o f fas t am ino acid synaptic  transm iss ion  in CA1 
pyram idal neurones.
A. Diagram illustrating the position of recording and stimulation electrodes 
within the hippocampal slice. B. Representative voltage traces recorded 
from a CA1 pyramidal neurone in response to a single stimulus (lOOpA, 
0.02ms) delivered within the stratum oriens. Bi. Shows the response 
evoked in control medium (control) illustrating the production of a fast EPSP 
followed by an IPSP (trace is an average of 5 traces at 15s intervals). Bii. 
Illustrates the near complete blockade of this fast synaptic transmission 
following addition of NBQX (2pM), CGP40116 (SOpM), picrotoxin (50pM) 
and CGP555845A (1pM). C. Point plots showing reduction in the mean 
amplitude of the EPSP and IPSP after addition of antagonist cocktail (each 
point is an average of 5 traces recorded at each time point for a single 
experiment). D. Table shows the components of the antagonist cocktail 
used to block all fast amino acid synaptic transmission including; the 
transmitter and receptor responsible for each response, the antagonist and 
the concentration applied to inhibit each response. In this and all 
subsequent figures, filled triangles (A) below each voltage trace indicates 
the time point of afferent stimulation.
3.2.3. Stimulation evoked slow EPSPs
Having blocked fast amino acid transmission and in the continued presence of the 
amino acid receptor antagonist cocktail, subsequently increasing the stimulus 
intensity and duration (10-400pA, 0,2ms) uncovered a slow excitatoiy 
postsynaptic potential (EPSP) in 10 of 11 CAl pyramidal neurones in which this 
was attempted. Such responses were similar to those previously reported (Cole & 
Nicoll, 1984a; Morton, 1998) in that they displayed a slow waveform with a mean 
peak amplitude of 5.078 ±1.82mV and mean time to peak of 10.07±2.972s. This 
slow EPSP could be suprathreshold for action potential generation, which resulted 
in an intense discharge of action potential firing.
Although clearly present this slow EPSP was very small in the majority of 
pyramidal neurones recorded, with a mean peak amplitude of 2.08+0.5 ImV and a 
mean time to peak of 14.18+4.084s (n=6). However in the presence of the 
acetylcholinesterase inhibitor eserine (l|_iM) this response could be significantly 
enhanced to a mean peak amplitude of 6.09±0.846mV and mean time to peak of 
13.33±4.767s (P= 0.0208, n=6, Fig. 3.3 & 3.4). In order to obtain robust and 
consistent responses from all pyramidal neurones recorded all subsequent 
experiments were carried out in the presence of IpM eserine.
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Figure 3.3. The s low  EPSP evoked by electrical stim ulation  w ith in  the  
stratum oriens.
A. Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow EPSP, with a peak amplitude of 2.05mV, evoked by a train of 
stimuli (5 x 0.2ms, 10|iA pulses @ 20Hz) delivered within the stratum oriens 
when all fast synaptic transmission was blocked by the antagonist cocktail.
B. Representative voltage trace recorded from the sam e pyramidal neurone 
showing a slow EPSP, with a peak amplitude of 6.75mV, evoked by the 
sam e stimulation param eters in the presence of the acetylcholinesterase 
inhibitor eserine (1fiM). Note that the peak amplitude of depolarisation was 
enhanced in the presence of eserine by 229% in this example, and that the 
membrane potential was more likely to be depolarised to firing threshold. 
Unless otherwise stated all subsequent responses shown will be in the 
presence of 1 pM eserine.
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Figure 3.4. E ffect o f the  chollnesterase inh ib itor eserine on the slow  
EPSP.
A. Successive voltage traces recorded from a CA1 pyramidal neurone at 5- 
10 minute intervals illustrating the augmentation of the slow EPSP as  IpM 
eserine w ashes into the bath B. Point plot of the corresponding peak 
amplitudes of the successive EPSPs evoked every 5-10 minutes. The solid 
bar indicates duration of eserine application. Note that full augmentation of 
the slow EPSP was seen within 15-35 minutes after eserine application. 0 . 
Bar chart of pooled data from 4 individual pyramidal neurones illustrating 
the significant potentiation of the mean peak amplitude of the slow EPSP 
from 2.08+0.51 mV to 6.09±0.846mV in the presence of eserine (n=4, P= 
0.0208). D. Bar chart in which the pooled data for the peak amplitude of 
EPSPs recorded after 15-30 minutes of eserine application is expressed as 
a percentage of the mean value of peak amplitude prior to eserine 
application. Note that eserine application results in a 200% increase in 
mean peak amplitude. Values are expressed as a mean ± S.E.M, P value 
was calculated using a paired t-test after data passed test for normal 
distribution.
Overall 11 out of 12 pyramidal neurones responded to stimulation within the 
stratum oriens with a slow, often suprathreshold, depolarisation in the presence of 
eserine showing a mean peak amplitude of 6.109 ±0.54mV and a mean time to 
peak of 10.14+2.743s. The slow EPSP could be consistently evoked every 5 
minutes with no significant rundown of the second response (n =6, P=0.609). This 
is shown graphically in figure 3.5, which compares consecutive responses evoked 
at 5-minute intervals.
3.2.4. Stimulation parameters
A consistent finding was that the amplitude and duration of the slow EPSP was 
dependent upon the precise stimulation parameters used. In particular, the 
stimulus amplitude (intensity), presumably reflecting the number of cholinergic 
fibres recruited, and the number of stimuli, presumably reflecting the amount or 
reliability of transmitter released at any given stimulated fibre, were critical 
determinants.
Figure 3.6A shows voltage traces from a representative pyramidal neurone where 
an initial single shock stimulus (lOpA, 0.2ms) delivered within the stratum oriens 
evoked a slow EPSP with a peak amplitude of 4.3mV. Subsequent application of a 
brief train of 5 stimuli (lOpA, 0.2ms) at a frequency of 20Hz dramatically 
increased the peak amplitude of depolarisation to 6.75mV and increased the firing 
duration and firing rate of the evoked slow response. This potentiation was seen in 
5 of the 6 cells tested (Fig. 3.6B).
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Figure 3.5. C onsis tent s low  EPSPs can be evoked using a 5 m inute  
stim ulus in terval.
A. Representative voltage traces recorded from a CA1 pyramidal neurone 
showing two successive slow EPSPs, of peak amplitude of 5.75mV and 
6.75mV respectively, evoked by a train of stimuli (5 x 0.2ms, IGpA pulses 
@ 20Hz) delivered within the stratum oriens at an inter-stimulus interval of 
5 minutes. Note that the second response shows no depression in peak 
amplitude, although a slight reduction in firing rate is apparent this was not 
a consistent finding in all cells. B. Bar chart showing no depression of the 
second synaptic response in 6 individual pyramidal cells when an inter­
stimulus interval of 5 minutes was used. The second response is expressed 
as  percentage of the peak amplitude of the first response (taken to be 
100%). 0 . Bar chart of pooled data showing no significant depression of the 
second EPSP (n=6, P=0.609). P value was calculated from the raw data, 
using a paired t-test after data passed test for normal distribution.
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Figure 3.6. S low  EPSPs evoked by delivery o f a 20H z tra in  o f s tim uli 
w ith in  the stratum  oriens.
A, Representative voltage traces recorded from a CA1 pyramidal neurone 
showing a slow EPSP, of peak amplitude 4.3mV, evoked by a single 10pA 
(pulse duration 0.2ms) stimulus delivered within the stratum oriens (Ai) and 
a slow EPSP, of peak amplitude 6.75mV, evoked by a 20Hz train of 5 
stimuli of the sam e intensity and duration (Aii). Note the increase in peak 
amplitude, firing duration and firing rate on application of a train of stimuli.
B, Bar chart showing the mean peak amplitude of slow EPSPs evoked in 6 
individual CA1 pyramidal neurones with a single stimulus and subsequently 
with a train of 5 stimuli. C, Bar chart of pooled data illustrating the 
significant increase in mean peak amplitude of the slow EPSP from 
4.35±0.639mV when evoked with a single stimuli to 6.69±0.604mV when 
evoked by a train of stimuli (n = 6, P =0.0303). Values are expressed as  a 
mean ± S.E.M., P value was calculated using a paired t-test, after data 
passed test for normal distribution. Unless otherwise stated all subsequent 
responses shown in this chapter were evoked using a train of 5 stimuli @ 
20Hz and a pulse duration of 0.2ms.
Overall the mean peak amplitude of depolarisation significantly increased from 
4.53+0.639 to 6.69±0.604mV on application of a train of stimuli (n=6, P=0.0303, 
Fig. 3.6C).
Increasing the stimulation intensity also increased the amplitude of the slow 
EPSP. This effect was apparent whether a single or train of stimuli were applied. 
Figure 3.7A shows voltage traces from a representative pyramidal neurone where 
a slow EPSP, with a peak amplitude of 4.3mV, was evoked with a single stimulus 
of lOpA (0.2ms duration). Subsequently increasing the stimulation intensity to 
40pA increased the amplitude of the evoked slow EPSP to 5.65mV. Fig 3.7B 
shows a similar potentiation of the slow EPSP from 6.75mV to 9.4mV using a 
20Hz train of 5 stimuli at lOpA and 40pA respectively.
In order to evoke robust and consistent slow EPSPs we routinely included the 
AChE inhibitor, eserine, in the aCSF and used a train of 5 stimuli at 20Hz every 5 
minutes. The stimulation intensity needed to evoke a slow EPSP varied between 
cells, possibly due to the fact that the position of the stimulation electrode relative 
to the impaled cell and cholinergic afférents differed across slices.
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Figure 3.7. E ffect o f stim ulation  intensity on the s low  EPSP
A, Representative voltage traces recorded from a single CA1 pyramidal 
neurone showing a slow EPSP, with a peak amplitude of 4.3mV, evoked 
by a single 10pA (0.2ms duration) stimulus delivered within the stratum 
oriens (Ai) and a slow EPSP, with a peak amplitude of 5.65mV, evoked by 
a single 40pA (0.2ms duration) stimulus (Aii). B, Representative voltage 
traces from the sam e pyramidal neurone showing a slow EPSP with a 
peak amplitude of 6.75mV, evoked by a train of 10pA stimuli (5 x 0.2ms, 
10pA @ 20Hz) delivered within the stratum oriens (Bi) and a slow EPSP, 
with a peak amplitude of 9.4mV, evoked by a train of 40pA stimuli (Bii). 
Note that increasing the stimulation intensity increased the peak amplitude 
of the slow EPSP whether a single or train of stimuli was used to evoke 
the initial response.
3.2.5. Carbachol evoked slow EPSPs
The effect of the acetylchoUne analogue carbachol on the membrane potential of 
CAl pyramidal neurones was compared with the effect of electrical stimulation of 
the stratum oriens. Rapid application of carbachol (lOpM) by pressure ejection 
through a carbachol filled pipette tip placed close (~50pm) to the recording site 
elicited a slow depolarising response in 4 CAl pyramidal neurones tested. This 
depolarising response displayed slow kinetics in a range similar to that of the 
previously described slow EPSP (mean peak amplitude 10.42±1.067mV, time to 
peak of 33.8±5.709s). As with evoked slow EPSPs direct carbachol application 
resulted in an intense discharge of action potential firing (Fig. 3.8).
3.2.6. Muscarinic nature of the slow EPSP
In order to establish the pharmacological nature of the slow depolarising synaptic 
responses, further studies were carried out using the selective mAChR antagonists 
atropine and pirenzepine.
Addition of atropine (5pM) significantly inhibited the mean peak amplitude of the 
evoked slow EPSP recorded in CAl pyramidal neurones from 6.574±0.621mV to 
0.866±0.252mV (n=8, P<0.0001) an inlribition of over 80% (Fig. 3.9 & 3.10).
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Figure 3.8 A com parison  o f the effects o f carbachol and electrical 
stim ulation  w ith in  the stratum oriens.
A. Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow depolarisation of the membrane potential, with a peak 
amplitude 13.2mV, induced by rapid application of carbachol (10pM). The 
point of carbachol application is indicated by the open triangle ( A ) .  This 
slow depolarisation in response to carbachol application was recorded in 4 
pyramidal neurones, with a mean peak amplitude of 10.42±1.067mV and a 
mean time to peak amplitude of 33.8±5.709s. B. A representative voltage 
trace recorded from a CA1 pyramidal neurone showing a slow EPSP, with a 
peak amplitude of S.SSmV, evoked by a train of stimuli (5 x 50pA, 0.2ms 
pulses @ 20 Hz) is shown for comparative purposes. Note that the 
carbachol induced depolarisation is similar in waveform to the slow EPSP 
evoked by electrical stimulation within the stratum oriens and that both 
protocols can induce repetitive action potential firing in CA1 pyramidal 
neurones. Values are expressed as  a mean ± S.E.M.
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Figure 3.9. E ffect o f the  selective  m A C hR  antagon ist a trop ine  on the  
slow  EPSP.
A. Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow EPSP, with a peak amplitude of 6.75mV, evoked by a train 
of stimuli (5 x10pA , 0.2ms @ 20Hz) delivered within the stratum oriens.
B. Representative voltage trace from the sam e pyramidal neurone 
illustrating the effect of the selective mAChR anatgonist atropine (5pM) on 
the production of a slow EPSP (peak amplitude 0.4mV). Note that atropine 
inhibits the slow EPSP evoked by electrical stimulation within the stratum 
oriens by over 90% in this example.
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Figure 3.10. The s lo w  EPSP is inhib ited by the selective  m A C hR  
an tagon is t atrop ine
A. Point plot showing the time course of the atropine (5|iM) effect as  it 
w ashes into the bath. Each data point is a mean of the peak amplitude of 
the slow EPSP expressed as  a percentage of its own control in 7 individual 
pyramidal neurones. Note that depression of the slow EPSP occurs within 
15-30 minutes of atropine application (n=7, solid bar indicates period of 
atropine application). B. Bar chart illustrating the reduction of the mean 
peak amplitude of the slow EPSP in 8 individual CAl pyramidal neurons. 
Control values are calculated a s  a mean of the peak amplitude of EPSPs 
recorded prior to atropine application, atropine values are calculated as  a 
mean of the peak amplitude of EPSPs recorded 15-30 minutes after 
atropine application. C. Bar chart of pooled data for all 8 pyramidal 
neurones illustrating that atropine significantly depresses the mean peak 
amplitude of the slow EPSP from 6.574±0.621mV to 0.866±0.252mV (n=8, 
P<0.001). D. Bar chart in which the pooled data for the peak amplitude of 
the slow EPSPs recorded 15-30 minutes after atropine application is 
expressed as  a percentage of the mean value of the control EPSPs 
recorded prior to atropine application. Note that atropine results in over an 
80% reduction in mean peak amplitude. Values are expressed as  a mean ± 
S.E.M., P values were calculated using a paired t-test, after data passed 
test for normal distribution.
In slices in which a cholinergic EPSP was repeatedly evoked every 5 minutes, 
addition of the selective mAChR antagonist atropine resulted in a gradual 
reduction of the response amplitude as the atropine washed into the bath and 
resulted in a near complete abolition of the evoked response within 15-3 Omins 
following the onset of application (Fig 3.10A).
The mean peak amplitude of the slow EPSP was also significantly reduced from 
5.207±1.2mV to 0.7±0.49mV (n=4, P-0.0092, 86% inhibition) by the addition of 
the selective mAChR antagonist pirenzepine (Fig. 3.11) applied at a concentration 
that is reported to show selectivity towards the Ml subtype of mAChR (Hammer 
et a l, 1980). These experiments confirmed that the slow EPSP is principally 
mediated by mAChR activation and extends the work of Cole and Nicoll (1984a) 
by suggesting that the EPSPm is principally mediated through activation of the 
Ml mAChR subtype.
3.2.7. Septo-hippocampal slices
The aim of preparing septo-hippocampal slices was to produce acute slices, which 
would contain an intact septo-hippocampal projection allowing us to activate this 
functionally significant pathway and observe the postsynaptic responses in CA3 
and CAl pyramidal neurones of the hippocampus (Fig. 3.12A). In total, 9 
pyramidal neurones were recorded in rat septo-hippocampal slices, their general 
properties are summarised in table 3.2.
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Figure 3.11. E ffect o f the  selective  m A C hR  antagon ist p irenzep ine on  
the  s low  EPSP.
A, Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow EPSP, with a peak amplitude of 7.7mV, evoked by a train of 
stimuli (5 x 4mA, 0.2ms @ 20Hz) delivered within the stratum oriens. Aii. 
Representative voltage trace from the sam e pyramidal neurone illustrating 
the effect of the selective mAChR anatgonist pirenzepine (10pM) on the 
slow EPSP (peak amplitude 1.45mV). Note that pirenzepine depressed the 
peak amplitude of the slow EPSP evoked on electrical stimulation within the 
stratum oriens by 81% in this example B. Bar chart of pooled data for 4 
pyramidal neurones illustrating the significant depression of the peak 
amplitude of the slow EPSP from 5.207±1.2mV to 0.7±0.49mV (P=0.0092).
C. Bar chart in which the pooled data for the peak amplitude of the slow 
EPSP recorded after 15-30 minutes in the presence of pirenzepine is 
expressed as  a percentage of the mean value of control E PSPs recorded 
prior to drug application (n=4). Note pirenzepine significantly depressed the 
slow EPSP by over 80%. Values are expressed as  a mean ± S.E.M., P 
value was calculated using a paired t-test, after data passed test for normal 
distribution.
Resting Cell input Action potential Action potential
membrane resistance amplitude (mV) duration (ms)
potential (mV) (MQ) , (measured at */i
amplitude
-58.27+2.54 73.11+3.04 71.8+5.2 1.45+0.1
Tab le  3.2 G eneral properties o f rat pyram idal neurones recorded from  septo - 
hippocam pal s lices.
In order to monitor the physiological status of hippocampal pyramidal neurones, four 
param eters were m easured throughout the sharp-electrode intracellular recordings. This 
table shows mean values ±S.E.M. of each param eter calculated from all pyramidal 
neurones recorded in the rat septo-hippocampal slice preparation (n=9).
Stimulation within the MSN elicited a slow EPSP in the 9 pyramidal neurones 
tested, with a mean peak amplitude of 10.32+1.65 ImV and a mean time to peak of 
11.797+1.166s. This slow EPSP was similar in waveform to that seen in the 
hippocampal slice preparation (Fig 3.12B) and was similarly blocked by 
application of atropine (n=2, data not shown). This data confirmed that activation 
of cholinergic afférents, originating in the MSN, produce a slow cholinergic EPSP 
in hippocampal pyramidal neurones.
Figure 3.12B shows simultaneous recordings from two pyramidal neurones 
displaying slow EPSP in response to MSN stimulation. Note the striking 
synchronous timing of the responses with both cells firing the first spike at exactly 
the same time. This illustrates the tight interconnection of cells within the
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hippocampal network and that release of ACh from septal cholinergic afférents 
may act to synchronise pyramidal neurone firing. In foiu of the recorded 
pyramidal neurones IPSPs could be seen tlu'oughout the evoked slow EPSP (fig 
3.12C) suggesting some activation of a GABAergic input to the pyramidal 
neurones on stimulation within the MSN.
The preparation of septo-hippocampal slices from the rat brain proved difficult in 
that from visual inspection as well as by electrical stimulation it was clear that 
only a minority of slices contained the intact septo-hippocampal connection. This 
is consistent with previous reports that only a single slice with the intact 
connection is obtained from a single rat brain (Toth et a l, 1997). By preparing 
similar slices from smaller mouse brains the overall size and fragility of the slice 
was reduced increasing the likelihood that a single slice would include an intact 
functional septo-hippocampal projection and allowed easier implementation of the 
experimental protocol. In total 6 pyramidal neurones were recorded in mouse 
septohippo campai slices, properties of the cells are summarised below in table 3.3.
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A Recording sites
B
Stimulation 
site
Pyramidal neurone 1
20m  V
Pyramidal neurone 2
2 0  m V
Î Î
5 s
Figure 3.12 Isolation o f a s low  EPSP in C A l pyram idal neurons  
using the septo -h ippocam pal s lice preparation.
A. Low power micrograph of the septo-hippocampal slice preparation 
indicating the position of the stimulation electrode within the medial septal 
nucleus (MSN) and the position of recording electrodes within the 
hippocampus. B. Representative voltage traces from two simultaneously 
recorded pyramidal cells illustrating the production of a slow EPSP in both 
cells on electrical stimulation within the MSN. Note the peak amplitude, 
delay and time course of the response is very similar in the two 
postsynaptic neurons. 0 . Shows a representative voltage trace for a 
pyramidal neurone where IPSPs (indicated by arrows) are present 
throughout the slow EPSP.
Resting Cell input Action potential Action potential
memtn*ane * resistance (MQ) amplitude (mV) duration (ms)
potential (mV) measured at Vi
mmpiw=de
-63.512.68 101.33112.02 70.5512.45 0.910.03
T ab le  3.3 G eneral Properties o f m ouse pyram idal neurones recorded from  the  
sep toh ippocam pal s lice preparation ..
In order to monitor the physiological status of hippocampal pyramidal neurones, four 
param eters were m easured throughout the sharp-electrode intracellular recordings. This 
table shows mean values ±S.E.M. of each param eter calculated from all pyramidal 
neurones recorded in the m ouse septo-hippocampal slice preparation (n=6).
Figure 3.13A shows the production of a slow EPSP on stimulation of the MSN in 
both rat and mouse slices. The rat and mouse responses were very similar in 
appearance and a paired t-test indicated no significant difference in the mean peak 
amplitude of the slow EPSP recorded from the rat pyramidal neurones 
(10.32±1.65mV, n=9) compared to those recorded from the mouse pyramidal 
neurones (6.962±0.97mV, n=6, P=0.1495). As there was no significant difference 
between the rat and mouse responses data collected from both species was pooled 
and presented as one data set from this point forward (mean peak amplitude 
8.975±1.123mV, mean time to peak 10.26+0.95, n=15).
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Figure 3.13 S low  EPSP evoked by electrical stim ulation  o f the MSN  
in both rat and m ouse slices.
A. Representative voltage traces recorded from CAl pyramidal neurones 
showing slow EPSPs evoked by electrical stimulation within the MSN. Ai 
illustrates a slow EPSP, with a peak amplitude of S.OmV evoked by a 
train of stimuli (5 x 5mA, 0.2ms @ 20Hz) in the rat septo-hippocampal 
slice. Aii Illustrates a slow EPSP, with a peak amplitude of 5.8mV, 
evoked by a train of stimuli (5 x 6mA, 0.2ms @20Hz) in the mouse 
septo-hippocampal slice (Aii). B. Bar chart of pooled data comparing the 
mean peak amplitude of the slow EPSP evoked by stimulation of the 
MSN in rat (10.32±1.65mV, n=9) and mouse (6.962±0.97mV, n=6) 
septo-hippocampal slices. An unpaired t-test indicated that there was no 
significant difference in mean peak amplitudes (P= 0.1495). Values are 
expressed a s  a mean ± S.E.M., P values were calculated using an 
unpaired t-test, after data had passed test for normal distribution.
In order to confirm the cholinergic nature of the slow EPSP evoked by electrical 
stimulation within the MSN of the septo-hippocampal slices, slices were perfused 
with the selective mAChR antagonist atropine (5pM). This concentration of 
atropine significantly inliibited the peak amplitude of the slow EPSP from 
9.021+2.878 to 0.0344±0.087mV (n=5, P=0.0489, Fig. 3.14), an inhibition of over 
96%. This data confirmed that the slow EPSP evoked by electrical stimulation 
within the MSN is mediated via activation of mAChRs.
Due to the difficulties in preparation of the septo-hippocampal slices and the 
generally low yield of slices, at best a single septo-hippocampal slice per 
experimental animal, we wished to asses whether there were qualitative or 
quantitative differences between the slow cholinergic EPSP obtained from 
stimulation of the cholinergic afferents within the MSN and direct stimulation of 
cholinergic fibres locally within the stratum oriens of the hippocampus.
Such a comparison, shown in figure 3.15, revealed a similar slow waveform 
showing no significant difference in amplitude or time course of slow EPSP. Slow 
EPSPs evoked on stimulation of the stratum oriens had a mean peak amplitude of 
6.109±0.54mV (n=ll) compared to 8.975±1.123mV on stimulation of the MSN 
(n=15, P=0.187), and a mean time to peak of 10.14±2.743s on stratum oriens 
stimulation compared to 10.264±0.95s on MSN stimulation (P=0.9620).
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Figure 3.14 A trop ine abolishes the s low  EPSP evoked by MSN  
stim ulation .
Ai. Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow EPSP, of peak amplitude 5.8mV, evoked by a train of 
stimuli (5 x 6mA, 0.2ms @20Hz) delivered within the MSN. Aii 
Representative voltage trace from the sam e pyramidal neurone illustrating 
the effect of atropine (5pM) on the production of the slow EPSP (peak 
amplitude 0.4mV). Note that atropine inhibits the slow EPSP evoked by 
electrical stimulation within the MSN. B. Bar chart of pooled data from 5 
pyramidal neurones illustrating that atropine significantly dep resses the 
mean peak amplitude of the slow EPSP from 9.021±2.878mV to 
0.0344±0.087mV (n=5, P= 0.0410). C. Bar chart in which pooled data for 
the mean peak amplitude of the slow EPSPs recorded 15-30 minutes after 
atropine application is expressed as a percentage of the m ean value of the 
control EPSPs recorded prior to atropine application. Note that atropine 
results in over an 90% reduction in mean peak amplitude. Values are 
expressed as  a mean ± S.E.M., P values were calculated using a paired t- 
test, after data had passed test for normal distribution.
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Figure 3.15 C om parison o f cholinerg ic responses evoked by MSN  
and oriens stim ulation
Ai. Representative voltage trace recorded from a CA1 pyramidal neurone 
showing a slow EPSP, with a peak amplitude of 5.8mV, evoked by a 
train of stimuli (5 x 6mA, 0.2ms @ 20Hz) delivered within the MSN of the 
septo-hippocampal slice preparation. Aii. Representative voltage trace 
recorded from a CA1 pyramidal neurone showing a slow EPSP, with a 
peak amplitude of 6.3mV, evoked by a train of stimuli (5 x 10pA, 0.2ms 
@ 20Hz) within the stratum oriens. Note that stimulation within either 
area results in a slow EPSP with similar characteristic waveform 
irrespective of stimulation site. B. Bar chart of pooled data comparing 
mean peak amplitude of the slow EPSP evoked by stratum oriens 
(6.109±0.54mV, n=11) and MSN (8.975±1.123mV, n=15) stimulation. An 
unpaired t-test indicated no significant difference in peak amplitude of the 
response (P=0.0512). 0 . bar chart of pooled data comparing mean time 
to peak of the slow EPSP evoked by stratum oriens (10.14±2.743s) and 
MSN (10.26±0.95s) stimulation. An unpaired t-test indicated no 
significant difference in time to peak (P=0.9620). Values are expressed 
as  a mean ± S.E.M., P values were calculated using an unpaired t-test 
after data had passed test for normal distribution.
This data indicates that stimulation within the stratum oriens region of the 
hippocampal slice is as robust and reliable a method for stimulating cholinergic 
fibres as direct stimulation within the MSN itself. It is also supportive of the fact 
that we activate the same fibres (albeit downstream) when we stimulate locally 
and that contamination by stimulation of other local fibres is not a confounding 
problem.
3 .3 . D is c u s s io n
3.3.1. The slow EPSPm
The results presented in this chapter build upon the original findings of Cole and 
Nieoll (1983) who first reported that electrical stimulation of intrinsic cholinergic 
fibres within the hippocampal slice resulted in a slow EPSP mediated by mAChRs 
(EPSPm) in hippoeampal pyi'amidal neurones. Although a number of locations in 
the sliee were chosen for the stimulation site Cole and Nicoll (1983) reported the 
strongest effects when stimulating within the stratum oriens.
The results presented here agree with these original findings showing that delivery 
of stimuli within the stratum oriens of the hippocampal slice preparation, in the 
presence of an antagonist cocktail, to block all fast amino acid transmission, 
consistently evoked a slow EPSP in CAl pyramidal neurones. This slow EPSP 
was most likely due to the action of synaptically released acetylcholine as septo-
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hippocampal cholinergic fibres are known to be present within the stratum oriens 
(Lewis & Shute, 1967b; Frotscher & Leranth, 1985). This observation was further 
supported by the subsequent data showing that the slow EPSP was enlianced in the 
presence of eserine, which acts to inhibit acetylcholinesterase (AChE) the enzyme 
that typically hydrolyses synaptically released ACh.
As the slow EPSP was more substantial and easier to evoke in the presence of the 
AChE inhibitor, eserine, this was routinely included in the perfusion medium. 
However, the fact that this slow EPSP could be uncovered in the absence of 
eserine provided evidence that the slow EPSP brought about by aetivation of 
cholinergic afferents is a physiologically relevant event and is not artificially 
produced due to the increased levels of ACh, which would not be achieved in 
vivo. However, it should be noted that more subtle electrophysiological changes 
have previously been reported at levels of afferent stimulation below that required 
to produce a membrane potential depolarisation. These include the reduction of 
the slow afterhyperpolarisation leading to a diminished level of spike frequency 
adaptation (Cole & Nicoll, 1983; Segal, 1988).
Application of a train of stimuli rather than a single stimulus enhanced the slow 
EPSP evoked by electrical stimulation. This result was expected and presumably 
reflects the accumulation of ACh following the repeated activation of cholinergic 
fibres. Moreover, it is known that putative cholinergie cells within the MSN which 
project to the hippocampus fire repetitively and in relation to the hippoeampal 
theta rhythm in vivo (Brazlmik & Fox, 1999).
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Increasing the stimulus intensity also increased the amplitude and duration of the 
slow EPSP. This agrees with previous studies (Segal, 1988; Morton & Davies, 
1997; Morton et a l, 2001) and presumably reflects the fact that an increase in 
stimulation intensity would ultimately recruit more fibres and subsequently 
increase the amount of synaptically released acetylcholine.
Although not thoroughly investigated here the slow EPSP is known to show a 
significant refractory period in which responses are unable to be evoked or show 
diminished peak amplitudes if stimuli are delivered less than 5 minutes after prior 
stimulation (Morton, 1998). Due to these previously reported results we evoked 
subsequent slow EPSPs no less than 5 minutes after the previous response was 
recorded and as such observed no obvious depression of the second EPSP.
A similar slow depolarisation of the membrane potential could be produeed by 
application of the cholinergic agonist carbachol. The similar nature of this 
depolarisation suggested that the response produced by electrical stimulation 
within the stratum oriens was due to activation of cholinergic receptors on 
pyramidal neurones. However as carbachol is a non-selective agonist at both 
nAChRs and mAChRs this did not allow determination of the receptor subtype 
responsible.
Application of the selective mAChR antagonist atropine substantially inhibited the 
slow EPSP produced by stimulation of cholinergic afferents. These data allowed
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the slow EPSP to be attributed to activation of mAChRs present on hippocampal 
pyramidal neurones and as such to be defined as the EPSPm. These data support 
previous pharmacological and immunocytochemical studies, which have shown 
the expression of mAChRs on hippocampal principal cells (Benardo & Prince, 
1981, 1982; Haas, 1982; Segal, 1982; Spencer et a l, 1986; Levey et a l, 1995) and 
confirms Cole and Nicolls (1983) original observation that the slow EPSP 
produced on stimulation of the stratum oriens is mediated by mAChRs.
A second mAChR antagonist pirenzepine also significantly inliibited the slow 
EPSP and thus may indicate a role of the Ml mAChR, as this agonist is known to 
show some selectivity for this mAChR subtype (Hammer et a l, 1980). This 
finding agrees with a number of previous studies, which reported a blockade of 
slow EPSP in the presence of pirenzepine (Müller & Misgeld, 1986; Dutar & 
Nicoll, 1988a; Segal, 1988; Pitler & Alger, 1990). Although these data suggest 
that a significant part of the slow EPSP is due to activation of the Ml mAChR 
subtype, pirenzepine’s lack of complete selectivity for Ml and previous reports for 
a role of the M2 and M3 mAChR subtypes (Müller & Misgeld, 1986; Segal, 1988; 
Pitler & Alger, 1990) do not allow an exclusive role for the Ml mACliR subtype 
to be concluded.
The complexity and numerous components of the cholinergic response is 
produced by the depression of a variety of potassium currents and it is likely that 
this diversity is the result of an activation of different mAChR subtypes rather 
than the coupling of a single mAChR subtype with different ionophores. The
122
subtle effects such as depression of the slow AHP and resulting blockade of SFA 
are thought to be due to an inhibition of the slow ealeium activated current ( I a h p )  
(Madison et a l, 1987), most likely mediated via activation of the M2 mACliR 
subtype (Müller & Misgeld, 1986; Segal, 1988), whereas the production of the 
slow EPSP is thought to be due to an inhibition of a leak cunent ( I k (l e a k )) 
(Madison et a l, 1987; Benson et a l, 1988), hence the previously reported 
associated increase in input resistance (Cole & Nicoll, 1983, 1984a; Morton, 
1998), and activation of a non-selective cation current (Colino & Halliwell, 1993) 
presumably mediated via activation of the Ml (Müller & Misgeld, 1986; Benson 
et a l, 1988) and/or M3 mAChR subtypes (Pitler & Alger, 1990).
That the production of the slow EPSP was mainly due to activation of mAChRs 
and not nAChRs is consistent with other reports. Whilst pyramidal neurones do 
appear to express nAChR subunits (Sudweeks & Yakel, 2000), most 
electrophysiological studies in acute hippocampal slices suggest that activation of 
nAChRs does not produce any significant membrane response in pyramidal 
neurones. McQuiston and Madison (1999c) recently showed a barely detectable 
inward current on applieation of nAChR agonists in a minority of cells but this 
was in contrast to the overt membrane currents observed in hippocampal 
interneurones.
In general, the activation of mAChRs acts to excite hippocampal pyramidal 
neurones. This excitation can take the form of that seen here in production of the 
slow EPSP but also can take the form of plateau potentials. Although these events
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arise tlii'ough slightly different mechanism the ultimate outcome of either event is 
a sustained depolarisation of these neurones. This prolonged excitation of 
pyramidal neurones could be detrimental and if left unregulated may ultimately 
result in epileptogenesis. However the slow EPSPm is known to be regulated by 
other endogenous neuromodulators such as adenosine and GABA (Morton & 
Davies, 1997; Morton et a l, 2001). Adenosine acts to inhibit the slow EPSPm via 
activation of the A1 receptor subtype present at the presynaptic locus, presumably 
by an inhibition of ACh release. GABA also acts to inliibit the slow EPSPm via 
activation of GAB As receptors. These neuromodulators are active tonically and 
provide an important mechanism for controlling prolonged excitation in these 
cells.
3.3.2. Integrity of the septo-hippocampal projection
The primary source of ACh in the hippocampus is released from cholinergic 
afferents originating within the medial septal nucleus (MSN). Cell bodies within 
the MSN send their non-myelinated axons to the hippocampal formation where 
they ramify extensively. These fibres along with GABA afferents make up the 
septo-hippocampal projection. However, other sources of ACh do exist including 
intrinsic cholinergic interneurones (Frotscher et a l, 1986; Frotscher et a l, 2000) 
and other midbrain inputs including the basal nucleus of Meynert (Kitt et a l ,
1982).
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The aim of preparing septo-hippocampal slices was to produce acute slices, which 
would contain an intact septo-hippocampal projection allowing us to activate this 
functionally significant pathway and observe the responses in hippocampal 
pyramidal neurones. Similar stimulation protocols to those used in the 
hippocampal slice were carried out on the septo-hippocampal slice preparation. 
However with this preparation the stimuli could be directly applied to the MSN 
while recording the resulting membrane responses evoked in CAl pyramidal 
neurones within the hippocampus. This protocol elicited a similar slow EPSP to 
that produced on stratum oriens stimulation.
Atropine again significantly inhibited the slow EPSP, this together with the lack of 
significant difference between responses evoked by stratum oriens stimulation and 
MSN stimulation confirms that the slow EPSP produced in pyramidal neurones on 
stimulation of the MSN is the same EPSPm produced when stimulation is applied 
within the stratum oriens of hippocampal slices. We suggest that stimulation 
within the stratum oriens presumably activates the same cholinergic afferent fibres 
as direct stimulation within the MSN. However this is only likely to be confirmed 
directly through lesioning experiments.
The observation that the mouse septo-hippocampal slice was easier to prepare in 
that it was more likely to encompass the whole septo-hippocampal projection 
indicates a promising model system for future studies. Indeed, an interesting 
approach would be to pharmacologically induce patterned oscillatory activities in 
the MSN and then assess the consequence of this upon hippocampal circuitry
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dynamics. Authors in the past have been forced to use septo-hippocampal co­
cultures (Gahwiler & Brown, 1985) which have many drawbacks including 
immature circuitry and a predisposition to epileptiform activity.
3 .4 . S u m m a r y
These results show that electrical stimulation within the stratum oriens of the 
hippocampal slice preparation can activate cholinergic afferents originating from 
the MSN. Stimulation of these septo-hippocampal afferents results in a robust 
slow EPSP in pyramidal neurones, mediated by mAChRs. This directly confirms 
the notion that activation of the septo-hippocampal cholinergic system causes 
general excitation of the principal cell population in the hippocampus.
Evidence is also provided that the functional integrity of the septo-hippocampal 
cholinergic projection is maintained within the hippocampal slice preparation, 
despite the presynaptic axons being severed, as the same response is produced 
whether the cholinergic cell bodies are directly stimulated within the MSN or just 
the projection fibres within the stratum oriens of the hippocampus.
Due to the difficulties associated with the production of septo-hippocampal slices 
and the above evidence that the structural integrity of the cholinergic projection is 
maintained within the hippocampal slice preparation, it is therefore reasonable to 
use only the hippocampal slice preparation for all subsequent experiments.
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4. ISOLATION OF SLOW CHOLINERGIC RESPONSES IN
CAl GABAERGIC INTERNEURONES
4.1. I n t r o d u c t i o n
A large body of evidence suggests that in addition to the principal cell population, 
hippocampal interneurones are also regulated by the cholinergic input from the 
medial septal nucleus (MSN). The production of cholinergic responses in 
hippocampal interneurones has previously been shown pharmacologically by the 
use of cholinergic agonists (Benardo & Prince, 1982; Reece & Schwartzkroin, 
1991; Jones & Yakel, 1997; Frazier et a l, 1998b; Pan'a et a l, 1998; McQuiston & 
Madison, 1999c, a). However, much less is known about the action of 
physiologically released ACh upon the varied population of hippocampal 
interneurones.
As mentioned in chapter one, CAl interneurones are known to express both 
nACliR and mAChRs (Freedman et al, 1993; Levey et a l, 1995; Hâjos et a l, 
1998; Fabian-Fine et a l, 2001; Kawai et a l, 2002). A recent detailed study by 
McQuiston and Madison (1999a) reported that CAl interneurones responded to 
mAChR agonists with one of four’ types of postsynaptic response
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1) A depolarisation from resting membrane potential.
2) A hyperpolarisation from resting membrane potential.
3) A biphasic response consisting of the hyperpolarisation followed by the 
depolarisation.
4) No response.
mAChR agonists are also thought to act at presynaptic mAChRs to directly 
influence GABA release from presynaptic terminals. Previous studies have shown 
that mAChR activation leads to a decrease of miniature IPSP (mIPSC) frequency 
recorded in CAl pyramidal neurones indicating an inhibition of GABA release 
from presynaptic terminals of interneurones (Behrends & TenBruggencate, 1993). 
Subsequent immunocytochemical studies showed that parvalbumin-containing 
basket cells and axo-axonic cells expressed M2 mAChRs exclusively on their 
terminals which may be responsible for this inliibition of GABA release (Hajos et 
al, 1998).
In addition to these mAChR mediated responses, hippocampal interneurones also 
respond to nAChR agonists with a depolarisation from resting membrane 
potential. However these nACliR-mediated depolarisations vary in time course. 
The two major response types reported are a fast depolarisation mediated by a7 
subunit containing receptors (Alkondon et a l, 1997b; Jones & Yakel, 1997; 
Frazier et a l, 1998b; McQuiston & Madison, 1999c) and a slower depolarisation 
mediated by a4|32 subunit containing nAChRs (Alkondon et a l, 1999).
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Stimulation of cholinergic afferents within the stratum oriens has also provided 
some evidence of a synaptic nAChR response in CAl interneurones consisting of 
an EPSC (Alkondon et a l, 1998; Frazier et a l, 1998a) but the mAChR responses 
have not been investigated in this mamier.
The aim of this chapter was to investigate and characterise the synaptically 
mediated effects of ACh release on CAl interneurones evoked by stimulation of 
septo-hippocampal afferents within the hippocampal slice preparation, primarily 
focusing on eliciting the mAChR mediated responses that have been observed 
under direct application of ACh (McQuiston & Madison, 1999a).
4.2. R e s u l t s
4.2.1. Verification of the septo-hippocampal projection
The whole-cell patch clamp technique on visually identified neurones was 
employed throughout this chapter in order to increase yield of successful 
recordings from the numerically sparse population of CAl interneurones. As 
stated in chapter two, slices to be used for patch clamping were prepared from 
neonatal rats between 16 and 21 days old (PI6-21). This change in age group was 
necessary due to the fact that slices prepared from younger animals have less 
connective tissue allowing easier visualisation and access to individual cells. 
However the septo-hippocampal cholinergic projection is not fully formed to adult 
level until at least postnatal day 14 (PI4) (Matthews et a l, 1974; Milner et a l,
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1983) with full adult expression of mAChRs present at P I6 (Goidbach et a l, 
1998). Therefore immunocytochemical studies, using antibodies directed towards 
the acetylcholine synthesising enzyme, choline acetyltransferase (CliAT) were 
initially carried out to ensure that the age of rat used in these experiments showed 
sufficient development of the septo-hippocampal cholinergic system.
Immunofluorescence labelling of a septo-hippocampal slice prepared from PI 6-21 
Wistar rats revealed intensely labelled ChAT immunopositive neurones within the 
medial septal nucleus (MSN). The ChAT immunopositive neurones gave rise to a 
dense ChAT immunopositive axonal projection that coursed towards and 
innervated the hippocampal region of the slice. Within the hippocampal formation 
these ChAT immunopositive axons branched extensively, ramifying tliroughout 
all subfields where they formed a dense meshwork of varicosities. ChAT 
immunolabelling was present in all laminae but was particularly intense within the 
stratum oriens and stratum radiatum. Dual immunofluoresence with a second 
antibody directed toward the calcium binding protein parvalbumin (PV), a marker 
for a subpopulation of GABAergic interneurones (Kosaka et a l, 1987; Nitsch et 
a l, 1990; Gulyas et a l, 1991; Sik et a l, 1995), showed that PV immunopositive 
interneurones were present in both the MSN and the hippocampal formation. This 
dual labelling also suggested a strong cholinergic innervation of the hippocampal 
PV immunopositive cells with the appearance of putative sites of synaptic contact 
(Fig 4.1).
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Figure 4.1 S tructu re  o f the septo -h ippocam pal (S -H ) pro jection  
revealed by dual an ti-cho line  acety ltransferase (C hA T) and anti- 
parvalbum in (PV) im m unolabelling .
A. Low power micrograph montage showing S-H cholinergic projection in 
which ChAT-immunoreactive neurones are indicated in green and PV- 
immunoreactive profiles in red. Insets indicate relative position of 
structures. Section was cut to optimise S-H connectivity a s  described in 
methods. B. Higher power micrograph indicating the abundance of ChAT- 
immunoreactive and PV-immunoreactive cell bodies within the septal 
nucleus. 0 . Higher power micrograph indicating a dense projection of 
ChAT-immunoreactive fibres (arrowheads) coursing towards the 
hippocampal formation. Note also the presence of PV-immunoreactive 
som ata within the pathway. D. Micrograph showing PV-immunopositive 
interneurones within the hippocampus together with ChAT- 
immunoreactive axon fibres which form boutons and ramify extensively 
within the hippocampus. E. High power micrograph indicating a PV- 
immunopositive neurone and putative sites of synaptic contact from ChAT 
immunoreactive fibres.
Abbreviations: hf, hippocampal formation; ff, fimbria-fornix; ms/db, medial 
septal nucleus / diagonal band complex; ac, anterior commissure. Scale 
bars: A, 250pm; B-C, 50pm;D, 100 pm; E, 10pm.
4.2.2. Characterisation and identification of cell types.
Hippocampal neurones were patch clamped under visual control and recorded in 
the whole-cell formation using KmeS0 4  based pipette solution as described in 
chapter two. Putative pyramidal neurones were easily distinguished from putative 
interneurones on the basis of their cell body location (pyramidal neurone somata 
being mainly restricted to the cell body layers) and biophysical membrane 
properties such as spike frequency adaptation and afterhyperpolarisations. 
Characterisation of the patched cells was identical in manner to that used in 
chapter three. Positive and negative current injections were applied to produce 
depolarising and hyperpolarising voltage responses respectively (Figure 4.2). The 
resulting voltage traces were used to give a tentative indication of cell type. 
Putative pyramidal neurones were again identified by the presence of a 
pronounced spike frequency adaptation (SFA) and small slow 
afterhyperpolarisations (AHPs) (Fig 4.2A) whereas GABAergic interneurones 
show little or no SFA and the presence of large fast AHPs (Fig 4.2B). During 
each individual recording the neurone was loaded with the intracellular marker 
Neurobiotin (Vector laboratories, U.K.), once again allowing the putative cell type 
to be confirmed by post hoc morphological light microscope examination (Fig 4.2 
C).
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Whole-cell patch clamp recordings from a CA1 pyramidal neurone and a 
CA1 Interneurone A. Shows an example of a representative recording 
showing voltage traces (upper trace) from a CA1 pyramidal neurone in 
response to applied current injection (lower trace). Positive and negative 
current steps applied to a CA1 pyramidal neurone resulted in depolarising 
and hyperpolarising voltage responses respectively. Note the characteristic 
properties of a pyramidal neurone such as pronounced spike frequency 
adaptation (SFA, indicated by increasing arrow length) and small slow 
afterhyperpolarisations (AHP). B. Similar representative current and voltage 
traces recorded from a CA1 interneurone with somata located within the 
stratum oriens. Note this neurone shows little SFA and large fast AHPs 
(indicated by arrows) characteristic of hippocampal interneurones. 
Subsequent post hoc morphological LM examination was used where 
possible to confirm cell identity. C. Camera lucida partial reconstruction of 
the corresponding pyramidal neurone and stratum oriens interneurone. 
Note the conical shape of the CA1 pyramidal neurone soma located within 
the stratum pyramidale. The basal dendrites branch into the stratum oriens 
and the primary apical dendrites extending and branching through the 
stratum radiatum and stratum lacunosum-moleculare. The axons of CA1 
pyramidal neurones (not shown) typically entered stratum oriens where 
they branched before running parallel with the alveus. The interneurone 
recorded in stratum oriens has a more rounded soma that is oval in shape 
located within the stratum oriens with dendrites running horizontally in both 
directions throughout the stratum oriens. The axon from this cell ascended 
into the stratum radiatium before becoming too faint to follow further.
Overall 59 CAl interneurones with cell bodies located in both the stratum oriens 
and stratum radiatum of the hippocampus were recorded using the whole-cell 
patch clamp technique. These 59 interneurones had a mean resting membrane 
potential of 67.4+1.49mV, a mean input resistance of 738.8+43.1IMQ and a mean 
action potential height and duration of 68.7+1.787 and 2.3+0.1128 respectively. 9 
CAl pyramidal neurones were also recorded using the whole-cell patch clamp 
technique. These cells had a mean resting membrane potential of 74.5±2.502mV a 
mean input resistance of 265.8+35.64MO and a mean action potential height and 
duration of 80.45+4.577 and 2.3+0.1036 respectively. These properties were 
measured tliroughout each whole cell recording and could be used to further 
characterise neurone type and monitor the physiological status of each cell. In 
general, interneurones have a larger input resistance than pyramidal neurones and 
pyramidal neurones display characteristic overshooting action potentials. A full 
comparison of these cell properties is summarised in table 4.1.
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Resting  
m em brane  
potentia l (m V) 
(w ith  JP  
allow ance)
C ell Input 
resistance  
(M f2)
A ction
potentia l
am plitude
(m V)
A ction  
potentia l 
duration  (m s) 
(m easured  at 
% am plitude)
CA1 -67.2±1.41 738.8±43.11 68.7±1.787 2.3±0.1128
Interneurones 
(n=59)
CA1 Pyramidal -74.5±2.502 265.8±35.64 80.45±4.577 2.3±0.1036
neurones (n=9)
Tab le  4.1 C om parison  o f C A l pyram idal and In terneurone properties.
In order to give a complete characterisation and monitor the physiological status of 
hippocampal pyramidal neurones and interneurones, resting m em brane potential, cell 
input resistance and action potential amplitude and duration were recorded from all 
neurones throughout the whole-cell recordings. This table shows the mean values ± 
S.E.M. for the 59 CA1 interneurones and 9 CA1 pyramidal neurones recorded. Note the 
larger input resistance of the interneurones and the overshooting action potentials of the 
pyramidal neurones provided two additional discriminating factors.
4.2.3. Evoked cholinergic responses
Application of a low intensity (0.1-0.5mA, 0.02ms) single stimulus within the 
stratum oriens of the hippocampal slice produced a fast EPSP-IPSP complex in 
recorded CAl intemeurones consistent with the activation of glutamatergic and 
GABAergic afferents (n=12) (Fig. 4.3Ai). This fast synaptic transmission was 
inhibited by the addition of a cocktail of competitive antagonists for amino acid
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receptors (Fig 4.3AÜ). The antagonist cocktail consisted of NBQX (2pM), 
CGP40116 (50p,M), CGP55845A (IpM) and Bicuculline (lOqM) blocking 
AMP A, NMD A, GABAb and GABAa mediated responses respectively. The 
nature of evoked glutamatergic and GABAergic synaptic responses are well 
documented (Lacaille, 1991; Buhl et a l, 1994b; Sik et a i, 1995; Buhl et a l, 1996) 
and were thus not subjected to any further rigorous investigation.
Further studies were carried out to investigate and characterise evoked cholinergic 
responses from this cell population. Increasing the stimulus intensity and duration 
( l“20mA, mean 7.99±0.985mA, 0.2ms), in the continued presence of the amino 
acid antagonist cocktail, uncovered a slow depolarisation of the membrane 
potential, with a mean peak amplitude and time to peak of 7.0910±0.5212mV and 
16.29±0.983s (Fig 4.3B) respectively in 42 of the 59 CAl interneurones in which 
this was attempted. In order for a depolarisation to be included as a synaptically 
evoked response the change in membrane potential after afferent stimulation had 
to be greater than 2mV. Addition of the mAChR antagonist atropine (5jrM) 
significantly inliibited the peak amplitude of the slow depolarisation recorded in 
CAl interneurones from 8.262+0.8006 to 1.56±0.3648mV, an 81% inhibition 
(?<0.0001,n=12. Fig 4.3C).
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A. Representative voltage traces recorded from a stratum oriens 
interneurone (SO interneurone) in the whole-cell patch clamp configuration. 
Ai. Illustrates a fast EPSP evoked in response to a single 0.5mA (0.02ms) 
electrical stimulation of afferents within the stratum oriens. Aii. Illustrates 
the complete blockade of this fast evoked synaptic response following the 
addition of NBQX (2pM), CGP40116 (50|iM) and bicuculline (10 pM). B. 
Representative voltage trace illustrating that subsequently increasing the 
stimulation intensity and duration (1mA, 2ms) elicited a much more 
pronounced and prolonged depolarising response, with a peak amplitude of 
9.1mV, similar to that described in CAl pyramidal neurones. Slow 
depolarising responses were recorded in 42 out of 59 intemeurones tested 
with a mean peak amplitude 7.86±0.533mV and a mean time to peak of 
16.29±0.983s. 0 . Representative voltage trace showing the effect of the 
selective mAChR antagonist atropine (5pM) on the evoked slow 
depolarisation (peak amplitude 1.9mV). Note that atropine inhibits the peak 
amplitude of the slow depolarisation by 80% in this example. Application of 
atropine (5pM) significantly inhibited the peak amplitude of the slow 
depolarisation in 12 of 12 intemeurones tested from 8.26±0.801mV to 
1.56±0.365mV (P<0.0001). Values are expressed as a mean ± S.E.M., P 
values were calculated using a paired t-test after data passed test for 
normal distribution. Filled triangles (A) below each voltage trace indicates 
the time point of afferent stimulation.
In order to fully characterise and quantify these depolarisations from CAl 
intemeurones four individual parameters were measured, as outlined in figure 4.4. 
These parameters were 1. Peak amplitude of depolarisation, measured in millivolts 
(mV) as the difference between the membrane potential before afferent 
stimulation and the peak membrane potential recorded after afferent stimulation. 
2. Peak latency, measured in seconds (s) as the time taken to reach the peak 
amplitude of depolarisation from the point of afferent stimulation. 3. Time to first 
action potential, measured in seconds (s) as the time taken from point of afferent 
stimulation to the first action potential fired. 4. Number of action potentials fired 
throughout the recorded response.
Slow mAChR-mediated EPSPs of mean peak amplitude 7.797+1.75 ImV were 
also recorded in 8 out of 9 pyramidal neurones under similar conditions (Fig 4.5). 
These responses were analysed in a similar manner and the results are summarised 
in table 4.2. As the slow EPSPm recorded in CAl pyramidal neurones was 
thoroughly investigated with traditional sharp intracellular recording in the 
previous chapter, the remainder of this chapter will concentrate only on the 
responses obtained from CAl intemeurones.
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Figure 4.4 Q uantification o f th e  depo larisa tion  recorded  in CA1 
h ippocam pal in tem eu ro n es.
In order to provide quantitative evaluation of evoked cholinergic responses 
in CA1 intemeurones, four param eters representing the magnitude and 
timecourse of the response were measured. Peak am plitude of 
depolarisation was defined as the difference between the membrane 
potential before afferent stimulation and the peak membrane potential after 
afferent stimulation (distance between solid lines) and expressed as a value 
in millivolts (mV). Tim e-to-peak depolarisation was defined a s  the interval 
from the end of the stimulation train to the first point of peak depolarisation 
(distance between dotted lines) and expressed as  a value in seconds(s). 
Time to  first ac tion  potential was defined as the interval from the end of 
the stimulation train (sam e time point used for time to peak depolarisation) 
to the first action potential fired and expressed as  a value in seconds (s). 
The num ber of action po ten tia ls fired were simply counted.
AÀ CONTROL
20 mV
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Figure 4 .5  isolation o f cholinerg ic  responses in CA1 pyram idal 
neurones recorded in the w hole -ce ll configuration .
A. Representative voltage trace recorded from a CA1 pyramidal neurone in 
the whole-cell patch clamp configuration, showing a slow EPSP, with a 
peak amplitude of 4.7mV, evoked by a train of stimuli (5 x 3mA, 0.2ms @ 
20Hz) delivered within the stratum oriens. A slow EPSP was recorded in 8 
of 9 pyramidal neurones recorded with a mean peak amplitude of 
7.797±1.751mV and a mean a time to peak of 17.55±2.24s. B. 
representative voltage trace from the sam e pyramidal neurone illustrating 
an 85% inhibition of the slow EPSP, to peak amplitude of 0.7mV, in the 
presence of mAChR antagonist atropine (S^iM). Note that electrical 
stimulation within the stratum oriens elicits a mAChR-mediated response in 
CA1 pyramidal neurones recorded in the whole-cell configuration similar to 
that previously reported in chapter 3 using traditional sharp electrode 
recording. Values are expressed as  a mean±S.E.M.
g  M ean Peak T im e to  peak T im e to N um ber o f
m em brane am plitude o f 1 am plitude firs t action  | action
potentia l(m V ) depo larisation potentia l p otentia l
at w h ich (m V) g (s) fired
response
w as evoked
(w ith  J P )
CA1 -69.17+1.66 7.910+0.5212 16.29+0.9831 7.866+1.081 22.65+3.527
intemeurones (range -96 .3 (range 2.4- (range 4.5- (range 0.08- (range 0-
(n=42) to -52.0 ) 17.3) 29.54) 22.97) 87_
C Al -69.1+2.69 7.797+1.751 17.55+2.24 5.863+0.789 37.5+7.420
pyramidal (range -77 .3 (range 2.95- (range 8.1- (range 2.65- (range 14-
neurones to -55.4 ) 15.8) 25.52) I I  8.45) 66)
(n-8)
Tab le  4.2  C om parison o f evoked depo larisations in CA1 in tem euron es  and CA1 
pyram idal neurones.
This table shows the individual properties for a mAChR-mediated slow depolarisation in 
both CA1 intemeurones and CA1 pyramidal neurones. Note the similarities in each 
individual property.
4.2.4. The interneurone response
Initially all experiments were conducted in the presence of the acetylcholinesterase 
inhibitor eserine (IpM) to increase the likelihood of evoking a response. In total 
28 of the 59 intemeurones investigated were recorded in this manner. In all, 19 of 
these 28 (68%) intemeurones responded to electrical stimulation (3-20mA, mean 
9.158+1.5mA, 0.2ms) within the stratum oriens with a slow depolarisation, with a 
mean peak amplitude of 7.33±0.0.7088mV, a mean peak latency of 17.1+1.566s, a 
mean time to first action potential of 8.751+1.778s and mean number of action
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potentials fired of 21.21+5.742. The remaining 9 (32%) cells were unresponsive to 
this stimulation protocol (N.B. no overt membrane potential fluctuation >2mV).
However, to ensure physiological relevance to the in vivo state we carried out an 
additional 31 experiments in which eserine was absent from the bath at the start of 
the experiment. In total 19 out of these 31 (61%) cells responded to electrical 
stimulation (l-20mA, mean 7.184+1.305mA, 0.2ms) with a depolarisation from 
resting membrane potential with a mean peak amplitude of 7.298±0.66mV, a 
mean peak latency of 14.73+1.308s, a mean time to first action potential of 
6.955+1.522s and mean number of action potentials fired of 18.54+3.380. The 
remaining 12 cells (39%) showed no response. Moreover, subsequent addition of 
IqM eserine allowed a pronounced depolarising response to be uncovered in a 
fuither 4 cells with a mean peak amplitude 13.08±2.005mV, a mean time to peak 
amplitude of 19.78±3.323s, a mean time to first action potential of 7.913+3.142s 
and a mean number of action potentials fired of 49+16.08. The other 8 cells 
remained unresponsive even in the presence of eserine.
Overall, 23 CAl intemeurones responded to stimulation in presence of eserine 
with a mean peak amplitude of 8.329±0.806mV, a mean time to peak of 
17.57+1.403s, a mean time to fist action potential of 8.598+1.535s and a mean 
number of action potentials fired of 26.04+5.785. 19 cells responded to 
stimulation in absence of eserine with a mean peak amplitude of 7.298±0.66mY, a 
mean time to peak of 14.73±1.308s, a mean time to first action potential of
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6.955±1.522s and a mean number of action potentials fired of 18.54±3.380 and 
the remaining 17 cells were unresponsive even in the presence of eserine. Overall 
there was no significant difference between the corresponding parameters 
measui'ed from the slow depolarisations recorded in the presence and absence of 
eserine. This is illustrated graphically in figure 4.6, which compares the mean of 
each parameter measured from slow depolarisations evoked in the presence and 
absence of eserine.
4.2.5. Stimulation parameters
As with the pyr amidal neurones discussed in chapter three, the peak amplitude of 
the depolarisation was dependent upon the precise stimulation parameters used. 
Figure 4.7A shows a voltage trace from a representative CAl interneurone. 
Initially a single stimulus (10mA, 2ms) delivered within the stratum oriens 
evoked a modest slow depolarisation of 5.15mV, subsequent application of a train 
of 5 stimuli (10mA, 2ms) at a frequency of 20Hz increased the peak amplitude of 
depolarisation by 140 % to 12.55mV. This was associated with a concomitant 
increase in the firing rate and the duration of the action potential discharge train. 
This potentiation was consistent in 7 of 7 cells tested (Fig 4.7B). Overall the mean 
peak amplitude of depolarisation was significantly increased from 4.964±1.28mV 
to 9.147±1.351mV (P=0.0192) on application of a train of stimuli (Fig. 4.7C).
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Figure 4.6  m A C hR  m ediated  responses In CA1 In tem euron es  In the  
presence and absence o f eserine
Initially all experiments were conducted in the presence of the 
cholinesterase inhibitor eserine (5|iM) to increase the likelihood of 
evoking a cholinergic response. However to ensure physiological 
relevance to the natural in vivo state additional experiments were 
conducted where eserine was absent. A. Scatter plot showing each 
individual param eter m easured (peak depolarisation, peak latency, time 
to first action potential and number of action potentials) to quantify the 
slow depolarisation recorded in each CAl interneurone where eserine 
was present throughout the entire experiment (n=19) and the slow 
depolarisation recorded in each CAl interneurone where eserine was 
absent (n=19). Note that responses recorded in the presence of eserine 
were similar in all param eters to responses recorded in the absence of 
eserine. B. Bar chart comparing the mean value of each param eter 
m easured in the presence and absence of eserine. Unpaired t-tests 
indicated no significant difference between any recorded param eter of 
the slow depolarisation recorded in the presence and absence of 
eserine. However 4 CAl intemeurones that did not respond to 
stimulation within the stratum oriens in the absence of eserine 
subsequently responded in the presence of eserine. In total a slow 
depolarisation was recorded from 23 CAl intemeurones in the presence 
of eserine and 19 CAl intemeurones in the absence of eserine.
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Figure 4 .7 . P otentiation  o f the s low  EPSP w hen evoked by a train  o f 
stim uli.
A, Representative voltage traces recorded from a stratum oriens CA1 
interneurone showing a slow depolarising response, with a peak amplitude 
of 5.15mV, evoked following delivery of a single stimulus (10mA, 0.2ms) 
within the stratum oriens (Ai) and the slow depolarising response, with a 
peak amplitude of 12.55mV, evoked by a train of 5 stimuli of the sam e 
intensity and duration delivered at 20Hz within the stratum oriens (Aii). Note 
the 140% increase in peak amplitude and the increase in action potential 
discharge on application of a train of stimuli. B. Bar chart showing the peak 
amplitude of a slow EPSP evoked in 7 individual CAl intem eurones firstly 
with a single stimulus and subsequently with a train of 5 stimuli. 0 . Bar 
chart of pooled data illustrating the significant increase in mean peak 
amplitude of the slow EPSP from 4.964±1.28mV when evoked with a single 
stimulus to 9.147±1.351mV when evoked with a train of stimuli (n = 7, P 
=0.0192). Values are expressed as a mean ± S.E.M., P values were 
calculated using a paired t-test, after data passed test for normal 
distribution. Unless otherwise stated all subsequent responses shown in 
this chapter were evoked using a train of 5 stimuli @ 20Hz and a pulse 
duration of 0.2ms.
All other parameters of the slow depolarisations evoked by a single stimulus and 
subsequent train of stimuli were also examined. The mean time to peak amplitude 
was unchanged whether a single or train of stimuli were used, 15.98+1.45s and 
15.98±2.758s respectively. However, this parameter showed great variation 
between individual cells. The time to first AP was significantly decreased from 
21,55±4.416 to 5.56±2.599s (P=0.0308) ultimately increasing the duration of 
firing and thus number of action potentials fired from 1.714+0.892 to 24.19+8.646 
(P=0.0474).
Overall, all parameters of the slow depolarisation were entranced with increasing 
stimulation intensity. Figure 4.8A shows a slow depolarisation evoked with a 
single stimulus of 0.5mA (pulse duration, 0.2ms) and subsequent enhanced 
responses in the same cell with increasing stimulus intensity (Fig 4.8B and C). 
Generally the peak amplitude of depolarisation and number of action potentials 
fired increased with increasing stimulation intensity. However it was noted that 
time to peak and the time to first action potential decreased with increasing 
stimulation intensity. These effects were consistent in 5 of 5 intemeurones tested, 
however no pooled data can be shown as the stimulus intensity required to evoke 
the initial response varied considerably between cells.
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Figure 4.8 Potentiation  o f th e  slow  EPSP on increasing  stim ulation 
intensity .
A. Representative voltage trace recorded from a stratum oriens CAl 
interneuron showing a slow depolarisation, with a peak amplitude of 
3.8mV and a time to peak of 28.7s, evoked by a single 0.5mA (0.2ms 
duration) stimulus delivered within the stratum oriens. B. Representative 
voltage trace from the sam e interneurone illustrating that subsequently 
increasing the stimulation intensity to 1mA increases the peak amplitude 
of response to 6.4mV with a time to peak of 19.4s and results in action 
potential discharge (14 action potentials fired with a time to first action 
potential of 13.3s). C. Representative voltage trace illustrating that 
increasing the stimulation intensity further to 2mA increases the peak 
amplitude to 7.9mV, decreases the time to peak amplitude to 12.3s and 
first action potential of 8.1s ultimately increasing the duration of firing and 
number of action potentials fired to 19.
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F igure 4.9  E ffect o f s tim ulus frequency on evoked s lo w  cholinerg ic  
responses In CA1 In tem euron es .
A. Representative voltages traces recorded from a stratum radiatium CAl 
interneurone illustrating that decreasing inter-stimulus interval (ISI) leads 
to diminished responses. Ai shows the initial slow depolarisation, with a 
peak amplitude of 10.45mV, evoked following the delivery of a train of 
stimuli (5 x 10mA, 0.2ms @ 20Hz) within the stratum oriens. Aii-iv. Shows 
subsequent slow depolarising responses evoked following the delivery of 
a train of stimuli (5 x 10mA,0.2ms @20Hz) within the stratum oriens after 
a 5-minute inter-stimulus interval (peak amplitude 11.35mV), a 2-minute 
inter-stimulus interval (peak amplitude 7.9mV) and a 1-minute inter­
stimulus interval (peak amplitude 5.85mV). B. Bar chart of pooled data 
from 5 CAl intemeurones in which the mean peak amplitudes of the slow 
depolarisations elicited after 5, 2 and 1-minute inter-stimulus are 
expressed a s  a percentage of the mean peak amplitude of the initial 
response. A paired t-test indicated a significant decrem ent in response 
when the inter-stimulus interval w as decreased from 5 minutes to 1 minute 
(n=5, P=0.0409). P values were calculated on the raw data using a one­
way analysis of variants and a Tukey’s post test after data passed test for 
normal distribution. As no obvious depression of the slow EPSP was 
apparent when using a 5 minutes inter-stimulus interval this w as chosen 
as  the inter-stimulus interval for all experiments.
Previous studies have shown that the inter-stimulus interval is also an important 
parameter in evoking consistent cholinergic responses in hippocampal neurones 
(Morton & Davies, 1997). Therefore a range of inter-stimulus intervals (1-5 
minutes), were tested when evoking these responses in CAl interneurones (n=5) 
(Fig 4.9A). This data showed that decreasing the inter-stimulus interval resulted in 
a decrease of the peak amplitude of the slow depolarisation. A 5-minute inter­
stimulus interval was sufficient to allow no significant decrement in the mean 
peak amplitude of subsequent responses (Fig 4.9B). All other measured 
parameters of the slow depolarisation were also measured at decreased inter­
stimulus intervals but did not show significant variation.
4.2.6. Carbachol.
Of the 59 CAl interneurones recorded 17 (29%) did not respond to electrical 
afferent stimulation within the stratum oriens (Fig. 4.10A). Indeed the percentage 
change in membrane potential as measured 17s after stimulation, which 
corresponds to the average peak time in responsive interneurones, was less than 
1% (“0.6±0.2%, n=17). In order to establish whether the lack of response was due 
to the electrical stimulation not resulting in the activation of cholinergic afferents 
or sufficient release of ACh we further tested these unresponsive interneurones 
with bath application of the acetylcholine analogue carbachol (lOpM). In all, 7 of 
these 17 interneurones responded to application of carbachol with a slow 
depolarisation of the membrane potential broadly similar to that produced by 
electrical stimulation in the afferent-stimulation responsive population of
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interneurones. The mean peak amplitude of depolarisation brought about by lOqM 
carbachol application was 11.10+1.089mV (Fig. 4.1 OB). A further 2 interneurones 
showed an oscillatory component to their depolarisation (Fig 4. IOC). However the 
remaining 8 (14% overall) interneurones showed no response to either electrical 
stimulation or subsequent application of carbachol (Fig. 4.10D) suggesting that a 
small population of interneurones are truly unresponsive to activation of 
mAChRs.
4.2.7. Input resistance
In order to gauge the effect of cholinergic modulation on the passive membrane 
properties of interneurones, a short series of experiments were carried out in 
which the input resistance of interneurones was monitored throughout the slow 
depolarising response. The input resistance of each interneurone was calculated 
from the membrane voltage responses to small negative current steps (-0,02nA) 
recorded at the same membrane potential before and during both carbachol- 
induced slow depolarisations and stimulus-evoked slow depolarisations.
The input resistance before and during the carbachol-induced depolarisations were 
701.8±128.9Mf2 and 787.2±144.5Mn respectively. This 13% increase in input 
resistance was not statistically significant (n=5, P=0.1002, Fig 4.11). The input 
resistance before and during the stimulus-evoked depolarisations were 
758.7±49.82MQ and 793.7±39.98MQ (n=3, P=0.3019, Fig 4.12). This 5% 
increase in input resistance was again not significant. Thus both carbachol-
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Figure 4.10 . C A l In terneurone responses to  carbachol application
In total 17 of 59 (29%) CAl interneurones did not respond to electrical 
stimulation within the stratum oriens and thus were further tested with bath 
application of the cholinergic agonist carbachol. A. Representative voltage 
trace recorded from a stratum radiatium CAl interneurone in which no 
depolarisation was apparent following a train of stimuli (5 x 30mA, 0.2ms 
@20Hz) delivered within the stratum oriens. B. Representative voltage 
trace from the sam e interneurone showing that subsequent bath application 
of carbachol (lOpM) resulted in a slow sustained depolarisation, with a 
peak amplitude of lO.SmV, and intense action potential discharge. The 
period of carbachol application is indicated by the open bar. In total 7 of the 
17 CAl interneurones responded in this manner, with a mean peak 
amplitude of 11.10±1.089mV. C. Representative voltage trace from a 
stratum oriens CAl interneuron (0-LM cell) showing an oscillatory 
component to the carbachol induced slow depolarisation. In total 2 of the 17 
CAl interneurones responded in this manner. D. Representative voltage 
trace from a stratum oriens CAl interneurone showing no depolarisation of 
membrane potential in response to carbachol application. In total 8 of the 
17 CAl interneurones showed no overt change in membrane potential in 
response to both afferent stimulation and 10|iM carbachol application. 
Values are expressed as a mean ± S.E.M.
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Figure 4.11 A ssessm ent o f input resistance changes during  
carbachol induced depo larisations.
A. Shows the effect of carbachol (CCh; 10|iM) on the membrane 
potential and input resistance of a stratum oriens CAl interneurone. The 
current injection was kept constant until the input resistance was 
m easured during the CCh-induced depolarisation at the time point 
indicated by the arrow. The open bar above the trace indicates the 
period of CCh application. B. Shows a comparison of a hyperpolarising 
response in the control period and a hyperpolarising response after CCh 
application on an expanded time scale. The input resistance was 
m easured from the change in membrane potential in response to 
hyperpolarising current step of -0.02nA applied for 0.2s every 2.0s. In 
this example the calculated input resistance was 405MQ and 419MQ 
before and during the CCh induced depolarisation respectively. C. Bar 
chart illustrating the change in input resistance associated with the CCh- 
induced depolarisation in 5 individual CA1 interneurones. D. Bar chart of 
pooled data showing no significant change in mean input resistance 
during the CCh-induced depolarisation (P=0.1, n=5) P values were 
calculated using a paired t-test after data passed test for normal 
distribution.
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Figure 4.12 . A ssessm ent o f input resistance changes during  s tim u lus- 
evoked depo larisations
A. Representative voltage trace recorded from a stratum radiatium CAl 
interneurone where the m embrane potential was manually clamped at -  
50mV before a stimulus was applied so that the voltage response to 
hyperpolarising current steps could be compared with that evoked at the 
peak of the stimulus-evoked depolarisation (also at -50mV). The time of 
afferent stimulation is indicated by the filled triangle. B. Shows a 
comparison of these voltage responses on an expanded time scale. In this 
example the calculated input resistances were 820MQ and 868MQ pre- and 
post stimulation respectively. The current injected into the cell (-0.02nA) is 
shown below the voltage traces. The initial membrane potential of this 
interneurone was -55mV (without junction potential taken into 
consideration). C. Bar chart illustrating the change in input resistance 
associated with the stimulus evoked depolarisation in 3 individual CA1 
interneurones. D. Bar chart of pooled data showing no significant change in 
input resistance during the stimulus-evoked depolarisation (P=0.3, n=3) P 
values were calculated using a paired t-test.
induced and stimulus-evoked slow depolarisations were not associated with any 
significant change in input resistance.
4.2.8. Diversity of responses in interneurones
By applying a similar protocol as used in chapter 3 to evoke mAChR responses in 
pyi’amidal neurones it was shown conclusively that broadly similar cholinergic 
responses may be evoked in CAl interneurones. The mACloR-mediated response 
in pyramidal neurones was a uniform slow depolarisation from resting membrane 
potential. However, this was not found to be the case in CAl interneurones. 
Although some form of consistent slow depolarisation was seen in 71% of all 
interneurones investigated, the pattern and time course of the depolarisation varied 
between cells. The majority of these responses could be separated and classified 
into 4 broad subtypes according to the specific waveform underlying the 
depolarising response, as illustrated in figure 4.13.
The most fi’equent type of response recorded was a simple slow depolarisation 
from resting membrane potential, often reaching threshold for action potential 
generation (Fig 4.13 A). This type of response was seen in 34% of interneurones 
with a mean peak amplitude of 8.207±0.852mV, a mean time to peak of 
15.99±1.459s, a mean time to first action potential of 8.851+1.232s and a mean 
number of action potentials fired of 20.34+5.430, n=20. These slow 
depolarisations could be inhibited by the addition of atropine (5p.M, n=2).
154
 ^^  f r ^  f  ^( f f 11 ^  f f p f f' c f! r < pfWm # t '
% !  : 'l;
depolarising response
0 n W iT ''A f ‘ H *'1 f r ' ...
delayed response
«#« I,
D
fast plateau response
oscillatory bursting response
Figure 4.13 D iversity  o f the cholinerg ic  response in C A l in terneurones
Although a consistent depolarisation from resting m embrane potential was 
seen in 42 of 59 recorded, the patterns and time course of the response 
varied between interneurones. All of the above traces are representative 
cholinergic responses recorded from CAl interneurones in response to 
electrical stimulation within the stratum oriens. The majority of responses 
could be classified into one of the above types A. A simple slow 
depolarisation of the membrane potential. B. A delayed response in which 
the depolarisation was preceded with a large hyperpolarisation. C Fast 
plateau depolarisation in which the slow depolarisation was preceded by a 
fast depolarisation. D. Oscillatory bursting response in which the cell initially 
discharges at high frequency before switching to an oscillatory mode in 
which the m embrane potential displays. Scale bars: vertical 20mV , 
horizontal A-Di 5s, Dii, 1s
In a smaller proportion of interneurones (17%) a large hyperpolarisation of mean 
peak amplitude -9.011±1.646mV, a mean time to peak of 1.565+0.2076s and 
8.74+1.232s in duration (n=10), preceded the slow depolarisation (Fig 4.13B). 
This lead to the latency to peak depolarisation and first action potential of the slow 
depolarisation to be slightly longer in these cells at 19.14+1.95s and 15.20+1.978s 
respectively, hence we termed this response type “delayed” (Fig 4.13B). Addition 
of atropine (5-1 OqM) significantly depressed the mean peak amplitude of both the 
hyperpolarisation and the slow depolarisation from -8.442+0.9115 to - 
6.73+1.25mV (P=0.0231) and from 8.124+1.318 to 1.379±0.437mV (P=0.0109) 
respectively. However the hyperpolarisation was inhibited to a lesser degree (21% 
inhibition) than the slow depolarisation (83% inhibition) (Fig. 4.14).
In (17%) of interneurones a fast depolarisation of mean peak amplitude 
9.841+1.175mV and a mean time to peak of 1.025+0.189s was seen to precede the 
slow depolarisation (Fig 4.13C). These were termed “fast plateau” responses, as 
both responses seemed to merge to form a plateau. This merging effect made it 
very difficult to separate response types particularly when trying to establish the 
time to first action potential and number of action potentials for each response. 
These two properties were therefore combined for this response type. Ultimately 
the fast response decreased the time taken to first action potential and thus 
increased the number of action potentials fired. The addition of atropine (5- 
lOjuM) to these cells again significantly inhibited both the fast and slow 
depolarisation from 11.03+1.697mV to 6.17+1.348mV (P=0.0251) and from
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Figure 4 .14  E ffect o f a trop ine on both com ponents  o f the “de layed ” 
response
Ai. Representative voltage trace recorded from a stratum oriens CAl 
interneurone illustrating a “delayed” response evoked following delivery of 
a train of stimuli (5 x 10mA, 0.2ms @20Hz). This response consisted of a 
hyperpolarisation of peak amplitude -11.3mV, followed by a slow 
depolarisation of peak amplitude 12.55mV. Aii. subsequent addition of the 
mAChR antagonist atropine (lOpM) depressed the peak amplitude of 
both the slow depolarisation (peak amplitude 0.25mV) and the preceding 
hyperpolarisation (peak amplitude -lOmV). Note the hyperpolarisation is 
not completely inhibited by atropine. Bi. Bar chart showing the depression 
of the hyperpolarisation recorded in 5 individual CAl interneurones. Bii. 
Bar chart of pooled data for all 5 individual interneurones illustrating the 
significant depression of the mean peak amplitude of the hyperpolarisation 
from -8.442±0.9115mV to -6.73±1.25mV (P=0.0231). Ci. Bar chart 
showing the depression of the slow depolarisation in the sam e 5 CAl 
interneurones. Cii Bar chart of pooled data illustrating the significant 
depression of the mean maximum amplitude of depolarisation from 
8.124±1.318mV to 1.379±0.437mV (P=0.0109). Values are expressed as  
mean ± S.E.M. P values were calculated using a paired t-test, after data 
passed tests for normal distribution.
9.536+1.052mV to 1.76+0.816 (P-0.003) respectively. Although the initial fast 
response was significantly reduced by atropine (44% inhibition), it was not 
completely abolished and thus allowed part of the initial fast response to be 
uncovered and isolated from the slow depolarisation (Fig 4.15). In a single 
experiment it was also observed that hyperpolarisation of the membrane potential 
by current injection abolished the slow depolarisation while increasing the fast 
depolarisation. These effects suggest that two specific conductances underlie the 
fast and slow components of the depolarisation. Detailed properties of each 
response type are summarised in table 4.3.
In a minority of cells (n=2/59, 3%) we observed an oscillatory depolarisation with 
phasic bursts of spikes with an interburst interval of l-2Hz (Fig 4.13Di and ii). 
These responses were similar to the oscillatory responses noted on carbachol 
application (n=2/9) and were classed separately from the slow depolarisations. 
These cells did not display any differences from the other cells with respect to 
resting behaviours prior to stimulation.
158
AB
20m V
5 s
I| t - 0
m  control 
■ M  AtropineI l l  l l  i i
3Q/07/D2 2/KV02 4/1 (XQ 18/08/02 08/04/03
C e H c o d t t Atropine
I f
r g a  contro l 
■ ■ A tr o p in e
30/07/02 02/10A)2 4/10/02 18*9/02 09/04/03 
Cell Codes Atropine
Figure 4 .15  E ffect o f a trop ine on both com ponents  o f the “fast 
pla teau” responses.
Ai. Representative voltage trace recorded from a stratum radiatium  CAl 
interneurone illustrating a "fast plateau” response evoked following delivery 
of a single stimulus (30mA, 0.2ms). This response consisted of an initial 
fast depolarisation of peak amplitude 10.25mV, followed by a slower 
depolarisation, with a peak amplitude of S.ImV. Aii. subsequent addition of 
the mAChR antagonist atropine (lOpM) depressed the peak amplitude of 
both the fast depolarisation (peak amplitude 8.45 mV) and the slow 
depolarisation (peak amplitude 0.3mV). Note the fast depolarisation is not 
completely inhibited by atropine. Bi. Bar chart showing the depression of 
the fast depolarisation recorded in 5 individual CAl interneurones. Bii. Bar 
chart of pooled data for all 5 individual interneurones illustrating the 
significant depression of the mean peak amplitude of the fast depolarisation 
from 11.03±1.697mV to 6.17±1.348mV (P=0.0251). Ci. Bar chart showing 
the depression of the slow depolarisation in the sam e 5 CAl interneurones. 
Cii Bar chart of pooled data illustrating the significant depression of the 
mean maximum amplitude of depolarisation from 9.536±1.052mV to 
1.76±0.816mV (P=0.003). Values are expressed as mean ± S.E.M. P 
values were calculated using a paired t-test, after data passed tests for 
normal distribution.
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T ab le  4.3  Ind iv idual p roperties o f each m A C hR -m ediated  response type  seen in 
CA1 in terneurones.
This table sum m arises the individual properties for each response type. Note that peak 
amplitude of the depolarisation for all slow depolarisations are similar (show no significant 
difference if analysed with a one-way analysis of variants. P>0.05) However Peak latency 
and time to first action potential are increased in the “delayed” slow depolarisation and 
time to first action potential is decreased in the “fast plateau” response leading ultimately 
to an increase in number of action potentials fired. Abbreviations: PD-peak amplitude of 
depolarisation, AP-action potential.
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4.2.9. Location and morphology of interneurones
In order to determine whether CAl interneurones that displayed a particular type 
of mAChR-mediated response could be categorised by their morphological 
subtype each interneurone was intracellularly labelled with neurobiotin. Post-hoc 
anatomical analysis of each interneurone showed that the majority of the 
interneurones in this study had a cell body location in either the stratum oriens or 
stratum radiatum. Stratum radiatum interneurones generally had a stellate-like 
appearance with dendrites radiating within the dendritic layer of the stratum 
radiatum and the stratum lacunosum moleculare (n=24. Fig 4.16). In contrast all 
stratum oriens cells were bipolar and displayed dendrites, which extended in a 
horizontal axis parallel with the stratum oriens (n=24). All types of mAChR- 
mediated responses were recorded in interneurones in both locations.
In the stratum oriens 38% of cells were unresponsive to synaptic stimulation, 
although 21% did respond to carbachol (17% with a slow depolarisation and 4% 
with an oscillatory response) therefore only 17% of stratum oriens ceils were 
entirely unresponsive to mAChR activation. Of the cells that did respond to 
synaptic stimulation 29% responded with a depolarisation, 8% responded with a 
delayed response, 21% responded with a fast plateau response and 4% responded 
with an oscillatory response. In stratum radiatum only 17% of cells were 
unresponsive to synaptic stimulation, although 13% did respond to carbachol (9% 
with a slow depolarisation and 4% with an oscillation) therefore only 4% were 
entirely unresponsive to mAChR activation. Of the cells that did respond to
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synaptic stimulation 33% responded with a depolarisation, 29% responded with a 
delayed response and 21% responded with a fast plateau response. This data is 
summarised in table 4.4.
SO
SR
D epolar. Delayed Fast O scill. C arbachol No response Total
29% 8% 21% 4% 21% 17% 100%
(n=7) (n=2) (n=5) (n=1) (n=5) (n=4) (n=24)
33% 29% 21% 0% 13% 100%
(n=8) (n=7) (n=5) (n=0) (n=3) (n=1) (n=24)
Tab le  4 .4  D istribution  o f m uscarin ic  response types w ith  s tratum  oriens and  
stratum  rad iatum  o f the CA1.
Table shows percentage of CA1 Interneurones with soma located within the stratum 
oriens (SO) and the stratum radiatum (SR) displaying each type of mAChR response. 
Note interneurones in both locations responded with all types of mAChR-mediated 
response although the slow depolarisation seem ed to be the most frequent response in 
each layer.
One recorded intemeurone showed soma location within the stratum pyramidale 
and responded to synaptic stimulation with an oscillatory response (1.5Hz). Thus 
soma location of CAl interneurones showed no obvious correlation with type of 
mAChR-mediated response recorded.
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Further classification of interneurones into subtypes with particular presumed 
functions, such as dendritic or perisomatic inliibition requires detailed analysis of 
the dendritic and axonal projections. Throughout this study problems with the 
intracellular labelling of the axonal projection did not allow further classification 
of the recorded interneurones. However, three CAl interneurones with rounded 
somata located in the stratum oriens^ horizontal dendrites extending through the 
stratum oriens and an axonal projection to the stratum lacunosum-moleculare 
characteristic of the O-LM subtype were identified. All three identified O-LM 
eells displayed a mAChR-mediated cholinergic response. One responded to 
electrical stimulation within the stratum oriens with a slow depolarisation (Fig 
4.16), the others did not respond to electrical stimulation but did respond to 
carbachol application with either a slow depolarisation or oscillatory response.
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Figure 4 .16. Exam ple o f filled  interneurones w ith  associated  
electrophysio logy.
Ai. Cam era lucida reconstruction of a representative O-LM cell. Aii 
Representative voltage traces (upper traces) recorded from the sam e cell in 
response to applied intracellular current injection (lower trace) illustrating the 
firing properties of this O-LM cell. Alii. Typical cholinergic response from this 
O-LM cell. Bi. Cam era lucida reconstruction of a representative stratum 
radiatum interneurone. Bii representative voltage traces (upper traces) 
recorded from the sam e cell in response to applied intracellular current 
injection (lower traces) illustrating the firing properties of this interneurone. 
Biii. Typical cholinergic response from this stratum radiatum interneurone.
4.3. D iscussion
4.3.1. Verification of the septo-hippocampal projection
It was apparent from our immunohistochemical staining of the septo-hippocampal 
projection that in the juvenile rats used in the electrophysiological experiments, 
the cholinergic septo-hippocampal projection was complete and that such 
cholinergic afferents ramified extensively within the hippocampus. Furthermore, 
the presence of multiple boutons in close apposition with PV-immimopositive 
interneurones strongly suggested that the functional connection was indeed intact. 
This was subsequently demonstrated conclusively using an electrophysiological 
approach to monitor the cellular (pyi*amidal and interneurone) response to 
cholinergic afferent stimulation in the juvenile tissues. Previous studies have 
reported that an adult pattern of theta rhythm is established by P I5 or P16 
(Leblanc & Bland, 1979; Lanfumey et a l, 1982). As theta rhythm is partly driven 
by the cholinergic input from the MSN (Stewart & Fox, 1990) this indicates that 
the pathway is functional at some level. This together with the findings presented 
in this chapter suggest that the septo-hippocampal cholinergic projection is 
sufficiently developed to be functional by postnatal day 16 in Wistai- rats.
4.3.2. Evoked cholinergic responses
Electrical stimulation within the stratum oriens produced an atropine sensitive 
slow and sustained depolarisation from resting membrane potential in both CAl
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interneurones and pyi'amidal neurones. All slow depolarisations seen in pyramidal 
neurones were recorded in the presence of the acetylcholinesterase inhibitor 
eserine and were similar in amplitude and waveform to the responses recorded in 
chapter three using sharp KmeS0 4  filled micro electro des. Although the 
depolarisation seemed slightly slower in nature, reaching peak depolarisation at 
17.55+2.24s compared to 10.14±2.73s. This may be due to the fact that patch 
clamp protocol was carried out at room temperature (thermostatically controlled at 
26±2°C) rather than 37°C. This slow depolarisation was therefore concluded to be 
the same EPSPm investigated in chapter three. Previous studies investigating 
cholinergic responses have mainly focused on using sharp microelectrodes with 
the rational behind this choice of recording configuration being to minimise cell 
dialysis in order to prevent rundown of the G-protein coupled response. However, 
it is clear from these studies that use of the whole-cell patch clamp configuration 
with low resistance (~8MQ) electrodes, which would inevitably cause some 
degree of dilution of intracellular millieu, nevertheless does not prevent the ability 
of the cell to display evoked mAChR-mediated responses similar to that seen in 
pyramidal neurones with sharp electrodes. Having confirmed that the whole-cell 
configuration was not adversely affecting the expression of evoked cholinergic 
responses in pyramidal neui'ones, this recording configuration was employed to 
investigate and characterise these responses in CAl interneurones.
The atropine sensitive depolarisation observed in the CAl interneurones is the 
first demonstration of a physiological synaptic mAChR-mediated response in 
these cells on electrical stimulation of cholinergic fibres within the stratum oriens,
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71% of CAl interneurones responded in this manner with the other 29% showing 
no overt depolarisation of the membrane potential.
Although initially responses were recorded in the presence of the cholinesterase 
inhibitor eserine, further experiments showed depolarisations of similar amplitude 
and duration could be evoked in the absence of eserine. This suggests that the 
response is a physiologically relevant event and is not an artefact of artificially 
increased levels of acetylcholine present within the slice by cholinesterase 
inhibition. Application of eserine was able to uncover slow depolarisations in 
interneurones, which seemed unresponsive in the absence of eserine. This is 
presumably due to an increase in the levels of released ACh by cholinesterase 
inhibition. It may therefore have been expected that all responses recorded in the 
presence of eserine would be of larger magnitude or require lower stimulation 
parameters to evoke than responses recorded in the absence of eserine, however 
this was not found to be the case. The fact that we did not add eserine to the 
perfusion medium when recording from cells which responded to afferent 
stimulation in the absence of eserine does not allow a direct analysis on the 
potentiating effect of eserine in CAl interneurones as was carried out on the 
pyramidal neurones in chapter three. The reason that we did not investigate this 
effect was due to the fact that where possible responses were recorded in the most 
physiological state and not in artificially elevated levels of ACh as has been the 
case in the past when recording these responses in pyramidal neurones (Pitler & 
Alger, 1990).
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Once again the synaptic response was dependent upon the stimulation parameters 
used. This was to be expected due to the similar protocol employed to evoke these 
responses. As mentioned in the previous chapter, trains of stimuli increased the 
amplitude of the synaptic response presumably due to the accumulation of 
acetylcholine following repeated activation of the cholinergic fibres and increasing 
stimulation intensity increased the response presumably by recruiting more fibres 
to release acetylcholine. It seems reasonable that both of these effects were 
apparent in both interneurones and pyramidal neurones as both cell types are 
innervated by the cholinergic fibres of the septo-hippocampal projection 
(Frotscher et a l, 1986), thus any protocol increasing or decreasing the release of 
ACh from these fibres would affect both cell types in a similar manner.
Earlier studies reported a fatigue of the cholinergic response in the pyramidal 
neurone population and found that an inter-stimulus interval length of 5-8 minutes 
was sufficient to avoid depression of the second evoked response (Morton & 
Davies, 1997). Here we report a similar effect in CAl interneurones and show no 
significant depression of the slow depolarisation if an inter-stimulus interval of 5 
minutes is adhered to. The fatigue of the slow depolarisation if evoked less than 
every 5 minutes may be due to presynaptic factors affecting the release of 
acetylcholine such as depletion of releasable ACh from terminals, or may also be 
due to postsynaptic factors such as desensitisation of mAChR receptors and 
depletion of Ca^ "*" from internal stores. Due to the long duration of the fatigue a 
presynaptic effect alone seems unlikely, it may be more likely that both pre- and 
postsynaptic factors contribute in some way.
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In all, 17 of 59 (29%) of the CAl interneurones recorded in this study were 
unresponsive to electrical stimulation within the stratum oriens. These cells were 
further tested with bath application of the cholinergic analogue carbachol. In total 
9 of these unresponsive cells, a further 15% of the CAl interneurones recorded, 
responded to carbachol application with either a slow depolarisation or an 
oscillatory response. Possible reasons for this lack of response to electrical 
stimulation within the stratum oriens and subsequent response to carbachol 
application may include problems in positioning of the stimulation electrode, in 
that too few fibres were activated and thus resulting in insufficient release of 
acetylcholine to evoke a postsynaptic response, or problems in slice preparation 
and maintenance in that, the septo-hippocampal cholinergic afferents may have 
degenerated after cutting of the slices or some factor within the slice is inliibiting 
ACh release. Morton and colleagues (Morton et al, 1997; Morton & Davies, 
1997; Morton et a l, 2001) showed that the EPSPm recorded in CAl pyramidal 
neurones could be suppressed by the activation of presynaptic GABAg and A1 
receptors to inhibit the release of ACh. As such high tonic levels of adenosine or 
G ABA in slices may inhibit the production of a postsynaptic response, as GABAg 
receptor antagonists were included in the perfusion medium tliroughout the 
recordings a role of GABA can be discounted. However, no adenosine antagonists 
were present and as such a lack of response may be due to inhibition of ACh 
release by presynaptic A1 receptors. Pharmacological activation of mAChRs via 
application of carbachol would not be affected by any of the factors and thus 
would still elicit a response in interneurones expressing mAChR receptors. A
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similar observation that synaptically evoked responses were indeed harder to 
evoke than responses evoked with agonist application was noted by two individual 
research groups (Alkondon et a l, 1998; Frazier et a l, 1998a) when trying to elicit 
nAChR-mediated response in CAl interneurones. These groups suggested the 
main reason behind this the lack of response was due to the precise positioning of 
their stimulation electrodes to activate cholinergic fibres.
In contrast to pyramidal neurones these results suggest that the mAChR-mediated 
depolarisations in interneurones were not accompanied by any significant change 
in input resistance. The result was the same for both carbachol-induced and 
stimulus-evoked depolarisations. These findings are in agreement with McQuiston 
and Madison (1999a) who also reported no change in input resistance during 
agonist-evoked depolarisations in CAl interneurones. These authors suggested 
that the depolarisations were caused by the simultaneous inhibition of resting 
channels and the activation of a voltage independent nonselective cation current. 
Therefore the contribution of both chamiel types would cancel out the effect of the 
other on the input resistance of the cell, resulting in a depolarisation without 
reversal or any net change in input resistance. However the mAChR-mediated 
depolarisation in pyramidal neurones, due to depression of the leak current and 
activation of a non-selective cation conductance, is associated with an increase in 
input resistance. It seems more likely that no significant change in input resistance 
could be attributed to the fact that CAl interneurones have a higher initial input 
resistance than pyramidal neurones, presumably in part due to a lower basal 
leak conductance, therefore if the slow depolarisations are a result of the inhibition
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of the leak conductance as suggested this will not be apparent as a large change 
in input resistance and thus may be too small to show significance.
4.3.3. Diversity of the interneurone response.
As the interneurone population itself shows a large amount of diversity in terms of 
morphology, physiology and receptor expression it would be unreasonable to 
assume that all interneurones would respond to mAChR activation with a single 
uniform response. The results presented in this chapter show that CAl 
interneurones show diversity in the characteristics of their evoked cholinergic 
responses and that they respond to mAChR activation in one of five ways.
1. A slow depolarisation, in which a slow, sustained depolarisation of 
the membrane potential is apparent.
2. A “delayed” response, in which a lai’ge hyperpolarisation precedes a 
slow, sustained depolarisation.
3. A “fast plateau” response, in which a fast depolarisation precedes a 
slow, sustained depolarisation with the responses merging to form a 
plateau.
4. An oscillatory response, in which oscillatory bursting was seen 
throughout the slow depolarisation.
5. No response, in which no detectable change in membrane potential 
was measured.
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The results presented here show that the simple slow depolarisation of the 
membrane potential was the most frequent mAChR-mediated response to 
electrical stimulation of cholinergic fibres, recorded in 34% of CAl interneurones. 
This finding is in agreement with previous studies carried out by McQuiston and 
Madison (1999a) who reported a depolarisation of membrane potential to be the 
most frequent response to application of mAChR agonists, in 48% of 
interneurones. Problems with the synaptic activation of cholinergic fibres most 
likely account for the lower percentage of cells showing this response type in this 
study. If the interneurones, which did not respond to electrical stimulation but did 
respond to carbachol application with a slow depolarisation, are included in the 
total of responsive cells the percentage is increased to a more comparable 46% of 
interneurones responding to mAChR activation with a slow depolarisation.
The mACliR-mediated response type termed “delayed” in this study was similar in 
nature to the “biphasic” response to mAChR agonists reported by McQuiston and 
Madison (1999a), in that it consisted of a large hyperpolarisation preceding a 
slower depolarisation. This study showed 17% of interneurones responding in this 
manner compared to 15% in the McQuiston study. However, in this study addition 
of the selective mAChR antagonist atropine, significantly reduced the initial 
hyperpolarisation but did not completely abolish it, as was shown to be the case 
for the biphasic responses reported in the McQuiston study. The remaining 
component of the hyperpolarisation may be due to action of another 
neurotransmitter such as noradrenaline or serotonin (5-HT) as both transmitter 
have been shown to elicit hyperpolarising responses in CAl interneurones (Parra
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et a l, 1998). It may also be an AHP in response to direct antidromic activation of 
the cell axon or may simply reflect the competitive nature of the inhibition and 
that increasing the concentration of atropine applied may have decreased the 
response further, although this latter suggestion seems the most unlikely due to the 
relatively high concentration of atropine applied.
17% of the CAl interneurones recorded in this study responded with the “fast 
plateau” type of response. This type of response resembled the plateau potentials 
recorded in CAl pyramidal neurones in response to current injection in the 
presence of cholinergic agonist carbachol due to activation of a Ca^’^ -activated 
nonselective cation conductance and high-voltage-activated Ca^  ^channels (Fraser 
& Macvicar, 1996). However, although both the fast and slow components of this 
response were significantly inhibited by the selective mAChR antagonist atropine, 
the fast depolarisation was not completely abolished. A possible reason for this 
may be that the fast component was elicited by activation of a ligand gated ion 
channel such as the nAChR. Although the action of nAChR antagonists was not 
tested on this remaining response, as nicotinic responses have previously been 
reported in CAl interneurones by two other groups (Alkondon et a l, 1998; 
Frazier et a l, 1998a) it remains a possibility. If a portion of the fast component 
was due to nACliR activation, this may explain why McQusiton and Madison 
(1999a) did not report this type of response, as these authors routinely included 
nAChR antagonists in their aCSF when using the non-specific agonists ACh and 
carbachol to evoke mAChR-mediated responses.
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In total, 3% of CAl interneurones responded to electrical stimulation of 
cholinergic afférents with an oscillatory component to the depolarisation and an 
additional 3% of intcrncuroncs that were unresponsive to electrical stimulation but 
responsive to carhachol responded with an oscillatory component. McQuiston and 
Madison (1999a) also reported an interneurones responding with slow membrane 
oscillation hut chose not to investigate it further as it was such an infrequent 
response. In this study, the slow oscillatory responses displayed a sinusoidal 
waveform with short trains of action potentials occurring at the top (most 
depolarised) peak of each cycle. This is similar to reported patterns of 
interneurone activity recorded in vivo (Ylinen et a l, 1995; Klausberger et al., 
2003). It is possible that such oscillatory activities recorded in vivo may be driven 
by cholinergic excitation.
Overall, only 14% of interneurones were entirely unresponsive to inAChR 
activation, this was comparable to the 21% reported by the McQuiston study. This 
suggests that a subpopulation of CAl interneurones may not express mAChRs. 
However, application of mACliR agonists could produce effects in CAl pyi’amidal 
neurones such as the reduction in SFA and AHPs at levels which did not produce 
a mAChR mediated membrane depolarisation (Cole & Nicoll, 1983; Segal, 1988). 
In addition a subsequent study by McQuiston and Madison (1999b) reported that 
the AHP following train of action potentials in response to injected current, could 
be replaced by a afterdepolarisation (ADP) on application of mAChR agonists. 
This effect was often accompanied by an effect on membrane potential but was 
seen in interneurones where no effect on resting membrane potential was apparent.
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Thus it may be possible that the interneurones recorded in this study, which 
showed no membrane depolarisation may not be entirely unresponsive to mAChR 
activation, although future studies are required to fully address this possibility.
These results differed from the agonist studies carried out by McQuiston and 
Madison (1999a) in that we did not observe a hyperpolarisation of interneurone 
membrane potential alone without a subsequent depolarisation. However this 
response was only reported in 17% of interneurones and these authors performed a 
larger study recording from interneurones located in all strata of the CAl, 
including the stratum pyramidale and the stratum lacunosum-moleculare. Thus 
the subset of interneurones that respond with a hyperpolarisation may not have 
been recorded from due to the smaller sample size in this study.
The majority of interneurones recorded in this study showed cell body location in 
either the stratum oriens or stratum radiatum. Whilst the stratum oriens 
horizontal cells are indeed most likely to project to dendrites in the SLM, a 
proportion of cells located in the stratum oriens are known to project to the 
stratum pyramidale (Sik et a l, 1995; Buhler & Dunwiddie, 2001), whilst others 
may project back to the medial septal nucleus (Toth & Freund, 1992; Gulyas et 
a l, 2003). Interneurones with soma in the stratum radiatum may project to any 
region and often project to the stratum pyramidale (Vida et a l, 1998). Due to the 
lack of axonal staining in this study it is difficult to classify the recorded 
interneurones into any subclasses, such as dendritic inhibitory cells or perisomatic 
inliibitory cells. However, it can be reported that interneurones showing cell body
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location in both the stratum oriens and stratum radiatum responded to mAChR 
activation with all types of mAChR-mediated response, including no response and 
thus concluded that cell body location cannot be used to predict mAChR mediated 
response type of CAl interneurones.
Three of the recorded interneurones could be classified as the O-LM cell type, all 
of which were excited by mAChR activation. These findings are again in 
agreement with McQuiston and Madison (1999a) who reported that two O-LM 
cells responded to mAChR activation with a depolarisation. As these cells are 
known to express the neuropeptide somatostatin it is interesting to note that the 
immunocytochemical studies by Hajos (1998) showed only 15% of m2 expressing 
interneurones in the stratum oriens expressed this neuropeptide. All cells that did 
show co-expression of somatostatin and m2 showed relatively low levels of m2 
receptor protein. However, the main finding of this immunocytochemical study 
reported that a subset of interneurones located within the stratum oriens with 
horizontal dendrites and an axonal projection to dendritic region of pyramidal 
neurones expressed M2 receptors on their soma and dendrites and postulated that 
these cells would be excited by muscarinic activation. The results presented in this 
chapter are consistent with the suggestion that stratum oriens interneurones are 
indeed excited by muscarinic activation, although this study makes no attempt to 
decipher the subtype of muscarinic receptor involved.
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4.4. Summary
The results presented in this chapter provide the first direct evidence that CAl 
interneurones respond to synaptieally released ACh on electrical stimulation of 
septo-hippocampal cholinergic afférents with a mAChR-mediated depolarisation. 
In contrast to the inAChR-mediated slow depolarisation observed in CAl 
pyramidal neurones, the evoked depolarisation in CAl interneurones was not 
accompanied by any change in input resistance and showed greater heterogeneity 
in pattern and timecourse.
In summary, with respect to membrane depolarisation CAl interneurones respond 
to mAChR activation in one of five ways including; 1, a slow depolarisation, 2. a 
“delayed response”, 3. a “fast plateau response”, 4. an oscillatory response, 5. no 
change. This variety of mAChR-mediated responses recorded from CAl 
interneurones further reinforces the diversity and complexity of interneuronal 
function.
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5. INVESTIGATION OF THE ACTION OF NICOTINIC
ACETYLCHOLINE RECEPTOR AGONISTS ON
GLUTAMATE AND GABA RELEASE WITHIN THE
HIPPOCAMPUS
5.1. I n t r o d u c t i o n
Previous studies have shown that both mAChR and iiAChR agonists can alter 
neurotransmitter release within the hippocampus (Gray et a l, 1996; Alkondon et 
a l, 1997a; Qian & Saggau, 1997). NAChRs in particular have been shown to 
modulate the release of a range of neurotransmitters in the central nervous system 
including glutamate (McGehee et a l, 1995; Gray et a l, 1996; Girod & Role, 
2001; Liu et a l, 2003), GABA (Alkondon et al, 1997a; Albuquerque et a l, 1998; 
Alkondon et a l, 1999; Zhu & Chiappinelli, 1999; Covernton & Lester, 2002), 
ACh (Araujo et a l, 1988a; McGehee et a l, 1995), dopamine (Rapier et a l, 1990; 
Zhou et a l, 2001) and noradrenaline (Clarke & Reuben, 1996; Sacaan et a l, 
1996).
With respect to glutamatergic transmission nAChRs have previously been shown 
to enhance evoked EPSCs, evoked EPSPs and miniature EPSCs in numerous 
brain regions including the hippocampus (McGehee et a l, 1995; Gray et a l, 1996; 
Radeliffe & Dani, 1998; Chiodini et a l, 1999; Liu et a l, 2003) with such studies
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indicating a predominantly presynaptic location of the nAChRs involved 
(McGehee et a l, 1995; Gray et a l, 1996). In contrast, studies investigating the 
modulation of GABAergic transmission within the hippocampus have indicated a 
predominantly aetion potential dependent meehanism (Alkondon et a l, 1997a; 
Alkondon et a l, 1999; Hulo & Muller, 2001). Such studies used 
electrophysiological recording techniques to record from hippocampal 
interneurones and pyramidal neurones and showed that application of ACh could 
increase hoth the frequency and amplitude of spontaneous GABAergic IPSPs 
recorded in hoth cell types. However this effect of ACh could be prevented by the 
application of the Na"** channel blocker tetrodotoxin (TTX). These experiments 
therefore indicated that the effect is dependent upon propagation of action 
potentials from the cell soma to the axon terminal and not activation of 
presynaptic receptors situated at the axon terminal.
The neuromodulatory role of nAChRs is thought to be one of their prominent 
functions within the brain (Vizi & Leiidvai, 1999) and could underlie numerous 
processes such as cholinergic involvement in learning and memory (Fujii et a l, 
1999; Fujii et a l, 2000). In addition, there is significant evidence that iiACliRs are 
important in a number of disease states including dementia, schizophienia and 
epilepsy (James & Nordberg, 1995; Steinlein et a l, 1995; Freedman et a l, 1997; 
Phillips et a l, 1998; Freedman et a l, 2000; Loscher et a l, 2003). With regard to 
epilepsy, findings from this laboratory (see below Roshan-Milani et a l, 2003) 
using extraeellular field recording techiniques within the acute hippocampal slice 
preparation have shown that nAChR agonists increase the frequency of 4-AP and
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bicuculline induced epileptiform bursting activity. These results together with in 
vivo studies by Damaj and collègues showing nicotine induced seizures in mice 
(Damaj et a l, 1999) suggest that nAChR modulation of hippocampal synaptic 
transmission may be an important factor in epileptogenesis. It is unlikely that 
nAChRs are significantly affecting GABAergic transmission to promote this 
epileptiform activity as the frequency facilitation was observed in the presence of 
the GABAa receptor antagonist hicueulline (Roshan-Milani et al., 2003). It may 
therefore be more likely that the frequency facilitation may reflect an enhancement 
of glutamate transmission.
The aims of this chapter were to investigate the effect of nicotinic agonists on both 
glutamate and GABA release from hippocampal pyramidal neurones and 
interneurones within the CAl and CA3 regions of the hippocampus with a view to 
uncovering possible mechanisms responsible for the pro-epileptogenic action of 
nicotine.
5.2. R e s u l t s
5.2.1. Proepileptogenic action of nAChR agonists in the hippocampus.
Previous published data from our laboratory reported a range of nAChR agonists 
to exacerbate epileptiform activity in the rat hippocampus (Roshan-Milani et a l , 
2003).
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The extracellular recording configuration was used in order to measure 
synchronous neuronal discharges that form epileptiform aetivities. Experiments 
were performed on hippocampal slices prepared from 2-6 week old male Wistar 
rats. Slices were maintained in an interfaee-type of recording chamber with 
recording electrodes placed close to the stratum pyramidale within area CA3 
(CA3c). Voltage recordings under control (drug free) conditions revealed the 
absence of any detectable spontaneous extracellular field events in all slices. Bath 
application of the potassium channel blocker 4-aminopyridine (4-AP, 20pM) 
resulted in the development of spontaneous epileptiform bursting activity apparent 
as spontaneous field potentials. These occurred every 2.6+O.ls (range 1.5-3.3s), a 
mean instantaneous frequency of 0.4±0.02Hz (n=37). Such activity was highly 
stable and lasted for the duration (up to many hours) of 4-AP perfusion. Upon 
subsequent co-application of the selective nAChR agonist 1,1 -dimethyl-4-phenyl- 
piperazinium iodine (DMPP, 10-30pM, n=31/37) a sustained increase in burst 
frequency was produced (Fig. 5.1 A and C), which was reversed upon DMPP 
washout. The mean maximal frequency potentiation induced by co-application of 
30jj,M DMPP was 37 ± 5% (n=31, P<0.05, Fig 5.1 D). Further studies by 
laboratory co-workers (Roshan-Milani et a l, 2003) confirmed the nAChR- 
mediated nature of hurst frequency potentiation as demonstrated by a reversal of 
the potentiation upon co-application of selective nAChR antagonists, including 
dihydro-p-erythroidine (20qM).
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In order to examine whether nAChR activation modulates hippocampal network 
activity more widely, fuither studies were carried out to assess the action of 
nAChR activation upon network bursting brought about by bicuculline activation 
(reduced inhibition).
Bath application of the GABAa antagonist bicuculline (20pM) also induced 
epileptiform bursting within hippocampal slices. Such activity was apparent as 
spontaneous field potentials occurring every 3-3 3 s, mean instantaneous frequency 
of 0.15±0.02Hz (n=30). Subsequent co-application of DMPP (30pM) again 
potentiated the burst frequency (Fig 5.IB and C). The mean maximal frequency 
potentiation of bicuculline (20pM)-induced bursting model was 248 ± 76% 
(11=14/14, P<0.05,Fig5.1 D).
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A. Scatter plot showing instantaneous burst frequency in response to 
continuous application of 20 pM 4AP (horizontal bar) for the duration of a 
representative experiment. Co-application of the selective nAChR agonist 
DMPP (10-30|iM) (horizontal bar) resulted in an increase in burst frequency. 
This was reversed upon subsequent co-application of the selective nAChR 
antagonist Dihydro-p-erythroidine (DHpE, 20pM). Inset voltage traces show 
epileptiform bursting activity before and during DMPP application and on 
addition of DHpE. 6. Similar scatter plot in which disinhibition of the slice 
following application of the GABA^ receptor antagonist bicuculline (20 pM) 
produced a regular synchronised extracellular discharge. Application of the 
nAChR agonist DMPP (30 pM) resulted in an enhanced burst frequency that 
was reversed upon subsequent co-application of dihydro-p-erythroidine 
(30|iM).Inset voltage traces show corresponding epileptiform bursting activity. 
C. Histogram summarising 10-30 pM DMPP-induced burst frequency 
potentiation in 4AP and bicuculline models. D. Similar histogram showing 
normalised frequency potentiation. Note the relative burst frequency 
enhancem ent is greatest for bicuculline.
Having firmly demonstrated that nAChR activation has a modulatory influence on 
network oscillatory states and in agreement with previous studies (Williams & 
Kauer, 1997; Cobb et a l, 1999) the subsequent experiments performed and 
reported in this chapter were carried out to uncover possible mechanisms by which 
nAChR agonists activation may modulate hippocampal circuits and synapses.
5.2.2. Effect of nAChR agonists on field EPSPs.
Initial extracellular recording experiments were carried out to investigate the 
action of nAChRs on evoked glutamatergic transmission. All extracellular 
experiments were carried out in hippocampal slices prepared from 3-5 week old 
Wistar rats. Initial studies were made in an interface-recording chamber with 
recording electrodes (1-5MQ, filled with standard aCSF) placed on the surface of 
the hippocampal slice in stratum pyramidale of the CAl and CA3 regions. Bipolar 
stimulation electrodes were positioned within the stratum radiatum of the CAl 
and in the stratum lucidum of the CA3 to activate Schaffer collaterals and mossy 
fibres respectively.
Field excitatory postsynaptic potentials (fEPSPs) were recorded in the CAl region 
in response to stimulation of the Schaffer collaterals and in the CA3 region in 
response to stimulation of the mossy fibres. Stimuli were applied every 15s and 
stimulation intensity adjusted to evoke a fEPSP that was 50% of the test fEPSP 
maximum. The fEPSP showed fast kinetics characteristic of glutamatergic
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transmission. The measured slope in the CAl and CA3 were -0.41±0.064mV/ms 
and ~0.8±0.16mV/ms respectively. Addition of the selective AMP A and NMDA 
antagonists, NBQX (2pM) and CGP40116 (50pM) completely abolished the 
fEPSPs confirming their glutamatergic nature (Fig 5.2A).
Bath application of the selective nAChR agonist DMPP (30pM) for a period of 
25-30 minutes resulted in a gradual but sustained and reversible enliancement of 
glutamate afferent evoked field EPSP slope at the mossy fibre-to-CA3 synapse of 
the hippocampus (30.84+5.98%, P=0.0078, Wilcoxon matched pairs test, n=S) but 
not at the Schaffer collateral-to-CA1 synapse (-16.99+7.04, P==0.125, Wilcoxon 
matched pairs test, n=5. Fig 5.2). These data suggest that glutamate transmission 
was significantly enhanced by nAChR activation at the mossy fibre-to-CA3 
synapse but not the Schaffer collateral-to-CAl synapse. As no GABA receptor 
antagonists were present throughout these experiments the small reduction noted 
in the fEPSP slope recorded at the Schaffer Collateral-to-CAl synapse may be due 
to an enhancement of GABA transmission, which may in turn reduce the 
glutamatergic fEPSP.
Further extracellular experiments, conducted in a submerged-type recording 
chamber, using nicotine and choline, a selective agonist of nAChRs containing the 
a7 subunit (Papke et a l, 1996), were carried out to confirm the lack of 
potentiation at the Schaffer collateral-to-CAl synapse. fEPSPs were recorded in 
the same manner as before. In order to ensure that the lack of nicotinic response
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Figure 5.2. E ffect o f D M PP on field  excitatory postsynaptic  potentia ls  
(fEP S Ps) evoked in the h ippocam pal s lice preparation
A. Representative voltage traces showing evoked fEPSP at the mossy fibre- 
to-CA3 synapse of the hippocampus, abolished by the addition of the AM PA 
and NMDA receptor antagonists NBQX (2pM) and CGP40116 (50pM) 
respectively Bi. Time-plot showing the evoked EPSP slope evoked at the MF- 
CA3 synapse upon application of the selective nicotinic agonist DMPP (30pM, 
horizontal bar, n=8) Each point is a mean of the mean fEPSPs recorded in 8 
pyramidal neurones. Note the reversible increase in fEPSP slope in response 
to DMPP application. Bii Similar time-plot showing no consistent change of the 
evoked EPSP slope at the Schaffer collateral-to-CAl synapse in response to 
DMPP application (n=5). C. Histogram summarising 30pM-induced change in 
fEPSP slope m easured between 25-30 minutes. Wilcoxon-matched pair test 
indicated a significant increase in the CA3 region (P= 0.0078) but no 
significant change in the CA1 region (P=0.125).
was not due to desensitisation of the receptors that may be produced by a 
prolonged period of agonist application, a picospritzer injection system was 
instead employed so that pressure ejection of small amounts of the agonists could 
be made directly onto the area of study. The ejection electrode was placed close 
to the recording site (-50-100pm) and application of 3-6PSI for a 10msec duration 
ejected agonists directly onto the region of study. Agonists were applied prior to 
afferent stimulation every 15s for 150s (10 ejections separated by 15s intervals).
In initial control experiments aCSF was applied to the slice in the same mamier to 
ensure that the injection protocol had no effect on the evoked responses. 
Picoinjection of aCSF consistently had no effect on the fEPSP slope (Fig 5.3Ai, 
11= 8).
Four concentrations of nicotine (lOpM, 20pM, lOOpM and ImM) and 1 
concentration of choline (lOmM) were used. The relatively high concentrations of 
agonists were selected, as with this method of agonist application in a submerged 
recording chamber a far smaller concentration of agonist will actually reach the 
tissue. No significant increase or decrease in the slope of the evoked fEPSPs was 
observed with any concentration of either agonist (Fig 5.3A-C). The fEPSP slope 
measuied in the presence of lOpM, 20pM, lOOpM and ImM nicotine were 
101,5+0.654% (n=4, P>0.05), 95.25+5.25% (n=4, P>0.05), 97.85+2.36% (n=4, 
P>0.05) and 93.83+2.173% (n=4, P>0.05) of the control fEPSP slope measured
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the  h ippocam pus.
A. Representative field recordings showing fEPSPs recorded in the CA1 
stratum radiatum evoked every 15s by stimulation of Schaffer collaterals, i, 
aCSF picoinjected onto cells produced no change in fEPSP slope, ii, similar 
nicotine application produced no effect, iii, application of carbachol decreased 
fEPSP slope. B.Point plot of EPSP slope against time. EPSP slope is 
represented as  a percentage of control (control value taken from initial 5 
sw eeps before drug application). Filled bars indicate period of drug application 
(picoinjection every 15s for 10 sweeps). C. Histogram summarising changes in 
EPSP slope. A one-way analysis of variants indicated that neither nicotine or 
choline produced a significant change of fEPSP. In contrast carbachol 
significantly decreased fEPSP slope to 11.88±2.66% of the control.
prior to drug application respectively. The field EPSP slope measured in the 
presence of lOmM choline was 96.38+5.736% (n=4, P>0.05).
To check that the injection method was effective in the delivery of agonists, the 
acetylcholine analogue carbachol was applied in the same manner. Similar 
pressure ejection of carbachol (ImM) produced a rapid and significant (P<0.0001) 
reduction of the EPSC to 11.88±2.66% of the control slope measured prior to 
carbachol application (n=5, P<0.001%). This 88.22% reduction of the fEPSP is 
most likely due to activation of the inAChRs, which is widely reported to suppress 
evoked glutamatergic EPSPs at the Schaffer collateral-to-CAl pyramidal neurone 
synapse (Rovira et a l, 1983; Hasselmo & Fehlau, 2001; Fernandez de Sevilla et 
a l, 2002; Fernandez de Sevilla & Buno, 2003) with a previous report by Qian & 
Saggau (1997) demonstrating an 85% inhibition of the fEPSP on application of 
carbachol mediated by mAChRs.
These results suggest that iiAChR agonists have no effect on fEPSCs recorded at 
the Schaffer collateral-to-CAl pyramidal neurone synapse and thus do not 
significantly alter glutamatergic transmission at this connection. Although an 
increase in GABA transmission at this synapse may have masked any effect on 
glutamate transmission, an increase in GABA transmission may account for the 
slight but not significant reduction in fEPSP slope in addition of DMPP.
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5.2.3. Effects of DMPP on Mini EPSCs.
An increase in the fEPSP slope at the mossy fibre-to-CA3 synapse of the 
hippocampus indicated that glutamate transmission was enhanced in this region by 
nAChR agonists. In order to identify the location of the receptors involved in the 
enhancement of glutamate transmission we employed the whole-cell voltage 
clamp configuration using a CsCl based pipette solution, as described in chapter 
two, to record spontaneous miniature glutamatergic events on CA3 pyi'amidal 
neurones in the presence of GABA antagonists and the Na"^  channel blocker TTX.
Perfusion of the hippocampal slices with the GABAa receptor antagonist 
bicuculline (lOpM) and the GABAb receptor antagonist CGP55845 (Ij-iM) was 
used to block all GABA-receptor mediated events so that any spontaneous PSCs 
recorded in the CA3 pyramidal neurones were likely to be glutamatergic in nature 
(Fig. 5.4A). Spontaneous inward currents were recorded at a frequency and 
amplitude of 21.9±2.8Hz and 35.7±0.9pA respectively at a holding potential o f -  
70mV (n=4). Subsequent perfusion of the hippocampal slices with the Na"*" 
channel blocker tetrodotoxin (TTX, IpM, n=4)) allowed only miniature 
spontaneous EPSCs (mEPSC) to be recorded at a frequency and amplitude of 
0.24±0.08Hz and 15.35±3.07pA respectively (Fig. 5.4B).
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A. Shows a representative whole-cell voltage clamp recording from a CA3 
pyramidal neurone. The GABA^ and GABAg receptor antagonists bicuculline 
(10pM) and CGP55845 (1pM) were included in the perfusion medium to 
ensure that only spontaneous glutamatergic EPSCs were recorded. 
Spontaneous events occurred at a mean frequency and amplitude of 
21.9±2.8Hz and 35.7±0.901pA respectively. B. On addition of the voltage 
operated Na"" channel blocker TTX (IpM) all action potential dependant 
events were abolished leaving only miniature spontaneous EPSCs (mEPSCs). 
These m EPSCs occurred at a mean frequency and amplitude of 0.24±0.08Hz 
and 15.3±3.07pA respectively (n=4).
Under these conditions and after a period of control recording of 5-lOmins, bath 
application of DMPP (30p,M) for a period of 5 minutes resulted in a significant 
increase in mEPSC frequency from 0.24±0.08Hz to 0.78±0.13Hz (n=4, P=0.0326) 
but not amplitude from 15.35±3.07pA to 12.60±1.50pA (n=4, P=0.4738) in CA3 
pyramidal neurones (Fig 5.5).
A similar experimental protocol showed 30qM DMPP to have no significant 
effect on either mEPSC frequency (1.52±0.7Hz to 1.06±0.34Hz, n=4, P=0.7840) 
or amplitude (14.11±2.72pA to 11.38±0.94Hz, n=4, P=0.1942) in CA3 
interneurones recorded with the stratum oriens and stratum radiatum (Fig 5.6).
A similar protocol was again employed to test the effect of DMPP on mEPSCs 
from both CAl pyramidal neurones and interneurones. DMPP had no significant 
effect on the frequency (0.44+0.16Hz to 0.58+0.39Hz, n=4, P==0.5808) or 
amplitude (9.03±0.58pA to 7.99+0.19Hz, n=4, P=0.1580) of mEPSCs recorded in 
CAl pyramidal neurones (Fig 5.7) and had no significant effect on frequency 
(0.85+0.26Hz to l.l+0.35Hz, n=4, P=0.0961) or amplitude (10.37±1.16pA to 
11.52±1.41pA, n=4, P=0.4707) of mEPSCs recorded in CAl interneurones (Fig 
5.8). This lack of effect on mEPSC in CAl region was consistent with the earlier 
data showing no effect of DMPP on the fEPSP in this region.
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Figure 5.5 E ffect o f D M PP on m iniature  EPSCs (m E P S C s) in CA3 pyram idal 
neurones.
A. Representative whole-cell voltage clamp recording trace and expanded raster 
plots illustrating m EPSCs in a CA3 pyramidal neurone. The neurone was 
clamped at -70m V in aCSF with bicuculline (10pM), GGP55845 (1pM) and TTX 
(1pM). Note the increase in frequency of mEPSCs (inward currents indicated by 
>k) in response to 30pM DMPP application. The delay in onset of the appearance 
of m EPSCs reflects the time taken for the drug to reach the bath and equilibrate 
therein. B. Representative cumulative inter-event interval and amplitude 
distributions created from m EPSCs before {filled squares) and during {filled 
circles) 30 pM DMPP application. Kolmogorov-smirnov tests indicated a 
significant increase in frequency but not amplitude distributions. C. Histograms 
summarising the effect of DMPP on mean mEPSC frequency and amplitude 
(n=4) expressed as  a percentage of control. Note the 300% increase in the 
frequency of mEPSCs. A paired t-test performed on raw data indicated a 
significant increase mEPSC frequency (P=0.0326) but not amplitude (P=0.474).
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Figure 5.6 E ffect o f D M PP on m EPSC s recorded from  C A3 in terneurones.
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating m EPSCs recorded in a CA3 stratum oriens 
interneurone.The neurone was clamped at -70mV in aCSF with bicuculline 
(10pM), CGP55845 (1pM) and TTX (1pM). B. Representative cumulative inter­
event interval distributions and amplitude distributions created from m EPSCs 
before (filled squares) and during (filled circles) 30pM DMPP application. The 
Kolmogorov-Smirnov test indicated no significant difference in cumulative 
distributions. C. Histograms summarising the effect of 30pM DMPP on mean 
mEPSC frequency and amplitude (n=4) expressed as  a percentage of the mean 
control value. A paired t-test on raw data indicated no significant change in 
either mean frequency (P=0.3781) or amplitude (p=0.2311) following DMPP 
application.
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Figure 5.7 Effect o f D M PP on m EPSCs recorded In CA1 pyram idal 
neurones.
A. Representative whole-cell voltage clamp recording trace and expanded raster 
plots illustrating m EPSCs recorded from a CA1 pyramidal neurone. The neurone 
was clamped at -70m V in aCSF, bicuculline (10pM), CGP55845 (1pM) and TTX 
(1pM). B. Representative cumulative inter-event interval distributions and 
cumulative amplitude distributions created from mEPSCs before (filled squares) 
and during (filled circles) 30pM DMPP application. A Kolmogorov-Smirnov test 
indicated no significant difference between cumulative distributions. C. 
Histograms summarising the effect of 30pM DMPP on mean mEPSC frequency 
and amplitude (n=4) expressed as  a percentage of the mean control value. A 
paired t-test performed on raw data indicated no significant change in either 
frequency (P=0.5808) or amplitude (p=0.1580) following DMPP application.
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Figure 5.8 E ffect o f D M PP on m EPSC s recorded in CA1 In terneurones
A. Representative whole-cell voltage clamp recordings trace and expanded 
raster plots illustrating m EPSCs in a CAl stratum oriens interneurone. The 
neurones was clamped at -70mV in aCSF with bicuculline (10pM), CGP55845 
(IpM) and TTX (1pM). B Representative cumulative inter-event interval 
distributions and cumulative amplitude distributions created from mEPSCs 
before (filled squares) and during (filled circles) 30pM DMPP application. The 
Kolmogorov-Smirnov test indicated no significant difference between 
cumulative distributions. C. Histograms summarising the effect of 30pM 
DMPP on mean mEPSC frequency and amplitude (n=4) expressed as  a 
percentage of the mean control value. A paired t-test indicated no significant 
change in either mEPSC frequency (P=0.0961) or amplitude (p=0.4707) 
following DMPP application.
However, DMPP did produce an inward current (mean amplitude of 
70.67+31.2IpA) in 3 out of 4 CAl interneurones all recorded within the stratum 
oriens. This inward current was activated in the presence of TTX suggesting a 
direct activation of nAChR present on the interneurone surface.
5.2.4. Effects of DMPP on spontaneous GABA transmission
As application of DMPP produced a slight but not significant decrease in the 
fEPSP evoked at the Schaffer collateral-to-CAl synapse and produced inward 
currents in CAl interneurones it seemed likely that although DMPP may have no 
effect on glutamatergic transmission within this region, it may be able to modulate 
GABA transmission.
To investigate the effect of nAChR agonists on GABA transmission within area 
CAl, we next investigated the action of DMPP (30pM) on spontaneous IPSC 
events recorded in both CAl pyramidal neurones and CAl interneurones.
CAl pyramidal neurones were recorded under the whole-cell voltage clamp 
configuration and in the presence of the AMP A receptor antagonist NBQX (2pM) 
and the NMDA receptor antagonist CGP40116 (50pM). In a period of control 
recording of 5-lOmins spontaneous IPSCs (sIPSC) were recorded with an average 
fi’equency and amplitude of 5.04±2.0Hz and 29.26+5.98pA respectively. These 
values were consistent with sIPSCs recorded in CAl pyramidal neurones in
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previous studies (Hajos & Mody, 1997). Subsequent bath application of DMPP 
(30pM) had no significant effect on sIPSC frequency (5.1±1.86Hz, P=0.8292, 
n=4) or amplitude (29.42+8.4pA, P=0.9565, n=4) (Fig 5.9).
A similar protocol was carried out for recording from CAl interneurones with cell 
bodies in either the stratum oriens or stratum radiatum. sIPSCs were recorded at 
an average frequency and amplitude of 7.48+1.93Hz and 20.42±2.47pA 
respectively. Bath application of 30qM DMPP resulted in a significant increase in 
frequency to 13.05+2.8Hz (P=0.0403, n=6) but had no significant effect on the 
mean amplitude (23.41+3.04, P=0.0836, n=6) (Fig. 5.10), although in some 
individual experiments a significant increase in amplitude was noted.
In CAl interneurones DMPP also elicited an inward cuiTent (mean amplitude 
131.7±63.13pA) in 3 of 6 (50%) interneurones recorded (Fig 5.10 A). Two of the 
interneurones responding with an inward current showed cell body location in the 
stratum radiatum and the other showed cell body location in the stratum oriens. 
No such inward currents were apparent in any of the CAl pyramidal neurone 
recordings (n=4).
These changes in sIPSC frequency indicate that nAChR activation results in an 
increase of GABA release onto CAl interneurones but not CAl pyramidal 
neurones. In addition activation of nAChRs can produce an inward current in a 
subset of CAl interneurones.
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Figure 5.9. E ffect o f D M PP on spontaneous IPSCs (s IPS C s) in CA1 
P yram idal neurones.
A. Representative whole-cell voltage clamp recording trace and expanded raster 
plots illustrating sIPSCs from a CA1 pyramidal cell. The neurone was clamped at 
-70m V in aCSF with NBQX (2pM) and CGP40116 (50pM) B. Representative 
cumulative inter-event interval distributions and cumulative amplitude 
distributions created from sIPSCs before (filled squares) and during (filled circles) 
30pM DMPP application. K-S test indicated no significant difference between 
cumulative distributions. C. Histograms summarising the effect of 30pM DMPP 
on mean sIPSC frequency and amplitude (n=4). A paired t-test performed on the 
raw data indicated a no significant change in sIPSC frequency (P=0.8292) or 
IPSO amplitude (P=0.9565) following DMPP application.
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Figure 5.10. E ffect o f D M PP on sIP S C s in CA1 in terneurones
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating sIPSCs from a CA1 stratum oriens interneurone. 
Neurone was clamped at -70mV in aCSF with NBQX (2pM) and CGP40116 
(50pM). Note the inward current and increase in mEPSC frequency in 
response to DMPP application B. Representative cumulative inter-event 
interval distributions and cumulative amplitude distributions created from 
sIPSCs before (filled squares) and during (filled circles) 30pM DMPP 
application. K-S tests indicated a significant increase in both frequency and 
amplitude in this example. C. Histograms summarising the effect of DMPP on 
mean sIPSC frequency and amplitude (n=7). A paired t-test performed on the 
raw data indicated a significant increase in sIPSC frequency (P=0.0403) and 
no change in IPSC amplitude (P=0.0836) following DMPP application.
5.2.5. Effect of DMPP on mini IPSCs
In order to investigate whether this increase in GABAergic transmission was due 
to pre- or postsynaptic mechanisms, studies were carried out on mIPSCs in this 
region. In studies to investigate the effect of nAChR activation on miniature 
IPSCs (mIPSCs) slices were bathed in the AMP A receptor antagonist NBQX 
(2|LiM), the NMDA receptor antagonist CGP40116 (50pM) and the Na"^  channel 
blocker TTX (IpM) to eliminate all fast glutamate events and action potential 
dependent IPSCs so that mIPSCs could be uncovered (Fig 5.11).
Recordings from visually identified interneurones within the stratum oriens and 
stratum radiatum of area CAl revealed mIPSCs with a mean frequency and 
amplitude of 0.46±0.0914Hz and 20.18±2.83pA respectively (n=4). Subsequent 
bath application of 30pM DMPP had no significant effect on either frequency 
(0.504+0.086Hz, P=0.395, n=4) or amplitude (20.87+2.09, P=0.6994, n=4) of 
mIPSCs (Fig 5.12). As before DMPP resulted in an inward current in 2 out of 4 
(50%) of CAl interneurones (mean amplitude 56.0±6.0pA). As inward cunents 
produced on DMPP application were apparent even in the presence of TTX (Fig 
5.12A), these data suggest a direct action of nAChR activation on a subpopulation 
of CAl interneurones. Thus it seems that the observed increase of sIPSC onto 
CAl interneurones is most likely due to a direct activation of somatodendritic or 
preterminal nAChRs increasing the action potential dependent increase in G ABA 
release and not a presynaptic modulatory effect.
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5.11 S pontaneous and m iniature  inhib itory postsynaptic  currents  
recorded from  C A l in terneurones
A. Shows a representative voltage clamp recording from a CA1 interneurone. 
The AMPA and NMDA receptor antagonists NBQX (1pM) and CGP40116 
(50pM) were included in the perfusion medium to ensure that only 
spontaneous GABAergic IPSCs were recorded. These spontaneous events 
were recorded at a frequency and amplitude of 7.4Hz and 20.42pA 
respectively (n=6). B. On addition of the voltage operated Na+ channel blocker 
TTX all action potential dependant events were abolished and only miniature 
spontaneous IPSCs (mIPSCs) were recorded. These mIPSCs were recorded 
at a frequency and amplitude of 0.46Hz and 20.18pA respectively (n=4).
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Figure 5.12. E ffect o f D M PP on m iniature IPSCs (m IPSC s) recorded in C A l 
in terneurones.
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating mIPSCs in a CA1 stratum oriens interneurone. The 
neurone was clamped at -70mV in aCSF with NBQX (2pM), CGP40116 (50pM) 
and TTX (IpM). Note the inward current evoked by 30pM DMPP application. B. 
Representative cumulative inter-event interval distributions and cumulative 
amplitude distributions created from mIPSCs before {filled squares) and during 
{filled circles) 30pM DMPP application. A K-S test indicated no significant 
difference in cumulative distributions following DMPP application. C. 
Histograms summarising the effect of 30pM DMPP on mean mIPSC frequency 
and amplitude (n=4) expressed as  a percentage of the mean control value. A 
paired t-test indicated a no significant difference in IPSC frequency (P=0.3695) 
and mIPSC amplitude (P=0.6994) following DMPP application.
A similar protocol was adopted to investigate whether nAChR activation affects 
mIPSCs recorded in CAl pyramidal neurones (fig. 5.13). During a 5-lOmin 
control period mIPSCs were recorded at a frequency and amplitude of 2.8±2.2Hz 
and 28.42±4.2pA respectively. Bath application of DMPP had no effect on the 
frequency (1.99±1.4Hz, P-0.578, n=4) or amplitude (28.59+2.9pA, P-0.979, 
n=4). Again no inward currents were apparent in any of the CAl pyramidal 
neurone recordings (n=4).
A similar protocol was again employed to test the effects of DMPP on mIPSCs 
recorded from both CA3 pyramidal neuiones and CA3 interneurones. DMPP had 
no significant effect on mIPSC frequency (0.5±0.09Hz to 0.6±0.15Hz, P=0.425, 
n=4) recorded in CA3 pyramidal neurones (fig. 5.14) and had no effect on mIPSC 
frequency (0.83±0.34Hz to 0.95+0.44Hz, P=0.368, n=4) or amplitude 
(27.28±4.9pA to 22.21±2.65pA, P=0.199, n=4) in CA3 interneurones (fig. 5.15).
The overall effect of DMPP on spontaneous and miniature EPSCs and IPSCs are 
summarised in table 5.1 and the most likely location of nAChRs indicated by 
these results are summarised in figure 5.16.
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Figure 5.13 E ffect o f D M PP on m IPSC s recorded in C A l pyram idal 
neurones.
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating mIPSCs recorded in a CA1 pyramidal neurone. 
Neurones clamped at -70m V in aCSF with NBQX (2pM) and CGP40116 
(50pM) and TTX (1pM) B. Representative cumulative inter-event interval 
distributions and cumulative amplitude distributions created from mIPSCs 
before (filled squares) and during (filled circles) DMPP application. K-S tests 
indicated no significant difference in cumulative distributions. C. Histograms 
summarising the effect of DMPP on mean mIPSC frequency and amplitude 
(n=4). A paired t-test indicated a no change in IPSC frequency (P=0.5783) 
and no change in mIPSC amplitude (P=0.9785) following DMPP application.
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Figure 5.14 E ffect o f D M PP on m IPSC s recorded in C A3 in terneurones
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating mIPSCs recorded in a CA3 stratum oriens 
interneurone. Neurone clamped at -70mV in aCSF with NBQX (2pM) and 
CGP40116 (50pM) and TTX (1pM) B. Representative cumulative inter-event 
interval distributions and cumulative amplitude distributions created from 
mIPSCs before {filled squares) and during {filled circles) DMPP application. 
C. Histograms summarising the effect of DMPP on mean mIPSC frequency 
and amplitude (n=4) expressed a s  a percentage of the mean control value. A 
paired t-test indicated a no change in IPSC frequency (P=0.4248) and no 
change in mIPSC amplitude (P=0.5837) following DMPP application.
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Figure 5.15 E ffect o f D M PP on m IPSC s recorded from  C A3 pyram idal 
neurones.
A. Representative whole-cell voltage clamp recording trace and expanded 
raster plots illustrating mIPSCs recorded in a CA3 pyramidal neurone clamped 
at -70m V in aCSF with NBQX (2pM) and CGP40116 (50pM) and TTX (IpM).
B. Representative cumulative inter-event interval distributions created from 
mIPSCs before (filled squares) and during (filled circles) DMPP application. K- 
S tests indicated no significant difference in cumulative distributions. C. 
Histograms summarising the effect of DMPP on mean mIPSC frequency and 
amplitude (n=4)expressed a s  a percentage of the mean control value. A 
paired t-test indicated a no change in IPSC frequency (P=0.3680) and no 
change in mIPSC amplitude (P=0.1989) following DMPP application.
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Tab le  5.1 S um m ary o f the effect o f D M PP on spontaneous and m in ia tu re  curren ts .
Table sum m arises the effect of DMPP on glutamatergic and GABAergic transmission in 
the hippocampus. DMPP increased the frequency but not amplitude of miniature EPSCs 
(mEPSCs) in CAS pyramidal neurones but had no effect on m EPSCs recorded in CA3 
interneurones, CAl pyramidal neurones and CA1 interneurones. DMPP increased the 
frequency of spontaneous IPSCs (sIPSCs) recorded in CA1 interneurones but not CA1 
pyramidal neurones, CA3 interneurones or CA3 interneurones. DMPP had no effect on 
miniature IPSCs (mIPSCs) recorded in any of the aforementioned cell types and 
consistently produced an inward current in CA1 interneurones.
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Figure 5.16 S um m ary  o f nA C hR  location w ith in  the h ippocam pus.
Diagram summarising the location of nAChRs as  indicated by the results 
presented within this chapter. DMPP induced an increase in the frequency of 
miniature EPSC s recorded in CA3 pyramidal neurones but not CA3 
intem eurones indicating that nAChRs are present presynaptically on the 
mossy fibre terminals synapsing onto CA3 pyramidal neurones but not CA3 
intemeurones. DMPP also produced an increase in spontaneous IPSPs in 
CAl intem eurones but not pyramidal neurones. This was shown to be a TTX 
sensitive effect and therefore indicates the presence of nAChRs 
postsynaptically on intem eurones innervating other CAl Intemeurones but not 
CAl pyramidal neurones.
5.3. D iscussion
Taken together, the results presented in the chapter suggest that nAChRs present 
on the mossy fibre terminals of dentate granule cells and intemeurones can 
regulate both glutamatergic and GABAergic circuits. However it is apparent that 
differences in such regulation exist within different regions and cell types.
5.3.1. Excitatory transmission
The results presented in this chapter report a significant 30.84+5.98% increase in 
evoked field EPSP slope on addition of the nAChR agonist DMPP at the mossy 
fibre-to-CA3 synapse indicating an enhancement of glutamate transmission within 
this pathway. This reported increase is small in comparison to other studies where 
iiACliR agonists have been shown to enhance evoked glutamate transmission. In 
another limbic system pathway, at synapses between medial habenula nucleus 
(MEIN) and the interpeduncular nucleus (IPN) the evoked EPSC (eEPSC) more 
than doubles in response to nicotine application (McGehee et a l, 1995). In 
autaptic synapses or synapses between two coupled cultured hippocampal 
neurones eEPSC amplitude was enhanced by 46% in response to nicotine 
application (Radcliffe & Dani, 1998). The larger effect in these different 
preparations may be due to differences in receptor expression patterns. 
Hippocampal cultures are known to show an increased expression of nAChRs 
compared to slice preparations (Sudweeks & Yakel, 2000).
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Further studies were carried out to assess whether this enhancement may be due to 
actions at somatodendritic, preterminal or presynaptic receptors (i.e. an increase in 
amount of glutamate released) or on the postsynaptic site (i.e. an increase in 
postsynaptic detection of glutamate). Generally modulation of transmitter release 
by presynaptic nAChRs is insensitive to blockade by the Na"^  channel blocker 
tetrodotoxin (TTX) whereas modulation of transmitter release by preterminal or 
somatodendritic receptors depends on the propagation of action potentials and will 
be therefore sensitive to TTX (Clarke & Reuben, 1996; Gray et a l, 1996; 
Wonnacott, 1997). In the case of TTX insensitive effects measuring changes in 
frequency and amplitude can discriminate between an increase in transmitter 
release via presynaptic receptors and an increase in the postsynaptic detection of 
transmitter. Increases in frequency but not amplitude indicate an increase in the 
rate of transmitter release and not postsynaptic detection (McGehee et a l, 1995; 
Gx?iy et a l, 1996).
In the case of nACliRs it has been reported that activation increases frequency not 
amplitude of mEPSCs in numerous brain regions including the CA3 pyramidal 
neurones of the hippocampus (McGehee et a l, 1995; Gray et a l, 1996; Girod & 
Role, 2001).
The data provided here, that DMPP indeed increases mEPSC frequency but not 
amplitude in CA3 pyramidal neurones confirms that hippocampal glutamate 
transmission is enhanced via a presynaptic mechanism. This finding is in 
agreement with previous studies in CA3 pyramidal neurones (Gray et a l, 1996).
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These authors also reported an increase in intracellular Ca^ "^  in mossy terminals in 
response to nicotine application and proposed that activation of presynaptic 
nACliRs on mossy terminals could allow a large influx of Ca^  ^ that may 
contribute to the enhanced glutamate release onto CA3 pyramidal neurones. 
Together these findings suggest that the increase in fEPSPs recorded at the mossy 
fibre-to-CA3 pyramidal neurone synapse may be mediated by activation of 
presynaptic nAChRs, which open to allow a large Ca^  ^ into the presynaptic 
terminal and thus increase release of glutamate. However a recent study by Vogt 
and Regher (2001) disagreed with Gray’s results showing no increase in Ca^’*' 
within the mossy terminal on application of nAChR agonists.
However, no increase in glutamate released onto CA3 intemeurones was noted. 
This may be due to the fact that mossy fibres innervate principal cells and 
intemeurones via anatomically distinct synapses. The CA3 intemeurones are 
innervated by small en passant or filopodial mossy fibre synapses rather than the 
large mossy terminals which innervate the CA3 pyramidal neurones (Acsady et 
a l, 1998). It therefore seems likely that nAChRs are not expressed at these mossy- 
flbre-to CA3 interneurone synapses.
DMPP had no significant effect on evoked fEPSPs at the Schaffer collateral-to- 
CAl pyramidal neurone synapse within area CAl of the hippocampus. One 
possible explanation for this lack of effect could be desensitisation of the 
nAChRs, although this is unlikely as a significant effect was apparent at the mossy 
fibre-to-CA3 synapse using the same concentrations of agonists and application
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protocol. However, desensitisation is particularly prominent for a7 containing 
nAChRs and these receptors have been strongly implicated in this modulatory 
role. In order to minimise the extent of desensitisation we carried out additional 
experiments within the CAl region using rapid pressure application of agonists. 
Application of nicotine in this manner had no effect on the fEPSP at Schaffer 
coIlateral-to-CAl pyramidal neurone synapse, although this paradigm was not 
used to investigate the mossy fibre-to-CA3 synapse. The nAChR agonist choline 
was also tested, as receptor desensitisation is much less pronounced with this 
agonist than nicotine (Alkondon et a l, 1997b) but again failed to record any effect 
on the fEPSP.
The lack of any effect on fEPSP slope at the Schaffer collateral-to-CAl synapse 
reported here disagrees with a previous study by Chiodini and colleagues (1999), 
which reported a significant increase in fEPSP slope of up to 54%. However, these 
authors reported a similar increase of fEPSP slope on application of nAChR 
antagonists and therefore postulated that the excitatory effects of nicotine at the 
Schaffer collateral-to-CAl synapse could be mediated through receptor 
desensitisation rather than activation of nAChRs on CA3 pyramidal neurones. For 
example desensitisation of nAChRs expressed on intemeurones or axonal fibres 
could enhance CA3 pyramidal neurone excitation by a reduction of intemeurones 
firing or modulation of action potential propagation in the axons. The 
concentration of DMPP used in our experiments may not have induced such a 
desensitisation and it is most likely that nicotine and choline applied by pressure
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injection did not induce a receptor desensitisation and therefore may explain why 
no change in fEPSP was observed.
These authors also reported an increase and decrease of GABA transmission 
within the CAl at low and high concentrations of nicotine respectively. Therefore 
another possibility for the lack of effect on fEPSPs evoked at the Schaffer 
collateral-to-CAl synapse in this study may be that glutamate transmission is 
enlianced but is masked by a concominant enhancement of GABAergic 
transmission. This seems a more likely possibility due to the slight, albeit non­
significant, decrease in the fEPSPs. An inliibition of glutamatergic EPSPs by 
activation of GABAb receptors has been shown previously at this synapse (Wu & 
Saggau, 1995; Hasselmo & Fehlau, 2001).
As the investigation of mEPSCs in CAl neurones in the presence of GABA- 
receptor antagonists and the Na^ channel blocker TTX, showed no change in the 
frequency or amplitude of mEPSC recorded in CAl pyramidal neurones or CAl 
intemeurones. These results suggest that there was no enhancement of glutamate 
transmission onto CAl pyramidal neurones, at least via a presynaptic effect that 
may have been masked by an increase in GABAergic transmission. These results 
disagree with findings (Gray et a l, 1996; Liu et a l, 2003) that reported an 
increase in mEPSC frequency on CAl pyramidal neurones. Gray and colleagues
(1996) reported an increase of mEPSCs onto CAl pyramidal neurones but did not 
show any data, claiming the mEPSCs were smaller and harder to analyse. 
Moreover, the lack of effect on glutamate transmission in the CAl region is
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supported by a study by Alkondon and colleagues (1997a) who stated that nAChR 
aetivation is linked to the release of GABA but not glutamate in the CAl region of 
the hippocampus.
5.3.2. Inhibitory transmission
An investigation into the regulation of GABA transmission within area CAl 
showed that application of DMPP elicited an inward current and increased the 
frequency of spontaneous IPSCs in CAl hippocampal intemeurones. These results 
indicate that nAChR agonists can depolarise CAl intemeurones and increase 
GABA release within the CAl region of the hippocampus agreeing with numerous 
previous studies (Alkondon et a l, 1997a; Jones & Yakel, 1997; Frazier et a l, 
1998b; Alkondon et a l, 1999; McQuiston & Madison, 1999c; Alkondon et a l, 
2000a; Alkondon et a l, 2000b; Ji & Dani, 2000; Sudweeks & Yakel, 2000; 
Alkondon & Albuquerque, 2001; Buhler & Dunwiddie, 2001).
An inward current in CAl intemeurones could be elicited by either nACliR 
agonists acting directly on nAChRs known to be expressed on the interneurone 
surface (Freedman et a l, 1993; Fabian-Fine et a l, 2001; Kawai et a l, 2002) or by 
nAChR exciting CAl pyramidal neurones, which in turn would release glutamate 
to act on glutamate receptors present on the interneurone surface and thus 
potentiate interneurone activity and GABA release tlirough a postsynaptic 
mechanism. However in the case of these experiments the latter proposal can be 
discounted due to that fact that glutamate receptor antagonists were present in the
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perfusion medium throughout all experiments and additionally that no inward 
current was noted in pyramidal neurones on application of DMPP. Thus it seems 
most likely that the inward current represents a direct effect of nACliR agonists on 
the CAl interneurone under study. Further experiments carried out in the presence 
of TTX showed that the inward current was insensitive to TTX further supporting 
the suggestion that it is the result of direct activation of nAChR on the 
interneurone surface. These results are in agreement with previous studies, which 
have reported inward currents in CAl interneuiones in response to 
pharmacological activation of nAChRs by rapid application range of agonists 
including ACh, nicotine, DMPP and choline (Alkondon et a l, 1997a; Jones & 
Yakel, 1997; Frazier et a l, 1998b; Alkondon et a l, 1999; McQuiston & Madison, 
1999c; Ji & Dani, 2000; Sudweeks & Yakel, 2000; Buhler & Dunwiddie, 2001). 
A recent study showed application of nicotine for a period of l-5mins, similar to 
the agonist application protocol performed in this study, elicited slowly 
desensitising inward currents in stratum lacunosum molecular e CAl 
intemeurones (Alkondon et a l, 2000b). The inward currents reported here show 
similar range in amplitude to those previously reported. The lack of inward cuiTent 
in CAl pyramidal neurones agrees with most previous studies (Jones & Yakel, 
1997; Frazier et a l, 1998b; McQuiston & Madison, 1999c; Sudweeks & Yakel, 
2000)
Previous studies indicate an inward current in dendritic inhibitory intemeurones 
and not perisomatic intemeurones (McQuiston & Madison, 1999c). As only 50% 
of our cells responded with an inward current it may be that we have recorded
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from both cells types and that the 50% of cells that did respond were dendritic and 
the 50 % that showed no inward current were perisomatie.
An increase in the frequency of sIPSCs recorded in CAl intemeurones in response 
to DMPP application showed that nAChR activation increased GABA release 
onto CAl intemeurones presumably due to an increase in GABAergic 
interneurone activity. The fact that no increase in mIPSC frequency was recorded 
in the presence of the Na’’ channel bloeker TTX illustrates that the increased 
release of GABA from CAl intemeurones is a TTX-sensitive effect. This finding 
indicates that GABA release from CAl intemeurones is action potential 
dependent and thus is due to the activation of nAChRs present on preterminal or 
somatodendritic sites. These results aie in agreement with previous studies by 
Alkondon and colleagues and Hulo and Muller who have also reported that 
activation of nAChRs on CAl intemeurones facilitates an action potential- 
dependent release of GABA (Alkondon et a l, 1997a; Albuquerque et a l, 1998; 
Alkondon et a l, 1999; Hulo & Muller, 2001).
That the frequency and amplitude of the sIPSC and mIPSCs in CAl pyramidal 
neurones remain unchanged by DMPP suggests that nAChRs activated to increase 
the release of GABA are most likely present on the interneurone-selective (IS) 
class of intemeurones as activation of these cells would increase GABA 
transmission onto other CAl intemeurones but not CAl pyramidal neurones.
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These findings disagree in part with some work by Alkondon and colleagues
(1997) in that these authors report nAChR agonists to increase sIPSC frequency 
and amplitude in both CAl intemeurones and CAl pyramidal neurones indicating 
an action potential dependent increase of GABA release from intemeurones 
synapsing onto both other CAl intemeurones and CAl pyramidal neurones. Hulo 
and Muller 2001 also reported an increase of sIPSC frequency and amplitude in 
CAl pyramidal neurones that was sensitive to TTX. These differences may be 
representative of the small sample size in this study.
5.3.3. Physiological relevance
The results presented in this chapter show that application of nAChR agonists 
enhanced the strength of glutamate transmission at the mossy fibre-CA3 synapse 
resulting in an inereased excitation of CA3 pyramidal neurones as well as 
activating the IS elass of CAl intemeurones to release GABA onto other 
intemeurones. In this section it will be discussed how these effects may relate to 
the pro-epileptogenic action of nicotine and specifically how these actions may 
result in the increase of burst frequency reported by Roshan-Milanin and 
colleagues (2003).
The mechanisms underlying the generation of epileptiform activities in the 
hippocampus is thought to arise ftom a hyperexcitability within the principal cell 
population (Jefferys, 1993). This hyperexcitability may be the result of either an
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increased excitatory drive (especially through recurrent connections) and/or 
decreased inhibition to these cells. The effects reported in this chapter are;
1) An increase of excitatory input onto pyramidal neurones via increased 
glutamate released from the mossy fibre terminals.
2) An inhibition of intemeurones via an increase in the frequency of 
inliibitory GABAergic events.
These effects may lead to a hyperexcitability of the principal cell population and 
thus have a pro-epileptogenic effect. However, how would these effects of nAChR 
activation on glutamatergic and GABAergic transmission lead to the observed 
increase in burst frequency seen in previous studies (Roshan-Milani et al., 2003)?
With regard to the appaient direct enhancement of evoked glutamatergic 
transmission (Fig 5.2B), Staley and colleagues have proposed that:
'‘The rate o f glutamate release (Rgih) is the product o f the number o f releasahle 
vesicles (Ns) multiplied by the probability o f release (Pp). ” (staiey et ai., i998)
R g i u  =Nr x Pr
By using the above equation the following possibilities exist:
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1) Burst termination is due to depletion of glutamate from recurrent collaterals (if 
Nr=0 then Rqiu =0). If DMPP increased the amount of glutamate released then 
depletion should occur more rapidly, thus decreasing the duration of the burst and 
allowing the next burst to come quicker. However, Staley (1998) stated that burst 
length does not predict the time interval until next burst, but length of interval 
preceding a burst is correlated with burst length.
2) The most likely explanation is that DMPP increases the probability of 
glutamate release (as agents that increase probability of release will increase burst 
frequency). Stately (1998) stated that “if probability of release is increased then 
the inter-burst interval decreases therefore resulting in an increase of frequency, 
which will cause a decrease of burst length”. This explanation fits with the 
original finding that nAChR agonists increase the burst frequency while 
decreasing overall burst length (Roshan-Milani et a l, 2003).
When an action potential reaches a presynaptic terminal voltage dependent 
calcium channels (VDCC) mediate an increase in intracellular ealcium. This does 
not ensure transmitter release from the presynaptic terminal but only increases 
probability of release. If DMPP acts to open presynaptic nAChR chamaels, which 
are permeable to Ca^ "^  (Seguela et a l, 1993), this may increase intracellular Ca^  ^
just prior to the arrival of an action potential that may be able to increase the 
probability of release in a similar manner to that seen with paired pulse 
facilitation. Another possibility may be that Ca^  ^ entry through nAChRs may
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promote dependent Ca^”^ release from intracellular stores resulting in an 
increase of transmitter release.(Engelman & Macdermot, 2004).
All inputs onto a neurone, whether excitatory or inhibitory, summate to decide if a 
cell will fire an action potential and increase the probability of transmitter release. 
With regard to the increased inhibition of CAl intemeurones, DMPP may infact 
lead to an overall disinhibition of pyramidal neurones. This decrease in inliibitory 
inputs onto pyramidal neurones may result in an increase in the probability of that 
cell to be able to release glutamate. Thus a similar situation may arise where the 
probability of glutamate release is increased resulting in a decrease of inter-burst 
interval and an increase of burst frequency. If this mechanism had a prominent 
role in epileptogenesis a decrease in sIPSCs recorded in CAl pyramidal neurones 
would have heen expected, however this was not the case. These observations, 
taken together with the faet that epileptic burst frequency was increased by 
nAChR agonists in the bicuculline model (Roshan-Milani et a l, 2003) suggest 
that it is unlikely that nAChRs aie significantly affecting GABAergic circuits to 
promote epileptiform activity.
Therefore the proepileptogenic action of nAChR agonists may be mediated mainly 
through glutamatergic mechanisms.
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5.4. Summary
The results presented in this chapter show that selective nAChR agonists increase 
both glutamatergic and GABAergic transmission within the hippocampus. 
Glutamatergic transmission is increased via activation of presynaptic nAChRs 
whereas GABAergic transmission is increased through an action potential 
dependent mechanism. The observed alteration in glutamate transmission seems to 
be confined to the CA3 region whereas the alteration in GABA transmission is 
confined to the CAl region (see table 5.1 & fig 5.16). However, it is possible that 
these effects may be capable of increasing the probability of glutamate release 
within the hippocampus as a whole and as such may play some role in the 
proepileptogenic action of nAChR agonists within the hippocampus.
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6. GENERAL DISCUSSION
The main aim of this thesis was to further investigate the physiological 
interactions of the cholinergic and GABAergic systems within the septo- 
hippocampal axis. This was achieved by conducting two parallel approaches. The 
first investigated mAChR-mediated synaptic responses in hoth the principal cells 
and GABAergic intemeurones in response to physiological activation of 
cholinergic afferents. The second study investigated the neuromodulatory role of 
nACliRs in hippocampal cells and circuits using nAChR selective 
pharmacological agents.
6.1.MUSCAR1NIC ACETYLCHOLINE RECEPTOR SYNAPTIC RESPONSES
Chapter 3 confirmed the presence of the mAChR-mediated slow EPSP in 
hippocampal pyramidal neurones. That this was a reasonably uniform response 
from all pyramidal neurones was most likely due to the fact that pyramidal 
neurones represent a relatively homogenous population of cells. The use of septo- 
hippocampal slices provided the first direct evidence, in vitro, that physiological 
activation of cholinergic afferents from the medial septal nucleus produces a slow 
depolarisation in hippocampal pyramidal neurones. In some cases IPSPs were 
noted thi'oughout the slow depolarisation. This observation along with previous 
pharmacological studies (McQuiston & Madison, 1999b, a) suggested that 
mAChR activation also excites GABAergic interneuiones within the
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hippocampus. This initial results chapter also confirmed that stimulation within 
the stratum oriens was an effective and sufficient method to stimulate cholinergic 
afferent fibres within the hippocampal slice preparation. Whilst the septal origins 
of such fibres cannot be guaranteed, previous lesion studies in which slices were 
prepared from fimbria/fornix transected animals suggest that the overwhelming 
majority of fibres originate from this structure (Cobb et a l, 1999). These results 
allowed us to proceed with this proposed method to stimulate these cholinergic 
afferents with a view to eliciting mAChR-mediated synaptic responses in the CAl 
interneurone population (chapter 4).
Chapter 4 provided the first direct evidence that stimulation of cholinergic 
afferents elicit a slow depolarisation in CAl GABAergic interneurones. In 
contrast to the response observed in pyramidal neurones, which was a stereotyped 
slow depolarising response, evoked cholinergic responses in interneurones showed 
great heterogeneity with respect to the resultant underlying waveforms and 
discharge patterns. A variety of mAChR-mediated responses were elicited in CAl 
interneurones including a slow depolarisation, a delayed response where an initial 
hyperpolarisation preceded a slower depolarisation, a fast plateau response where 
a fast and slow depolarisation were present, an oscillatory response and finally, 
interneurones which did not respond to cholinergic afferent stimulation at all. All 
of these response types, with the obvious exception of the non-response, were 
attributed to activation of inAChR receptors. As such, this study extends current 
knowledge of mAChR mediated synaptic transmission within the hippocampus 
and is summarised in figure 6.1.
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Figure 6.1. S um m ary o f evoked cholinerg ic  responses in pyram idal neurones and  
in terneurones in area C A l o f the h ippocam pus.
CA1 pyramidal neurones respond to stimulation of cholinergic afferents located within the 
stratum oriens with a stereotyped slow EPSP whereas the interneurones of area CA1 
respond with a range of EPSPs including a slow depolarisation, a delayed response, a 
fast plateau response, an oscillatory response or finally no response.
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The fact that the interneurone population shows diversity in their mAChR 
mediated response rather than the uniform response observed in pyramidal 
neurones provides a further level of diversity to the interneuronal population and 
suggests fuither complexity to interneuronal function and their control over the 
principal cell population. However, a more detailed anatomical study of the 
responsive interneurones may provide a clearer view, although previous studies 
have failed in this respect (Parra et a l, 1998; McQuiston & Madison, 1999a).
Although one type of response contained a fast component that was not fully 
abolished by selective mAChR antagonists, the precise identity of the fast 
component could not be established. One likely possibility is that this may have 
been due to released ACh activating nAChRs as previously reported (Alkondon et 
al, 1998; Frazier et a l, 1998a). However, in the previous studies which have 
shown the production of a nACliR-mediated response in CAl interneurones 
(Alkondon et a l, 1998; Frazier et a l, 1998a; Buhler & Dunwiddie, 2001), the 
responses were evoked via a single stimulation within the stratum oriens. Buhler 
and Dunwiddie (2001) showed that these synaptic responses were inhibited if a 
train of stimulation at lOHz was used. This is in contrast to the mAChR-mediated 
responses evoked in this study, which were instead potentiated upon delivery of a 
train of stimuli. This may suggest that differential signalling from the MSN may 
be able to evoke a predominantly nAChR mediated or a predominantly mAChR 
mediated response, depending upon the precise input pattern. When septal 
cholinergic neurones fire at relatively low rates nAChR-mediated responses will
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predominate, whereas when the septal cholinergic neurones fire at higher rate a 
mAChR-mediated response may predominate.
As hoth mAChR and nAChR activation has been shown to be involved in 
generation and patterning of network activities in the hippocampus and that 
addition of GABAa receptor antagonists abolished hippocampal theta-mode 
activity (Cobb et a l, 1999), the activation of mAChRs and nAChRs on 
hippocampal interneurones by ACh released from cholinergic afferents from the 
medial septum may mediate down stream phasic inhibition of pyramidal neurones 
contributing to the generation and maintenance of hippocampal oscillatory states.
Many septal neurones including putative cholinergic neurones fire in vivo at theta 
(4-12Hz) frequencies (Stewart & Fox, 1990; Brazhnik & Fox, 1999). The 
rhythmical activity of septal cholinergic neurones may be able to preferentially 
activate inACliRs on hippocampal pyramidal neurones and interneurones to 
initiate and sustain hippocampal oscillatory states. However, there is no direct 
evidence that the septal activity must be phasic and not tonic in order to induce 
hippocampal oscillatory states. The role for nAChR may be more complicated 
depending on the receptor subtypes involved.
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6.2. Neuromodulatory role of nicotinic acetylcholine receptors
The second study (chapter 5) concentrated on pharmacological activation of 
nACliRs in both pyramidal neurones and interneurones. The main focus was to 
look at the neuromodulatory role of these receptors rather than their role in direct 
ACh mediated fast synaptic transmission. Chapter 5 provided a detailed analysis 
of the effects of nAChR activation in modulating both glutamatergic and 
GABAergic synaptic transmission. The results confirmed that nAChRs are able to 
modulate the release of both neurotransmitters but showed that this modulation 
may be both regional and cell specific.
The data presented in this thesis shows that activation of presynaptic nAChR 
increased the frequency of mEPSPs onto CA3 pyramidal neurones but not CA3 
interneurones, indicating an increase of glutamate release onto CA3 pyramidal 
neurones but not CA3 interneurones. Thus nAChR activation acts to produce an 
overall excitation in the CA3 region. However, in the CAl region the outcome 
seems more complicated in that nAChR activation seems to have no effect on 
evoked fEPSPs or mEPSCs measured in CAl pyramidal neurones but activated an 
inward current and increased the frequency of sIPSPs in CAl interneurones. 
Analysis of the TTX sensitivity of these effects suggested that nAChR agonists 
appeared to act on somatic, dendritic or preterminal nAChRs located on CAl 
interneurones to produce an inward current and thus excite certain CAl 
interneurones to produce an action potential dependent release of G ABA from 
these cells. The ultimate outcome of this nAChR activation will depend on the
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postsynaptic target of the interneurone under study. As we have no detailed post- 
hoc neuroanatomical data for these results we are unable to conclude which 
interneurone subtype responded with an inward cuiTent and which subtype did not. 
However, as nAChR activation seems to produce an increase of GABAergic 
IPSPs onto other CAl interneurones hut not pyramidal neurones this indicates that 
nAChR activation may preferentially excite the interneurone selective (IS) cells 
(Acsady et ah, 1996a; Acsady et ah, 1996b; Gulyas et ah, 1996) and evoke an 
action potential dependent increase in release of G ABA onto other hippocampal 
interneurones. Although we did not observe any concomitant decrease in IPSCs 
recorded in pyramidal nemones as might be expected from such a disinhibitory 
mechanism, it is likely that the pyramidal neurone terminating interneurones may 
be silent in brain slices and that such activity would only be seen in a dynamically 
active network.
6.3. Sum m ary
The seemingly complex actions of the cholinergic system within the hippocampus 
is summarised in table 6.1. Cholinergic effects demonstrated throughout this thesis 
together with complimentary observations/citations are indicated in order to help 
build up a more complete picture of the way by which ACh modulates 
hippocampal circuits
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Pyramidal neurones:
Excitability-
Glutamatergic transmission- 
Interneurones: ,
. .  . . T
ExcUability-
GABAergic transmission-
MAChR I p ' I ^ A C h R
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f 3 or <r^
tVor^V
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T ab le  6.1 S um m ary o f the  cholinerg ic  m odulation  o f h ippocam pal system s.
Table sum m arises the effects of mAChR and nAChR activation on both pyramidal 
neurone and interneurone excitability and the effect on glutamatergic and GABAergic 
transmission within the hippocampus. Activation of mAChRs can lead an excitation of 
pyramidal neurones whilst at the sam e time resulting in a direct inhibition of glutamate 
transmission. Activation of nAChRs has no effect on the excitability of pyramidal neurones 
but can facilitate glutamate transmission at certain synapses. Activation of mAChRs can 
produce a variety of responses in hippocampal interneurones ranging from excitation to 
no effect to hyperpolarisation. mAChR activation also leads to an inhibition of GABAergic 
transmission. Activation of nAChRs can lead to an increase or no change in the 
excitability of hippocampal interneurones. nAChR activation also appears to increase 
GABAergic transmission at som e synapses.1. Effect confirmed in chapter three, 2. Effect 
confirmed in chapter four, 3, Effect confirmed in chapter five, 4. Frazier et al (1998b), 5. 
McQuiston and Madision (1999a), 6. McQuiston and Madison (1999c), 7. Behrends and 
TenBruggencate (1993).
230
6.4. F u t u r e  r e s e a r c h
This thesis has highlighted the complexity of interactions between the cholinergic 
and GABAergic systems and their ultimate influence over the principal cell 
population. However, a number of important questions remain unanswered 
including:
>  What precise types of interneurone are differentially modulated by ACh?
> How does such differential modulation effect somatic vs dendritic 
inhibition and ultimately hippocampal network dynamics?
> Are mAChR-mediated and nAChR-mediated responses differentially 
recruited depending upon the firing pattern of cholinergic afferents?
> How do intrinsic cholinergic neurones (Frotscher et a l, 1986; Frotscher et 
a l , 2000) modulate hippocampal circuits?
>  How does hippocampal activity feed hack to affect septal activity?
6.5. T h e r a p e u t i c  i m p l i c a t i o n s
As the hippocampus is a prominent region of the brain affected by numerous 
neurological disorders (Hyman et a l, 1990; Schwartzkroin, 1994) Further 
advances in understanding how different neurotransmitters interact within this 
structure will ultimately aid designing therapeutic strategies to combat dysfunction 
in such interactions.
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In Alzheimer’s disease in which there is a dramatic loss of cholinergic function 
(Kasa et al., 1997), greater knowledge of how ACh normally regulates 
hippocampal function might aid the development of targeted and rational attempts 
to compensate for such imbalance.
The hippocampus is also one of the most seizure prone structures in the brain 
(Schwartzkroin, 1994) and we have demonstrated that nAChR activation has 
proepileptogenic actions in this structure (Roshan-Milani et a l, 2003). Again, the 
nAChR specific pharmacology of this response will perhaps aid in determining 
future strategies to influence network pathology unbalances such as occurs in 
epilepsy. Indeed, the very specific cholinergic modulation of certain circuits might 
present a more selective scope for intervention than the currently used 
antiepileptic drugs which cause a rather general and non-selective suppression of 
neuronal activity resulting in unwanted side effects.
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